header
string
sequence
string
class
string
mechanism
string
type
string
label
int64
MEG_8737|Drugs|betalactams|Class_B_betalactamases|VIM
ATGTTCAAACTTTTGAGTAAGTTATTGGTCTATTTGACCGCGTCTATCATGGCTATTGCGAGTCCGCTCGCTTTTTCCGTAGATTCTAGCGGTGAGTATCCGACAGTCAGCGAAATTCCGGTCGGGGAGGTCCGGCTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCAGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAGAAGCAAATTGGACTTCCTGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGTAGAGGGGAACGAGATTCCCACGCACTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAACTCTTCTATCCTGGTGCTGCGCATTCGACCGACAACTTAGTTGTGTACGTCCCGTCTGCGAGTGTGCTCTATGGTGGTTGTGCGATTTATGAGTTGTCACGCACGTCTGCGGGGACCGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCATTGAGCGGATTCAACAACACTACCCGGAAGCACAGTTCGTCATTCCGGGGCACGGCCTGCCGGGCGGTCTAGACTTGCTCAAGCACACAACGAATGTTGTAAAAGCGCACACAAATCGCTCAGTCGTTGAGTAG
betalactams
Class B betalactamases
Drugs
1
MEG_8742|Drugs|betalactams|Class_B_betalactamases|YEM
ATGTTAAAAACAATATTACAATTTTTTGTTTTATTCACTGTAACTCAAGGTGCTTATGCATCTAAAATAGCATTGGTAAAATTAAGTGATAATCTTTATGTTGTCGAGGACGACTATTATTACAGAGAAAACTCCATGGTTTACATTGGTAAAGACTATATTACCGTTATTGGTGCCACCTGGACACCGGATACAGCTAAAGAATTAGATGCGCAAATCAAAAAAATAAGTAAAAAACCCATCGCTGAAGTTATCAATACCAATTATCATACGGACAGGGCCGGTGGTAATTTATATTGGAAAAGTATTGGTGCTGAATTGATTTCTACCAAAATGACGTATAATTTAATGGAAAAACATTGGCAAGATATTCTTGAGACTACCCGTAAAGGGTACGATGGCTTCCCTGATATTCCCCTTGTTTTGCCGACAAAGACTTTTGATAATAACTTTGAACTACAAAATGGCGAGATAAAAGCTATCTACACAGGTGAATCTCATACTCCTGACGGAATATTTGTTTATTTTCCGAAGGAAAAAACCTTATATGGAAATTGCATAATTAAAGAGAAATTAGGTAATTTGGCCTCTGCTAATATAAAGGAGTACCCTAAGACCTTACAGAAACTTAAAAATTTAAATCTCGATATAAAGACAGTTGTCGGTGGTCATGACTCACCAATACATGGTTCCGAACTTATCGATAGCTATAAAAAACTAATCGAAGCCGCTAATAAGTAA
betalactams
Class B betalactamases
Drugs
1
MEG_8273|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|NORC
ATGAATGAAACGTATCGCGGGGGCAACAAGTTAATCTTAGGTATTGTATTAGGTGTTATTACATTTTGGTTGTTTGCACAATCACTTGTAAATGTTGTGCCAAATTTACAACAAAGTTTTGGTGCAGACATGGGAACAATTAGTATTGCGGTAAGTCTAACCGCACTATTTTCAGGCATGTTTGTTGTTGGAGCAGGCGGCCTAGCAGATAAAATTGGACGCGTGAAAATGACAAATATCGGCTTATTATTAAGTATTATTGGTTCAGCATTAATTATTATTACAAATTTACCAGCATTGCTAATTTTAGGCCGTATTATACAAGGCGTATCAGCAGCGTGTATTATGCCTTCCACATTGGCCATTATGAAAACTTATTATGAGGGTGCTGAACGTCAGCGTGCCTTAAGCTATTGGTCTATCGGTTCTTGGGGTGGAAGTGGTATCTGTTCACTCTTCGGTGGGGCAGTTGCGACAACTATGGGTTGGAGATGGATTTTCATCTTCTCAATCATCGTTGCCGTACTTTCAATGTTACTCATCAAAGGGACGCCTGAAACGAAATCAGAAGTTACCAATACACATAAATTTGACGTTGCAGGTCTAATTGTTCTAGTAGTTATGTTATTAAGTTTAAACGTTGTCATTACTAAAGGTGCAGCACTTGGTTATACATCATTATGGTTCTTTGGTTTGATTGCAATCGTAATTGTAGCATTCTTTATTTTCTTAAATGTTGAGAAAAAAGTAGATAATCCGCTTATTGATTTTAAATTATTTGAAAATAAACCATATACAGGTGCAACGATTTCGAACTTCTTATTAAACGGTGTTGCAGGTACATTAATTGTAGCGAATACATTCGTACAACAAGGTTTAGGTTATACAGCATTGCAGGCAGGATACTTATCAATCACTTATTTAATCATGGTGTTATTGATGATTAGAGTTGGTGAAAAATTATTACAAAAAATGGGTTCTAAGCGACCAATGTTATTAGGTACATTCATTGTGATCATTGGTATTGCACTTATTTCATTAGTATTCTTACCAGGCATATTTTATGTTATCAGTTGTGTCGTAGGATATTTATGTTTTGGACTAGGCTTAGGTATTTATGCAACACCTTCTACAGATACAGCTATTTCAAATGCACCGTTAGATAAAGTTGGCGTTGCTTCAGGTATTTATAAAATGGCTTCATCACTTGGTGGTGCATTCGGTGTCGCAATTAGTGGTGCAGTATATGCCGGTGCAGTTGCTGCAACGAGCATTCATACAGGTGCGATGATTGCACTTTGGGTTAACGTATTAATGGGAATCATGGCATTTATCGCAATTTTATTTGCGATTCCTAATGATGATAAACGTGTCAAAGATGCGAAATAA
Drug and biocide resistance
Drug and biocide MFS efflux pumps
Multi-compound
1
MEG_8241|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|MDE
ATGACGAAACATTTACAAGATTTTTTAATAACAGTTATCGCAGGTATGGGAATGTTATTATCCACCCTTGATACAGGTATTATCAATGTTGCATTATCCTTTTTGAGGGGACAATTTCAAACCACAACTAACATTGCCTCTTTTACAATAACTGGATATACTTTAGCATTAGCTATCTCTATCTTACCTTTAGGAGTATTAAGCGATAAATTTGGAAAGTTAAAGATTTCCTACTTAGGATTTGTACTTTTTGGACTGAGCTCCTTATTTTGTGGATTTGCTAATAGTATTGGCTGGCTCATTACTGGCCGGATTATTCAAGGAATGGGAGCGGCGGCTTTGCAAGCTACTTCAGCAGCTCTGATTACCACTTTAGTTTCCGAAGACCGCAAAAACAGTGCTATTAGTATTTTAGGAGTTATGATTGGCTTAGGACCTGTCCTCGGTCCTTCCTTAGGAGGCATACTACTTTCTTTAAATCTCTGGCGCTTTATTTTCTGGATTAATGTTCCCTTTGCTCTTATTGTCATCATTTGTAATCACTATCTCCTTACTAAAGTCTCCGAACAAACTAGTGAGTGGACATTAGATTCTCTTGGAACAGTTCTCAATGCTTCTATGTTGGTTTGTCTTCTCTTAGGACTATCCTTACTCAGTAAGCCTCACCTATTAGGTATCAGTCTTATTTTGATCATCATTAGTTTCTTGATCGGGATTTGGTTTTACCGTCTTGAATGCAGCAAAGAGAGTGCTCTTGTCAATGTCAAGGGGCTGAGCGAGAATCCTCGAGTACTTTCTTATCTTTTTCAAACGGTCGCTTTTGGTTTTGCCTCTGCAATGATATTCTTACTTCCACCCTTCATTTTTGAACAATTATATCATTTAGGAGTGGGGCAGACAGGCTTTCTTGTACTAGGAGCACCTGCAGGCCTGGTTCTTTTTTCAAGAATATCTGGTAAAATCAATGATGGCAGTAAAAATAAATCATTTAGCCATATTGGTTTGGGTATCATTATTTTATCCTTAATTTTCCTCCTACTTCTCACGCCTAGCTGGCCCTATTTATTCTTAACTTTAGGATTATTTATTTATGGTATTGGCGGAGGATACTTTCAGCCTGCTAATATGGCTAGTATTATGCTAGCTAGTCCTATGAAAATGCAAGGTAGCACAGGAGCATTGCAACGAATGGTACAAAACATTGCTATTTCAGCTGGTTCAGCCATTGGATCAACTTGCTTAAACCTTTGGTCAAATAATCTATTATTGGCTACCCGAATTGGCTGGGGAATTACACTCGTTCTAGTTATTCTCAGTTTAAAAGAACTAACACCATTTAAAATGACTAATAAAACAGAATAA
Drug and biocide resistance
Drug and biocide MFS efflux pumps
Multi-compound
1
MEG_8693|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_pumps|SEPA
ATGATTGTGAACTTTTTCAAGCATAAATTTTATAATTTATTAACTACAATGATTGTTCTCTTTGTGTTTGTGTTGTCCGGTGCAATTTTTTTAACATTTCTAGGTTTTGGACTTTATGGTCTTAGCAGGATACTTATATACTTTAGGTTAGGTGATTTCACGTATAATAGAAATATGTATGATAATTTATTGTATTACGGTAGTTATATCATATTTGGTTATTTTATCATTTTTGCAGTCGAACATTTAATGGATTATTTTAGAAAGATGCTTCCTGAAAATGCATATTTTAGAGGAGCAACATTCCATTTAATATCTTATACGGTTGCTACTACATTATTTTATTTCATTATTCATTTACATTATGTGTATATTAATATTGATTTTTGGGTCATCATGGTAATCATAGGCTTTCTTTATGTATGTAAACTTCAATTTTACCCTGAAAGTAAAAATCTCAATAATAGAAAATAA
Drug and biocide resistance
Drug and biocide RND efflux pumps
Multi-compound
1
MEG_8692|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|SDRM
ATGCGATTAAAGTCAATCATAACTGTTATAGCTTTAATATTAATTATGTTTATGTCAGCGATTGAATCATCTATTATTTCGCTTGCATTACCTACAATTAAACAAGATTTAAATGCAGGAAATTTAATTTCATTAATTTTTACAGCGTATTTTATCGCATTAGTAATTGCCAATCCTATAGTGGGAGAATTACTTTCGAGATTTAAAATTATTTATGTGGCAATTGCAGGATTACTTTTATTTAGTATAGGTAGTTTTATGTGTGGTTTAAGTACTAATTTTACTATGCTAATTATATCACGCGTGATACAAGGTTTTGGATCAGGTGTATTGATGTCATTATCGCAAATTGTTCCAAAGTTAGCATTTGAAATTCCGTTACGATATAAAATTATGGGCATAGTTGGCAGTGTTTGGGGTATTTCGAGTATCATTGGACCGCTTCTAGGTGGTGGTATATTAGAATTTGCAACATGGCATTGGTTATTCTACATAAATATACCGATTGCGATCATTGCCATTATATTAGTTATATGGACATTTCATTTTCCAGAGGAAGAAACAGTTGCTAAATCAAAATTTGATACTAAAGGGCTCACGCTATTTTATGTATTTATTGGATTGATTATGTTTGCTTTATTAAACCAACAGCTATTACTTTTAAATTTCTTGAGTTTTATCTTAGCTATCGTTGTGGCAATGTGTTTATTTAAAGTAGAAAAACATGTTTCTTCACCATTTTTACCTGTGGTTGAATTTAATCGTTCGATTACTTTAGTTTTTATAACGGACCTTCTAACAGCTATTTGTTTAATGGGATTCAATTTATATATTCCAGTCTACCTTCAAGAACAACTAGGATTATCTCCATTGCAAAGTGGATTGGTTATTTTTCCTTTATCTGTAGCTTGGATTACATTGAATTTTAATTTACATCGAATTGAAGCAAAACTATCAAGGAAAGTTATTTACTTACTATCATTTACATTGTTACTAGTAAGTAGTATTATCATTTCATTTGGTATTAAATTGCCGGTACTTATAGCATTTGTGTTAATTTTGGCAGGATTAAGTTTTGGATATATTTATACGAAAGATAGTGTAATTGTCCAAGAGGAAACTAGCCCATTACAAATGAAGAAAATGATGTCATTTTATGGATTAACTAAAAATCTTGGGGCATCAATAGGTTCAACAATAATGGGATATCTTTATGCGATACAATCAGGAATCTTTGGTCCAAACTTACACAATGTGTTAAGTGCTGTTGCTGTAATTAGCATTGGGCTTATTGTTTTATGGGTCGTATTTTTTAAAGAACAGTCATCTCAATCAAAAGAATAG
Drug and biocide resistance
Drug and biocide MFS efflux pumps
Multi-compound
1
MEG_8628|Drugs|betalactams|Class_B_betalactamases|PFM
ATGAAGCTTATTAATATTCTGTCAGTCATCAGCCTGGCCTGCATTACCTCCCAGGTCTTCGCTAACAAGAGTGACTTGACCCTTACCCACTTCAAAGGCCCGCTCTACATCGTTGAAGACAAGGAATATGTGCAGGAGAACTCAATGGTCTACGTTGGCGAGCAACACATCACGGTTATTGGCGCAACCTGGACCCCAGCCACCGCTGAAAAGCTTGAGCAGGAAATCAGGAAAATCAGCCCCCTGCCCATCAAGGAGGTGATCAATACCAACTACCACACCGACCGCGCGGGAGGTAACGCCTACTGGAAGAAGCTCGGCGCCAGTATTGTCTCAACGCAGATGACCTATGACCTGGAAAAAAGCCAGTGGCGCAGTATTGTCGACTTTACCCGGCAAGGGATGGAGCACTATCCAATCCTGGAACAAAGCCTGCCAGACCAGGTATACCCGGGCAACTTCGACTTGCAAAACGGCCATGTTAGAGCACTGTATTTAGGCGCGTCTCACACCGAAGATGGGATTTTTGTGTACTTTCCAGAAGAGCGTGTGTTGTATGGAAACTGCATTCTCAAGGAAAAGCTGGGTAACATGACATTCGCGAATCGCAGCGAGTACCCGAAAACCCTGAAGAAATTGCAAGGGCTGATCCGCAGTGGTGAATTGCCCGTTGAAGCGATTATCGCAGGGCATAACTCACCGATACAGAACGTTGAGTTGATTGACCATTATCTGACCCTGCTTGAACACGGCGAGCAGTAA
betalactams
Class B betalactamases
Drugs
1
MEG_8267|Drugs|betalactams|Class_B_betalactamases|NDM
ATGGAATTGCCCAATATTATGCACCCGGTCGCGAAGCTGAGCACCGCATTAGCCGCTGCATTGATGCTGAGCGGGTGCATGCCCGGTGAAATCCGCCCGACGATTGGCCAGCAAATGGAAACTGGCGACCAACGGTTTGGCGATCTGGTTTTCCGCCAGCTCGCACCGAATGTCTGGCAGCACACTTCCTATCTCGACATGCCGGGTTTCGGGACAGTCGCTTCCAACGGTTTGATCGTCAGGGATGGCGGCCGCGTGCTGTTGGTCGATACCGCCTGGACCGATGACCAGACCGCCCAGATCCTCAACTGGATCAAGCAGGAGATCAACCTGCCGGTCGCGCTGGCGGTGGTGACTCACGCGCATCAGGACAAGATGGGCGGTATGGACGCGCTGCATGCGGCGGGGATTGCGACTTATGCCAATGCGTTGTCGAACCAGCTTGCCCCGCAAGAGGGGCTGGTTGCGGCGCAACACAGCCTGACTTTCGCCGCCAATGGCTGGGTCGAACCAGCAACCGCGCCCAACTTTGGCCCGCTCAAGGTATTTTACCCCGGCCCCGGCCACACCAGTGACAATATCACCGTTGGGATCGACGGCACCGACATCGCTTTTGGTGGCTGCCTGATCAAGGACAGCAAGGCCAAGTCGCTCGGCAATCTCGGTGATGCCGACACTGAGCACTACGCCGCGTCAGCGCGCGCGTTTGGTGCGGCGTTCCCCAAGGCCAGCATGATCGTGATGAGCCATTCCGCCCCCGATAGCCGCGCCGCAATCACTCATACGGCCCGCATGGCCGACAAGCTGCGCTGA
betalactams
Class B betalactamases
Drugs
1
MEG_8291|Drugs|betalactams|Class_D_betalactamases|OXA
ATGCCAAAAATACTAAAACATCTTAGCCTTTGCGCATCTGTAATGATTGGACTGACCTTGCTTGGTTGTCAAAATTTTCACGCCCCAACTCAAAGCGCCGTGTCAAAAAAACACGATCAAACCGAGATCGCTTCTTTATTCCAACATGCTCAAACTGTTGGCGTATTTGTTACATATGATGGGCAAACACTTCAAGCATATGGCAATGCGTTGAGTCGATCGAATACGGCTTATATTCCAGCCTCAACCTTCAAGATGTTAAATGCTCTGATTGGGATACAGCATCACAAAACTTCACCAAACGAAGTGTTTAAATGGGATGGCAAAAAGCGTGCTTTTGCGAGCTGGGAAAAAGATTTAACTTTAGCCGAGGCGATGCAGGCATCAGCAGTGCCTGTTTATCAGGAATTGGCTCGGCGTATCGGGTTAGAGTTGATGGCGAACGAAGTAAAACGCGTTGGCTTTGGCAATGCCGAGATCGGAACGCAAGTCGATGATTTTTGGTTGGTTGGCCCGCTTAAGATTACCCCAATTGAAGAGGTTAAATTTGCTTATGCTTTGGCAAATAAGCAGCTTGAATTTGACCAATCTGTGCAAAAACAAGTGAAACAGATGGTCTTCGTTGATGAAGTTCATGGAACTAAGATTTATGCCAAAAGTGGTTGGGGGATGGATGTAACACCGCAAGTGGGTTGGTGGACGGGCTGGATTGAACAACCGAATGGACAGGTGATTGCATTTTCTTTAAATCTGGAAATAAATAAGCCTGAGCACGGTGATGCGCGTAAAGCGATTGTTTATCAAGCATTACAACAATTGAAATTGTTACAGAAGCAATAA
betalactams
Class D betalactamases
Drugs
1
MEG_8688|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALB
ATGCTATTTTTATTTGAAGAAAAACCATTAGAAATTGAGAATAAACAGCTTATAAAACGTTTGTCATTTCATATCGAAGACCATGAGCATTTAGCCCTTATCGGTGTTAATGGTATTGGTAAATCTACGCTATTACATCATATTCATAAAAATGAATTGATTGATACAGCTATGATGGAACAAGATTTAAGTAAACATGATGATATTGATGTTATGGATTATGTCATGTCTGCATATCCAAAGTTAGTTGAATTGAGAAAAGATTTATCTGACATTGATTCTTTAAATAGTTATATAGAATTAGACGGATATAACGTTGAAAATAACATTATTATTGAAGGAAATAAATTAGGATTATCATCAACACATTTTGAGCAAAAGATAGGCACTTTAAGTGGTGGTGAGCAAACTAAAGTCTCATTTTTAAAAGTTATTTTATCAGATGCACCATTATTATTAATAGACGAACCAACTAACCATATGGATAAAGAGATGAAAGTGTGGTTAATAAAAGCTTTTAAATCAGAACAAAGAGCTATTCTATTCGTATCGCATGATAGAGAGTTTTTAAATGAAACACCAGATGCTATTTTAGAACTCACAAAAGATGGTGCAACTCGATATTCAGGTCATTATGATGATTATAAAAATCAAAAAGATATTGAAATTGAAACAGAAAAATTAAAATATGAAAAAGAACAGAAAGAACAAAAAGCAATAGAAGAAAGTATTAAGAAATACAAAGAATGGTATCAAAGGGCTGCTCAGAAAGCTTCTGTTCGTAGTCCATATGCTCAAAAACAATTAAGTAAATTAGCTAAAAGATTTAAATCAAAAGAACATCAGTTAAATCGTAAATTAGAAGAATCAAAATCTGATAATCCGTTAGAAGAAAATAAATCCTTTTCTATAGAAAATAATGAATTTAAATCACATTATTTAGTAAGATTCGAAAATGTTTCATTTTCATATAAGAGTCGTGAAATTTTTAAAGACACTTATTTTGAAATAAAGAGAAATCAAACTGTAATTATAGAAGGTAAAAATGGGTCCGGTAAATCTACATTGATACAATTAATTTTAGGTAACTTATTACCAATGAGTGGAGCTGTCAAAAAGCACCCAGACTTAGACATAGGATACTTCTCGCAAGATTTTCAAAATTTAAACCCAAACAACTCGGTATTAGAAGAAGTTATGGATATTGAGAATATGATGATAACAGACGCGAGGACTATTTTAGCGAGTTTTTATTTTGATAAGAGCAGGATGAATGATAAAGTTCGTCAGTTATCAATGGGAGAAAAGTGCAGGTTACAATTTGTAAAATTATATTTTTCTAACCCACACATCTTAATTTTAGATGAACCAACTAATTATTTTGATATTAGTATGCAAGAGAAAATCATACAATTAATCCAAAGTTTTAATGGTGCAGTAATTATTGTGTCGCATGATGAAATTTTTAAAGATGAAATAAGAGACCAAGTTTGGAAGATTGAAAACTGTAAGCTCATTCATGAAAATGTATCTATTAATACACCTATTGATGCTGAATCGATGAAGGATGAGTTAAAAATATTAGAGCAATATACAGATGAAAGAAATAAAGAAACAGACTTCTAG
Multi-drug resistance
Multi-drug ABC efflux pumps
Drugs
1
MEG_8689|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALC
ATGCTATTTTTATTTGAAAAAAAGTCTTTAGAGATTGACAATAAACTGCTCATACCTTCACTAACATTTATTATTGAAGAAAATGAACATTTGGCAATAGTCGGCATAAATGGTATCGGAAAATCTACACTTTTAAATAAAATCCATCATAAAGAAAATATTGAAACAGCAATGATGGAACAAGATTTAACTAAATATGGAACTTTAAATGTCATGGAGTATATTATGTTAACTTATCCACAATTATCATCGTTAAGAGAAAATCTAAGTGATTTGGATAATATAAATAGATATATTGAATTAGACGGTTACGAAATTGAGCAAAACATTATAATTGAAGGAAAAAAGTTAGGATTAACAGAAAGGCACTTTGATCAATTAATTTCTACTTTAAGTGGTGGTGAGCAAACAAAAGTTTCGTTTTTGAAAGTTAAATTAGATAAAGCACGATTATTATTAATTGATGAACCAACTAACCATATGGATGAAGAAATGAAAGTATGGTTAACTAATGCATTTAAACAAGAAAAACGTGCAATATTATTTGTTTCTCACGATAAGACTTTTTTAAATGAAACACCAGACGCAATTTTGGAACTGAGTAGTAGTGGTGCAACAAAATACTCAGGTCAGTATGACAATTACAAGCAACAAAAAGATTTAGAATATAAAACGATTAAGCTACAATACGAAAAACAAGAAAAAGAGCAACGAGCAATTGAAGAAACAATTAAAAAATATAAAGAATGGTATCAAAAAGCTTCACAAAAAGCTTCAGTAAGAAATCCTTATCAACAAAAACAACTTAGCAAGCTTGCGAAAAAGTTTAAATCGAAAGAATATCAAATGAATAAAAAACTTGAACAAACCAATTTATCAGATCCTGAAGAGGAAGGAAAAACATTTTCAATGCAACATCACGCCTTCAAATCTCATTATTTAGTTAAATTTAAAAATGTGACATTTTCATATAATGAAAAGCCTATTTTTAATGATGTCTCTTTTCATATTAAGCGAAATCAAAATGTTATCATTGAAGGTCAAAATGGCTCAGGTAAATCTACTTTGATCAAGTTGATACTAGGTCAACTGACACCTGATGAGGGAGAAGTAATCGTACATCCTGAATTAGAAATAGGTTATTTTTCACAAGATTTTAATAACTTAAATATGAAAAATACTGTGTTAGAAGAAATAATGTCTATTCAAGAAATGAAAGAAGCGGAAGCAAGAACAATTTTAGCGAATTATTATTTTAATGAAAATAGAATTAATGATGTTGTTGCCAATTTATCTATGGGTGAAAAATGTAGAATACAGTTTGTTAAATTGTATTTTTCAAATCCACATATACTCATATTAGATGAGCCAACTAACTATTTTGATATTGAAATGCAAGAAAAAATCATACAATTAATTCAATCTTTTCAAGGATCAACACTTATCATTTCACATGATAAATATTTTAAAGAAAAGCTTAAAGATCAAATTTGGACAATAAAGAATCTAGATTTGGTACATGAAAATCTTAAAATTGAGAATCCATTAAATGCTGATTCTATTAAAAATCAATTAAATGAATTAGAGCAATATACCGACGAAAGAAATAGAGAAACAGAGTTCTAG
Multi-drug resistance
Multi-drug ABC efflux pumps
Drugs
1
MEG_8690|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALD
ATGTCTTTTTATTTTACAGAAAAGCCATTTGAAAGGTTCGGCAAGACATTAATAGAAGAGGTTAATTTAAGTGTTGAACCAGGTGAACATATAGCAATTGTTGGTGATAACGGGGTAGGTAAATCAACATTACTCAATGCAATTTACAATAAATATAATGATTCAACGTATTTGATGGATCAAGAATTATCGAAGTATAAAAATGAAACGGCAATAAATTATATTATGTCGTGGTATCCAGAATTATTAGATATTAAACTTGCTATGCAAACTGATTATGAAAAAATTGGTGACTATATAGAACTTAATGGATATGAAATAGAAGAACAAATCATTTTACAAGCAAAGCAATTAAATTTAGAAGAGTCAGATTTAGATAAACAAATGGGGCAGTTAAGTGGCGGACAACAAACCAAAGTAGCATTAGTTCGAGCAATGATTTCAGAAAAAAATTTAATCTTGTTGGATGAACCAACAAATCACTTAGATAAACAAATGATTCATATTGTCGTGGATTATATAAAGCAAGCAAAGCAAAGTATATTATACGTGTCACATCATAGAGGATTTATCGACGAAACTGCAACGCACATTATTGAAATTACACCACAAGCTACAAGAAAATTTACTGGTAATTATAGTCAATATAAATCCATTATAGATGTTGAAAGAGAAACTCAAAAAAAGGTATACGAGAAAAAGCAAAAAGAAATAAAAGCTTTGGAAGCAACCGTAGATAGAGTTAAAAATTGGCATAAAACTGCGAATCAATCTGCAAGTGTTCGTAATCCGTTAGAGCAAAAGCGTTTGAGTAAATTAGCTCAAAAGGCAAAGGTTAAAGAATCACAAATAAATCAAAAACTTGAAAAGATTAAAGTCCAACAGCCTAAGTCGGATGATCGTCACTTCCATTTTGAGAATCAAGATGCGCTAAATAAAAAATATTTAATGCAATTATATGATTTTAGCATCACTATTGATGGTAAGAATATTTATCAAAATGCAAATTTCGAAATTAAAGATAATGAAAACATTATACTTACTGGCCCGAATGGTAGTGGCAAATCATTATTAATCTCAATTATCAAGCAGTCAATAATACCAGATGAGGGTGATATTTATATAACGCCTTCTCTAAAAATAGCTTATTTTGACCAAAAAAATGACAATTTAAATTATGACAGCACAGCATTAACAATGTTATTAAACATGGAGGGTATGGAACGTAGTCAAGCACAAACGATATTAGCGTCATTTGGATTTGATAACCAAAAAATAAACCTTCCAATTTCTCAATTATCTATGGGAGAGAAAAGTAGATTACAGTTTGTATTATTATATTTCTCAAATCCACATTTATTAATTCTCGACGAACCAACCAATTACTTCGATATTGCTACGCAAGATTTAATATTACAGATGCTAAAGCAATTTGCAGGACAAGTAATGATTGTGACGCATGATGAATACTTGAAATCTCAAATTACAGCGACACATTGGACAATTAAAGATAAAAAGTTAATGAATTTAACATTATCAGAGAAGCATTCACCCAATATGGTGGATGATACATTAAAATTATTAGATGATTATAAGTCGATAGATGAATTCGGACATTTTGAAACAGACAACTAG
Multi-drug resistance
Multi-drug ABC efflux pumps
Drugs
1
MEG_8691|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALE
ATGTCTTTTTATTTTGCCCAAAAACCTTTTGAAATGTTTGGAAAAACACTGATTCAGTCAGTGGATTTACAATTTGAAAAGGGTGAACATATTGCTGTGATTGGTAATAATGGCGTTGGGAAAACGACTTTATTAAAAGCATTAAATAATAAGTATAAAGAAGATACTTATTTGATGGACCAAAACATGACTACCTTTGGAAACATGACGGGGATAGACTATGTAATAAGCTTAAACACAGAATTGTTTCATTTAAAACAAGCGTTAATGGATAACTATGAAAAAGTTTCAGATTATATCGCTTTAAATGGCTATGAATTTGAACAAACCATTATAACTAAAGCGAAGCAAATGGCTCTAACGGAAGCAGATCTTGACAAACCAATTAAAGTATTAAGCGGCGGCCAACAAACTAGGCTTGCTTTATTGAGAGCATTTATTTCAAACAAACCATTGATATTGCTGGACGAACCAACCAATCATTTAGACCAAGAAATGATAGACCAATTGATTAACCATATACAACAATCAAAACGCACAATCATATATGTGTCGCATCATAGAGGATTTATAGATCAGACCGCGAGTCATGTTATAGAAATAACACCCGAAAGTACAAGAAAATTTAATGGCAATTATAAGCAATACAAAGAGATAAAAGATTTAGAAAGTCAAACAGAACAACGTATATATAATAAACAACAAAAAGAAATACAAGACCTCGAACGTACGATCAAACGCGTACAAACATGGCATCATTCTGCTCAGCAAAAAGCAAGTGTACGTAATCCGATTGAACAGAAAAAGTTGAGCAAATTAGCGCAAAGGGCAAAGGTGAAGGAAAAACAATTAAACCAAAAATTACAAGAAAAACATATTCAAGAACCGAGTAAAGAAACAAAGTCATATTACTTTAGTCATCAGACTAGCCTTCCTAAACGTTTCTTAATTCGTTTTGAAGATGTTAGCGTTAATATTGATGGACAAGCTATATATAAACACGCTCATTTTGAAATGAAACAAAATGAAAATATATTACTTACTGGTCCAAATGGAAGTGGTAAATCGCTTTTCATCGCTTTGATTAGACAGCATTTATCACCAGACGAAGGTATTATAGAGATTACGCCATCGTTAAAGATAGGTTACTTTGATCATACAAATAACAATCTAAATGAAGCAGAATCTCCATTATCAATGTTGTTAGTAAGAACTAACATAACGCGTAGCCAAGCGCAGACATTACTTGCTTCATTTAATTTTGATAAGGATCAAATCAAAAAACCAATTCGCTATTTGTCTATGGGGGAAAAAAGTCGTTTACAATTTGTATTATTATATTTTTCAGGTGCTAATTTATTAGTATTGGATGAGCCTACGAACTATTTTGATATTGTAACTCAAGATTTAATTTTAAGTATGATTCAAAGTTTTACCGGTCAAGTATTGATTGTTACACATGATTCATATTTACAATCTCAATTTAAAGCTGTACATTGGGAAATAAAAAATCAACAACTTTATAATGTATCTTTAACTCATACGCGTGAATCAAACTTAGATGAAACCCTTAAGTTACTAGGTGAATATAAATTTATAGATGAAAATGGTCATTTTGAAACAGACAACTAG
Multi-drug resistance
Multi-drug ABC efflux pumps
Drugs
1
MEG_8083|Drugs|MLS|23S_rRNA_methyltransferases|ERM52
ATGAAAAATCTTGGATATTCACAAAATTTTTTGGTTAATAAAAAGTTGGTAGAACGTTTAATAAGCAAGTCAAATATTGATGTAACAGATTATGTTATTGAAATTGGTCCTGGAAAAGGGATAATAACAGATGTACTTTCTCAGCATGCTGGAGAGGTTGTTGCAGTTGAATATGATCAAGAATTATATAATAATTTAGTAAGATATCACAGTCATGATAATGTTACATATATATTTGGTGATTTTTTAAAATATAAGTTGCCTTTAAATCGCAGATATAAAATATTCTCCAATATTCCTTTTCAGATAACAGCGGATATTATTAGGAAATTAACAGACGATGTAAATCCACCATCAGATATAAATATCATAATTCAAAGAGAGGCAGCTAAAAAGAATTGCGGTATTCCATTACAAAAATATGAAGGTTTTCGTGCTGCTATAATAAAGGCACAATATAAGGTAGAAATTACACATAGTTTTAAAAGGAGCGATTTTTTTCCTTCGCCTAATGTTGATACAGTTATGCTTCATATGCAGTTATGGGATGATAGATTGAGTGGTGATGATCTTCAAAATTATAAAGATTTAGTGGCTTTTTTTTACACTAATATTAAAGGAGAGACTGCTAAAGAGAGACTTTCTATTTTATTTTCTAATGAGCAAATCAAAAGATTGGGAAAAGCCAATAGAATTAGTCTTTCAAATTCATATACGTTAATCACGGCCGAGCAGTGGATGAATATTTATTATTACTCCAAAATTGGATTGACAGATGAAAAGAAAAAAAAGTTTCAAGATGCATATAAAAAACTTCAAAAAATGAATAAAAAATTGAAAAAGCAAAACAGAACATCTTTACGAAAGTCTAGTAGCAATAAGAAATGTAGAACAAGGATTGATACTTCTAATGGTACAAAAAATAGATAG
MLS
23S rRNA methyltransferases
Drugs
1
MEG_8259|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRG
ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTATGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGTTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCAGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGATTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA
MLS
MLS resistance ABC efflux pumps
Drugs
1
MEG_8262|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRL
ATGGAACAAATTTGTTTTGAATTAGAAAAAATTGAAGTAACTTATTTAGATAAAAAAGTATTAGAGATAGATCGTTTAGCAGTTCATCAATTTGATAGAATTGGTATTGTTGGAAAAAATGGTGTTGGTAAGAGTACTCTGCTAAAATTACTTGCAGGTCATATTCAACCTACAGTTGGAAAAGTAAAGCGTCAAGTAGAATATGGTTATTTTGAACAGGTAGAAGGTCCTAAAGATATATCAACAGATCCTAAGTTACTTAGCCAATTACATGTTGATGAGAATTCGAAAGGGCTAAGTGGTGGTGAACAAACAAGATTAAAACTTGCACAGTTATTTACGGACTATTATGAATCTTTATTAATTGATGAGCCAACTACACATTTGGACCAAGAAGGTATATCATTTTTAATAGAAGAGTTGAAATACTATTATGGGGCACTGGTATTAATAAGTCATGACCGATATGTTTTAGATGAACTTGTGACTACAATTTGGGAAGTTGATGATGGGAAAGTAAAAGTATATTCAGGAGATTACAGTGAATATATCGAGCAAAAGAAACTTGAAAGATCAAAACAAACTCAGGCTCATGAACAGTTCTTAAAGGAAAAAAAACGTTTAGAAAAAGCAGCAGAAGAAAAAATGAAAAAAGCAGAAAAAATTGCTAAATCTTCTGCTAAATCAAAAGACTCTAAAGTAAAAGCAAATCGTATGTTTGAATCAAAATCAAAGGGTACAACTCAAAAAGCGTTACAACGTGCTGCTAAGGCTGTTGAACAAAGAGTAAAAAAACTTGAAGTTATAGATGCGCCTAAAAAAGAACAAACTATCCGTTTTCATCAAACAAATATCATACTTGAGTTACATAACAAGTTTCCAATTATGGCTGATCAATTAACGATTACAGTAGGAAATAAGATACTTTTAAACAATGTTAACTTTCAATTTGCATTAGGTGAAACGATTGCTATTACTGGTAAAAATGGTTCTGGGAAATCAACATTAATTCACCACATATTACAACGTGAAAAAGGAATTACTATTTCTCCAAAGGCTGTTATAGGCTCTTATGAGCAGATGGGATATCAATTTAAAACTGATGAAACTGTAATGGACTTTATGAAAAATAGAAGCGATTATGGAGAAAGTAAAATACGTTCTGTACTATATGCTATGAGTTTTACTGGGAATGATTTAAAAAAGAGTGTTCAAAAATTAAGTGGTGGCGAGGCGACTCGTTTAGTCCTATGTCAATTATTTCTAGGAAGATACAACGTTTTGATTTTAGATGAACCTACTAACTTTTTAGATGTTTTTTGTATTGAAGCTTTAGAAACATTTTTAAAAGGCTATGAAGGAACAGTTATACTAATATCACATGATAAAACATTTTTAGATCGTGTAGCTGATAGTGAATACGTTCTAGAAAATCAGAACCTTAAAAAAAATAGATAG
MLS
MLS resistance ABC efflux pumps
Drugs
1
MEG_8244|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFF
ATGAATAATATGAATTGGAAACGGAAATTTATTGCGATTTTTACAGGGCAGTTCTTTTCACTATTAAGCAGTGCTGCTGTTCAATTTAGTATCATTTGGTGGTTAACAGATACATCAGGAGGTTCTCCACTGATTTTAACATTAGCAGGACTGGCTGGATTTATGCCACAAGCATTGTTAGGTCCTTTTGCAGGAACTATTACTGATCGTTATTCACGAAAAGTGATTATGATAATTGCAGATATGACGGTTGCACTTGGAAGTTTAGCTTTATTTGTATCAATGTATTTTTATGATCCGAGTATTATATTGGTGATAATTGTATTGATCGTTCGTTCATTAGCAACTGCATTCCATATGCCGGCTATGCAAGCGTCTATTCCACTAATAGCCCCAAAAGAGCATTTGACAAAAGTTTCTGGATGGGGACAGACAGTGGCTTCTATATCAAATATTGTTGGTCCAGCAGCGGGGATGTCATTACTAGCGATAAGCTCCGTTGAGTGGGTTCTATTACTAGATGTCTTTGGGGCAGTAATTGCTAGTAGTATTTTGCTATTTATTCACATTCCAAATGTACAGAGTTCAGAAACTGTTGATTCTTCTAGTTTTATCAGCGATATGAAAGAAGGATATCATGCACTTGTAAAACATCCTGTTTTATTAAGGTTAACAGTCACGATTACGATTGTTTCGGTGCTGTATATTCCGCTAGGCACTTACTTTCCGCTTATGACACGAAATCATTTCGAGAAGGGCGTAGTTGAAGCTGGAATAATCGAAATTGTTTTTGCTGTTGGCCTCATCTTTGGTGGTATATTAATGGGGATTTTCGGAGATCGATTTGAAAAATTGAAACTCATTGTTAGCGGAATGATACTGATGGGGATTGCCTTATTCATTTCTGGCACACTTCCATCAACTTTATTCTATGGATTTATCGTAATGGCTGGTCTAGTGGGATTGTCTGGTCCATTATTTTCAGCTCCGTTTTATGCTCTTATCCAAACCGAAATTGAACCTCATTTACTTGGGAGAGTGTTTAGTTTTGTTGGAAGTTTGGCATTACTTGCAACACCGTTGGGTTACGCATTTGCTGGGGTTCTGATCCACTTAACAAATGTGGCCGTATTATTTTTGATTACAGGTATATTAATTGTATTAAATGCTGTTATCGTAAGGAAAGCAAAATAG
MLS
MLS resistance MFS efflux pumps
Drugs
1
MEG_8082|Drugs|MLS|23S_rRNA_methyltransferases|ERM51
ATGCCTACCTACAGGCCGAACAAGGGCCGTCACGAGAACGGCCAGAACTACCTCGTCAACAAGTCAATGATTAAGAAGGTCGTTGACCTTGTCCCTGTCAGTGCGTCCGTCCCGGTCATAGAGATCGGCCCGGGACACGGGGCGCTGACCTTTCCCCTCCAGGACCGTGTCCTGGCTACCGGTGGATCGTTGACCGCCGTCGAGATCGACCCGGCCTCCGTCCGGTGGCTGGAGGAGCGGCTGCGCCCGGAGGTTCACCTGTACGAGCAGGACGTCCTTGATTTTGTGCTGCCGGACGGCCCGCACGTCCTGGTGGGGAACCTGCCGTTTCACCTGACCACCGCGATCCTGCGGCACGTCCTTCACTCACCGGGGTGGACTCACGCGGTCTTCCTGGTGCAGTGGGAGGTCGCGCGTCGCCGCGCCGGCGTCGGTGGTGCCACGATGATGACAGCCCAGTGGTGGCCCTGGTTCGACTTCGAACAGCACGGGCGAATACCATCCACACATTTCCGTCCCCGCCCCACCGTCGACGCCGGTGTCCTGGTGATGCGTCGCCGGGAAGAGCCTCTCGTCAACTGGTCGGAGCGTGCGCGGTACGCGTCGTTCGTCCATGCCGTGTTCACCGGCAAGGGCCGAGGCATCGCCGACATCGTGTCCCGGGTCGTGGGGCGTCGGCGTGAACGACGGTGTGCTGAGGTCCTGCGTGAGGCCGGTGTTCCGGCAAACGCACTGCCGAAACAGTTGGACGCGGGGCAGTGGGCCACACTGTTTAAGGCCGTGGGGCGCTAA
MLS
23S rRNA methyltransferases
Drugs
1
MEG_8246|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFJ
ATGGAAAACAACAAATGGAAGCAGAAGTTTTTTGCAATATATACAGGACAATTCTTTTCACTATTAAGTAGTGCGGCCGTTCAATTTGGTATTATTTGGTGGCTAACTGATAAAACTGGTGGTTCACCATTGCTTCTAACACTAGCAGGACTTGCAGGTTTTTTACCACAAGCATTAGTAGGACCTTTTGCTGGCACGATTACAGACCGTTATTCACGGAAGTTTTTGATGATTTCAGCAGATATGACTGTTGCGTTAGGTAGTTTAATTTTATTTTTAATATTGCATTTCTATGAGGCTAATATCATTTTTGTAATTCTGATTTTAGCACTTAGATCATTAGCAACTGCTTTTCATATGCCAGCAATGCAAGCATCAATTCCTTTACTTGCCCCTGAAGAAGCATTGACAAAGGTCGCTGGTTGGGGGCAAATGGTAGCATCCGTTTCTAATATAGTAGGACCAGCTGTAGGGATGTCAATTCTTTCAGTGAGCTCAATTAAATGGGTACTACTTTTAGATATACTTGGAGCTGTAGTTGCAAGTGGGATTTTACTTTTTATAAATATACCTAAAATACAAAAAACTGAATCTGTTGAACTTACAAGTTTTTTTGTAGAAATGAAAGAAGGGTATAATGCCCTTGTTAATCATCCTATCTTGTTGAAACTTACAATACTTATGACAATCGTAGCAGTCCTATACATACCACTTGGAACTTACTTCCCACTTATGACAAGAAATCATTTTGGGAAAGGTGTTGTTGAAGCTGGTACAGTAGAGATTGCATTTGCTATCGGTTTAATAGTAGGCGGTTCATTGTTAGGTATAATAGGTGATAAATTTGAAAAAGTGAAGACAATGGCAATTGGAATGCTATTGATGGGACTGGCACTATTTTTCTCTGGTCTTCTCTCACCATCACTTTTCTTTATCTTTATAATTTTGTCCGGATTGGTTGGATTTTCAGGACCTTTATTTTCTGCACCATTCTATGCTTATATTCAAACTGAGATTGAGCCACAATTATTAGGAAGAATTTTCAGTTTTGTAACAAGTCTCTCACTTTTAGCCACGCCAATTGGATATGCATTATCTGGTTTACTAATTGAATTTACTAGTGTTTCTATATTGTTTTCAATCATTGGTGTATTAGTAATACTAAGTGGTCTTATTACTTTAAAAGTGAAATAG
MLS
MLS resistance MFS efflux pumps
Drugs
1
MEG_8724|Drugs|betalactams|Class_B_betalactamases|VAM
ATGAATTTTCTGATAAAAAATATTCTGCTCATTACTCTTTTTGTTCCTTTTGTAACAGCAGCAAACAATACAGACACTAAAACGCTGGAGGTTAAACAATTAACCGATAATATCTATCAGCATATCTCATATAAACATGTTGAGCCTTGGGGGTTTATTGGCGCGTCTGGCTTAATTGTAGTCGATGGAGATGCGGCATACCTGATTGACACTCCTTGGACGACCAAAGCAACCAATCAACTTATTGAATGGATTGAAGATAGAGGTCTCGTACTAAAAAGCGCAATAGTAACTCACTTTCATGAAGATGCGAGTGGTGATTTACCACTTTTAAATGATTTAAAAGTTAACACTTATGCCACTTCACTCACTAATCAACTTCTTAAACTCAATAACAAAGAAATTTCGAATACTGAAATATCGAGCAATGAACTCAAAATTTTCAACGGCATTGCGACAGTGTATTATCCTGGCCCAGGCCATACTGAAGATAACATCGTTGTTTGGTTACCGAATGAAAAGCTATTATTTGGCGGTTGCTTTGTTAAAAGCCTCCGTAATAAAAGTCTAGGTTACACTGGAGATGCAAATATAGGCGAATGGTCGAACTCTATTCAAAGAGTGCTGCAACGCTATCCAGATATAGTCACTGTAGTGCCTGGGCATGGTCAGGTTGGAGACGTTAGTTTACTCCTTCATACACAAAAATTAGCATCATCCGATAAGACTTCTGACAAATAG
betalactams
Class B betalactamases
Drugs
1
MEG_8236|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR
ATGATGCAGCATACTTCTGTGTGGTACCGACGCTCGGTCAGTCCGTTTGTTCTTGTGGCGAGTGTTGCCGTTTTCTTGACCGCGACCGCCAATCTTACCTTTTTTGATAAAATCAGCCAAACCTATCCCATCGCGGACAATCTCGGCTTTGTGCTGACGATCGCTGTCGTGCTCTTTGGCGCGATGCTACTGATCACCACGCTGTTATCATCGTATCGCTATGTGCTAAAGCCTGTGTTGATTTTGCTATTAATCATGGGCGCGGTGACCAGTTATTTTACTGACACTTATGGCACGGTCTATGATACGACCATGCTCCAAAATGCCCTACAGACCGACCAAGCCGAGACCAAGGATCTATTAAACGCAGCGTTTATCATGCGTATCATTGGTTTGGGTGTGCTACCAAGTTTGCTTGTGGCTTTTGTTAAGGTGGATTATCCGACTTGGGGCAAGGGTTTGATGCGCCGATTGGGCTTGATCGTGGCAAGTCTTGCGCTGATTTTACTGCCTGTGGTGGCGTTCAGCAGTCATTATGCCAGTTTCTTTCGCGTGCATAAGCCGCTGCGTAGCTATGTCAATCCGATCATGCCAATCTACTCGGTGGGTAAGCTTGCCAGTATTGGGTATAAAAAAGCCAGTGCGCCAAAAGATACCATTTATCACGCCAAAGACGCGGTACAAGCAACCAAGCCTGATATGCGTAAGCCACGCCTAGTGGTGTTCGTCGTCGGTGAGACGGCACGCGCCGATCATGTCAGCTTCAATGGCTATGAGCGCGATACTTTCCCACAGCTTGCCAAGATCGATGGCGTGACCAATTTTAGCAATGTCACATCGTGCGGCACATCGACGGCGTATTCTGTGCCGTGTATGTTCAGCTATCTGGGCGCGGATGAGTATGATGTCGATACCGCCAAATACCAAGAAAATGTGCTGGATACGCTGGATCGCTTGGGCGTAAGTATCTTGTGGCGTGATAATAATTCGGACTCAAAAGGCGTGATGGATAAGCTGCCAAAAGCGCAATTTGCCGATTATAAATCCGCGACCAACAACGCCATCTGCAACACCAATCCTTATAACGAATGCCGCGATGTCGGTATGCTCGTTGGCTTAGATGACTTTGTCGCTGCCAATAACGGCAAAGATATGCTGATCATGCTGCACCAAATGGGCAATCACGGGCCTGCGTATTTTAAGCGATATGATGAAAAGTTTGCCAAATTCACGCCAGTGTGTGAAGGTAATGAGCTTGCCAAGTGCGAACATCAGTCCTTGATCAATGCTTATGACAATGCCTTGCTTGCCACCGATGATTTCATCGCTCAAAGTATCCAGTGGCTGCAGACGCACAGCAATGCCTATGATGTCTCAATGCTGTATGTCAGCGATCATGGCGAAAGTCTGGGTGAGAACGGTGTCTATCTACATGGTATGCCAAATGCCTTTGCACCAAAAGAACAGCGCAGTGTGCCTGCATTTTTCTGGACGGATAAGCAAACTGGCATCACGCCAATGGCAACCGATACCGTCCTGACCCATGACGCGATCACGCCGACATTATTAAAGCTGTTTGATGTCACCGCGGACAAAGTCAAAGACCGCACCGCATTCATCCGCTGA
Lipopeptides
Colistin phosphoethanolamine transferase
Drugs
1
MEG_8233|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|LSAD
ATGTCGAATATTAAAATAAATAATTTAACATTTGGTTATACCGATCAGCTTATTTTTGACAATGTAAATATCAATATTGATGACCAATGGAAGCTGGGATTGGTTGGCCGTAACGGGAGAGGGAAAACTACACTTTTAAAAATCCTTCTTGGAGAAGTGGATGTACATCTTGAAATTAAAACCAATAAGAGCTTTGTGTATTTTCCTCAGACGATTAATGATAAAGACCAGTTGACCTTATTTGTCTTGCAAGAGTTAGCTGACTTTGAGCAGTGGGAACTTGAGCGTGAATTGACACTAATGGGCGTAGATTTAGATACTTTATGGCGTCCTTTCAATAGTCTTTCTGGTGGAGAGCAAACAAAGACACTCTTAGCACTTTTATTCTTGGATGAGCATAATTATCCGCTCATCGATGAGCCAACCAATCATCTTGATAAAGCTTCACGTGAGAAAGTTGCAGCCTACTTGTCAGAAAAAAAGGGATATATTTTAATCTCACATGACCGTAATTTTCTCAATAAGACGACAGATCATACACTTGCGATAGAGCGTGCGGACTTACAAGTATATGCAGGTAATTTTGCTATCTACGAGGAGGAAAAAAGATTGCGAGATCTCACGGAAAAGGCACAAGATGATAAACTCAGGAAAGAAATCGGTAGATTGAAACAAACGGCGCGTGAAAAAGAAGCGTGGTCGCGTAACTTAGAAGCAACAAAATCCCGTAAGAAACGAGGTTTTGATTCGGAAACAAAACGTGTTGATAAAGGTTTTATTGGACGAAAAGCAGCAAATATGATGCAAAAGTCTAAAAATCTCGAAAAGCGCATGAAAGAGGATATCGCTGACAAGGAACTACTTCTAAAAAATTGGGAAGAAGTACCTGGATTGGAAATGAGTGTCTTAGAGAGTCATCAAAAACGCTTACTGACAGTGGAAAATTTAGCGGCTGGATTTGAAGACTTTCTTTTTGAACCTGTGTCTTTTACACTTGAACAAGGTCAGGTGCTTGCACTAACAGGAGAAAATGGTAGAGGAAAATCTTCTCTAATGAAAGTCCTCACAGGTGAATTTACTGGCCGTTATGTTGGAACATTTGAGTTGGCCCATAACTTGGTCATTTCCGAAGTAAGACAACTTGCAGATAATAGAGGGTTTCTGAACGAGTTTGCCAAAAAAGAAAACTTAGAATTAGAACTTTTTCTCAACAATTTGCGCAAATTAGGCGTAGAGCGCAAAGTTTTTGAGCAAAAAATCGAAAATATGAGTCAGGGACAGCAGCGTAAAGTCGAACTGGCCCGCGCCTTAAGTCAGCCGGCGCATATTTATCTTTGGGATGAACCCCTCAACTATCTTGATGTTTTTAATCAAGAACAAATTATTCAAATGATAAAGAGAAGCAAGCCTAGTATGCTTGTCATTGAGCACGATCAGTATTTTGTTGATCAAGTAGCAGATGCCCAAATCGAACTCATAAAAAGCAGCGTTTAA
Multi-drug resistance
Multi-drug ABC efflux pumps
Drugs
1
MEG_8640|Drugs|betalactams|Class_C_betalactamases|PRC
ATGCGCCACCTGTACCGCCCTCTGTTCGTCGCCCTGGCGCTGCTGGCCGCCAGCCACGCGCCGGCCGCACCTTCACTGGAAACACAGGTGGACGCCGCTGCGAAGTCGATGATGCAGACCCATGCCATTCCCGGCATGGCCATCGCCATCAGCCACAAGGGGCAGTCGCATTTCTTCGAATACGGCGTCGCATCCCTTGAAAACGGCCAGACGGTGGATCGCCATACCCTTTTCGAGCTGGGCTCGATCAGCAAACTCTTCACCGCCACCCTCGGCGCCTACGCCGAAGCGCGCGGCACGCTGAACCTCAGTGACAACGCCAGCCAGTATCTGCCGGCCCTGCAGGGCAGCGCCTTCGATCACATCAGTTTGCTGGATCTGGCCACTTACACCTCGGGCGGCCTGCCACTGCAGTTCCCGGACACGGTCAGCAACGAACGGCAGATGCTCGATTACTACCGCAACTGGCAGGCGGTGTATCCGCCGGGTACGCAGCGGCTGTATTCCAACCCCAGCATCGGCCTGTTCGGCCACCTGGCAGCAGCCAGTCTGGCCAAGCCGTTTCAGCAGTTGATGGAGAAGGATCTGCTGCCGCAACTGAGCATGCAGGAAAGCTACGTCCGTATACCGACCGAGCAGATGGAGCACTATGCCTGGGGCTACCGCGACGACAAGGCGGTGCGCGTGACGCCCGGCGCGCTGGATGCCGAAGCCTACGGGTTGAAATCTACTGCCGCCGACGTGCTACGCTTCATCGACGCCAATCTGCACCCGGATCAACTACCCGCACCACTGCGCCAGGCGATCAGCGCAACACATCGTGGCTACTACCAGGTCGGCGACATGACTCAGGCGCTGGGCTGGGAGCGCTACGCCTACCCCATCAGCCTAGAAAAACTGCAGGCTGGCAACTCAGCAGAAATGGCGCTGCAACCGCAGACCGTGGCGCGTTTCGCTGCGCCCAAGCCTGCCGAAGGTGACCTGCTGCTGAACAAGACCGGCTCGACCAACGGCTTCGGCGCCTACATCCTACTGCTGCCGGCGCGCGATACCGGCCTGGTGATACTCGCCAACCGCAATTACCCCAATGCCGAACGCGTGCGCCTGGCCTTGCAATTGCTGGACGCGATCGAGCCGTAG
betalactams
Class C betalactamases
Drugs
1
MEG_8185|Drugs|betalactams|Class_A_betalactamases|KPC
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8183|Drugs|betalactams|Class_A_betalactamases|KPC
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCACTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8008|Drugs|betalactams|Class_A_betalactamases|BLAZ
ATGTTCGTTTTAAACAAGTTCTTTACCAATTCACATTACAAAAAAATTGTACCTGTCGTATTACTTTCATGCGCGACACTGATAGGGTGTTCTAATAGTAATACGCAATCAGAATCAACTAAACAAACAAATCAAACCAATCAAGTTAAGCAAGAAAATATAGGTAATCATGCTTTTGCTAAACTTGAAAAAGAATATAACGCTAAACTTGGTATTTACGCACTGGACACAAGTACGAATCAGACTGTTGCTTACCATGCAGATGATCGTTTTGCATTTGCCTCTACATCTAAATCATTAGCAGTGGGAGCTCTTTTACGTCAGAATTCAATAGAAGCTCTTGATGAAAGAATTACGTATACACGTGAAGACCTATCTAATTATAATCCAATTACTGAAATGCATGTGGATACAGGAATGACGTTAAAAGAACTTGCAGATGCTTCTGTTCGATATAGTGACAGTACGGCACATAATTTAATTCTTAAAAAGTTAGGTGGTCCATCCGCATTTGAAAAAATCTTGAGGAAAATGGGTGATACTGTTACTAACTCCGAGCGATTTGAACCTGAATTAAATGAAGTAAATCCAGGAGAAACACATGATACGAGTACACCAAAAGCAATCGCTAAGACGCTTCAATCTTTTACATTAGGAACTGTACTACCATCTGAGAAACGTGAACTGTTAGTAGATTGGATGAAGAGAAATACGACTGGGAATAAATTAATTCGTGCGGGTGTACCAAAAGGATGGGAAGTAGCTGATAAAACAGGTGCAGGATCTTATGGAACAAGGAATGATATCGCAATTATTTGGCCACCAAATAAAAAGCCGATTGTTCTTTCCATCCTTTCTAATCATGATAAAGAAGATGCAGAATACGATGATACACTTATTGCAGACGCTACGAAAATCGTGTTAGAAACTCTAAAAGTTACGAATAAATAA
betalactams
Class A betalactamases
Drugs
1
MEG_8184|Drugs|betalactams|Class_A_betalactamases|KPC
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAACCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8667|Drugs|betalactams|Class_A_betalactamases|ROB
ATGTTAAATAAGTTAAAAATCGGCACATTATTATTGCTGACATTAACGGCTTGTTCGCCCAATTCTGTTCATTCGGTAACGTCTAATCCGCAGCCTGCTAGTGCGCCTGTGCAACAATCAGCCACACAAGCCACCTTTCAACAGACTTTGGCGAATTTGGAACAGCAGTATCAAGCCCGAATTGGCGTTTATGTATGGGATACAGAAACGGGACATTCTTTGTCTTATCGTGCAGATGAACGCTTTGCTTATGCGTCCACTTTCAAGGCGTTGTTGGCTGGGGCGGTGTTGCAATCGCTGCCTGAAAAAGATTTAAATCGTACCATTTCATATAGCCAAAAAGATTTGGTTAGTTATTCTCCCGAAACCCAAAAATACGTTGGCAAAGGCATGACGATTGCCCAATTATGTGAAGCAGCCGTGCGGTTTAGCGACAACAGCGCGACCAATTTGCTGCTCAAAGAATTGGGTGGCGTGGAACAATATCAACGTATTTTGCGACAATTAGGCGATAACGTAACCCATGCCAATCGGCTAGAACCCGATTTAAATCAAGCCAAACCCAACGATATTCGTGATACGAGTACACCCAAACAAATGGCGATGAATTTAAATGCGTATTTATTGGGCAACACATTAACCGAATCGCAAAAAACGATTTTGTGGAATTGGTTGGACAATAACGCAACAGGCAATCCATTGATTCGCGCTGCTACGCCAACATCGTGGAAAGTGTACGATAAAAGCGGGGCGGGTAAATATGGTGTACGCAATGATATTGCGGTGGTTCGCATACCAAATCGCAAACCGATTGTGATGGCAATCATGAGTACGCAATTTACCGAAGAAGCCAAATTCAACAATAAATTAGTAGAAGATGCAGCAAAGCAAGTATTTCATACTTTACAGCTCAACTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8668|Drugs|betalactams|Class_A_betalactamases|ROB
ATGTTAAATAAGTTAAAAATCGGCACATTATTATTGCTGACATTATTATTGCTGACATTAACGGCTTGTTCGCCCAATTCTGTTCATTCGGTAACGTCTAATCCGCAGCCTGCTAGTGCGCCTGTGCAACAATCAGCCACACAAGCCACCTTTCAACAGACTTTGGCGAATTTGGAACAGCAGTATCAAGCCCGAATTGGCGTTTATGTATGGGATACAGAAACGGGACATTCTTTGTCTTATCGTGCAGATGAACGCTTTGCTTATGCGTCCACTTTCAAGGCGTTGTTGGCTGGGGCGGTGTTGCAATCGCTGCCTGAAAAAGATTTAAATCGTACCATTTCATATAGCCAAAAAGATTTGGTTAGTTATTCTCCCGAAACCCAAAAATACGTTGGCAAAGGCATGACGATTGCCCAATTATGTGAAGCAGCCGTGCGGTTTAGCGACAACAGCGCGACCAATTTGCTGCTCAAAGAATTGGGTGGCGTGGAACAATATCAACGTATTTTGCGACAATTAGGCGATAACGTAACCCATGCCAATCGGCTAGAACCCGATTTAAATCAAGCCAAACCCAACGATATTCGTGATACGAGTACACCCAAACAAATGGCGATGAATTTAAATGCGTATTTATTGGGCAACACATTAACCGAATCGCAAAAAACGATTTTGTGGAATTGGTTGGACAATAACGCAACAGGCAATCCATTGATTCGCGCTGCTACGCCAACATCGTGGAAAGTGTACGATAAAAGCGGGGCGGGTAAATATGGTGTACGCAATGATATTGCGGTGGTTCGCATACCAAATCGCAAACCGATTGTGATGGCAATCATGAGTACGCAATTTACCGAAGAAGCCAAATTCAACAATAAATTAGTAGAAGATGCAGCAAAGCAAGTATTTCATACTTTACAGCTCAACTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8153|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation
ATGGGTAAAAACGAGGCCAGAAGATCGGCCCTGGCGCCCGATCACGGTACAGTGGTGTGCGACCCCCTGCGGCGACTCAACCGCATGCACGCAACCCCTGAGGAGAGTATTCGGATCGTGGCTGCCCAGAAAAAGAAGGCCCAAGACGAATACGGCGCTGCGTCTATCACCATTCTCGAAGGGCTGGAGGCCGTCCGCAAACGTCCCGGCATGTACATTGGCTCGACCGGTGAGCGCGGTTTACACCATCTCATTTGGGAGGTGGTCGACAACGCGGTCGACGAGGCGATGGCCGGTTATGCAACCACAGTGAACGTAGTGCTGCTTGAGGATGGCGGTGTCGAGGTCGCCGACGACGGCCGCGGCATTCCGGTCGCCACCCACGCCTCCGGCATACCGACCGTCGACGTGGTGATGACACAACTACATGCCGGCGGCAAGTTCGACTCGGACGCGTATGCGATATCTGGTGGTCTGCACGGCGTCGGCGTGTCGGTGGTTAACGCGCTATCCACCCGGCTCGAAGTCGAGATCAAGCGCGACGGGTACGAGTGGTCTCAGGTTTATGAGAAGTCGGAACCCCTGGGCCTCAAGCAAGGGGCGCCGACCAAGAAGACGGGGTCAACGGTGCGGTTCTGGGCCGACCCCGCTGTTTTCGAAACCACGGAATACGACTTCGAAACCGTCGCCCGCCGGCTGCAAGAGATGGCGTTCCTCAACAAGGGGCTGACCATCAACCTGACCGACGAGAGGGTGACCCAAGACGAGGTCGTCGACGAAGTGGTCAGCGACGTCGCCGAGGCGCCGAAGTCGGCAAGTGAACGCGCAGCCGAATCCACTGCACCGCACAAAGTTAAGAGCCGCACCTTTCACTATCCGGGTGGCCTGGTGGACTTCGTGAAACACATCAACCGCACCAAGAACGCGATTCATAGCAGCATCGTGGATTTTTCCGGCAAGGGCACCGGGCACGAGGTGGAGATCGCGATGCAATGGAACGCCGGGTATTCGGAGTCGGTGCACACCTTCGCCAACACCATCAACACCCACGAGGGCGGCACCCACGAAGAGGGCTTCCGCAGCGCGCTGACGTCGGTGGTGAACAAGTACGCCAAGGACCGCAAGCTACTGAAGGACAAGGACCCCAACCTCACCGGTGACGATATCCGGGAAGGCCTGGCCGCTGTGATCTCGGTGAAGGTCAGCGAACCGCAGTTCGAGGGCCAGACCAAGACCAAGTTGGGCAACACCGAGGTCAAATCGTTTGTGCAGAAGGTCTGTAACGAACAGCTGACCCACTGGTTTGAAGCCAACCCCACCGACGCGAAAGTCGTTGTGAACAAGGCTGTGTCCTCGGCGCAAGCCCGTATCGCGGCACGTAAGGCACGAGAGTTGGTGCGGCGTAAGAGCGCCACCGACATCGGTGGATTGCCCGGCAAGCTGGCCGATTGCCGTTCCACGGATCCGCGCAAGTCCGAACTGTATGTCGTAGAAGGTGACTCGGCCGGCGGTTCTGCAAAAAGCGGTCGCGATTCGATGTTCCAGGCGATACTTCCGCTGCGCGGCAAGATCATCAATGTGGAGAAAGCGCGCATCGACCGGGTGCTAAAGAACACCGAAGTTCAGGCGATCATCACGGCGCTGGGCACCGGGATCCACGACGAGTTCGATATCGGCAAGCTGCGCTACCACAAGATCGTGCTGATGGCCGACGCCGATGTTGACGGCCAACATATTTCCACGCTGTTGTTGACGTTGTTGTTCCGGTTCATGCGGCCGCTCATCGAGAACGGGCATGTGTTTTTGGCACAACCGCCGCTGTACAAACTCAAGTGGCAGCGCAGTGACCCGGAATTCGCATACTCCGACCGCGAGCGCGACGGTCTGCTGGAGGCGGGGCTGAAGGCCGGGAAGAAGATCAACAAGGAAGACGGCATTCAGCGGTACAAGGGTCTAGGTGAAATGGACGCTAAGGAGTTGTGGGAGACCACCATGGATCCCTCGGTTCGTGTGTTGCGTCAAGTGACGCTGGACGACGCCGCCGCCGCCGACGAGTTGTTCTCCATCCTGATGGGCGAGGACGTCGACGCGCGGCGCAGCTTTATCACCCGCAACGCCAAGGATGTTCGGTTCCTGGATGTCTAA
Fluoroquinolones
Fluoroquinolone-resistant DNA topoisomerases
Drugs
1
MEG_8287|Drugs|betalactams|Mutant_porin_proteins|OMP36|RequiresSNPConfirmation
ATGAAAGTTAAAGTACTGTCCCTCCTGGTACCAGCACTGCTGGTAGCGGGCGCAGCAAATGCGGCTGAAATTTATAACAAAGACGGCAACAAATTAGACCTGTACGGTAAAATCGACGGTCTGCACTACTTCTCTTCCGACGACAGCGTCGACGGCGACCAGACCTACATGCGTATCGGCGTGAAAGGCGAAACCCAGATCAACGACCAGCTGACCGGTTACGGCCAGTGGGAATACAACGTTCAGGCGAACAACACTGAAAGCTCCAGCGACCAGGCATGGACTCGTCTGGCCTTCGCGGGTCTGAAATTCGGCGACGCGGGTTCTTTCGACTACGGTCGTAACTACGGCGTTGTTTACGACGTAACTTCCTGGACCGACGTTCTGCCGGAATTCGGCGGCGACACCTACGGTTCCGACAACTTCCTGCAGTCCCGTGCTAACGGTGTTGCCACCTACCGTAACTCTGACTTCTTCGGTCTGGTTGACGGCCTGAACTTTGCTCTGCAGTACCAGGGTAAAAACGGCAGCGTGAGCGGCGAAGATCAGACCAACAACGGTCGTGACTTCCAGAAACAGAACGGCGAAGGCTTCGGCACCTCCGTAACTTATGATATCTGGGACGGCATCAGCGCTGGTTTCGCGTACTCCAGCTCTAAACGTACCGACGAGCAGAACAACTCTACCTTCGTGTCTAAGACCGATGGTGGTCGTTACGGTGTTCTGGGTGAAGGCGATCACGCTGAAACCTACACCGGTGGTCTGAAATACGACGCCAACAACATCTACCTGGCGACTCAGTACACCCAGACTTACAACGCAACCCGCACCGGTAACATCGGTTTTGCTAACAAAGCGCAGAACTTCGAAGTCGTTGCTCAGTACCAGTTCGACTTCGGTCTGCGTCCGTCCGTGGCTTACCTGCAGTCTAAAGGTAAAGACATGGGCCGTTACGGCGACCAGGACATCCTGAAATATGTTGACCTGGGTGCGACCTACTACTTCAACAAAAACATGTCCACCTACGTTGATTACAAAATCAACCTGCTGGACGACAACAAGTTCACTAAAGATGCAAGCATCTCTACTGACAACGTTGTGGCTCTGGGCCTGGTTTACCAGTTCTAA
betalactams
Mutant porin proteins
Drugs
1
MEG_8448|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation
ATGACCAGCCTTGCGCATCATGCGACAGAAAACCGCTCTGTAGCCGAATTTACTGAACAGGCTTACTTGAATTATGCCATGTACGTCATTATGGACCGTGCATTGCCGCATATCAGTGATGGCTTAAAGCCCGTACAGCGCCGTATTGTCTATGCTATGAGCGAGCTAGGCTTAAAAAGCAGTGGCAAGCCAAAAAAATCAGCGCGTACAGTGGGTGATGTACTTGGTAAATACCACCCACATGGTGACTTGGCATGTTATGAAGCCATGGTACTCATGGCTCAGCCATTTAGTTACCGCTATCCTTTAATCGAAGGTCAGGGGAACTGGGGTTCACCAGATGATCCTAAATCTTTTGCTGCGATGCGTTATACCGAAGCCAAACTCTCGGCTTATAGTGAATTATTGCTGAGCGAATTAGGTCAGGGCACTAGCGAATGGCAAGATAACTTTGATGGTTCTTTAAAAGAACCGATCACTTTACCTGCACGTGTACCTAATATTCTTCTTAATGGTACGACAGGTATTGCTGTCGGGATGGCAACTGATATCCCGCCACATAATTTGCGTGAAGTTGTAAAAGGCACAATTGCTTTAATCCGTAATCCGCAAACCTCGGACGAAAAATTAGCTGAATATATTCCGGCTCCGGATTTACCAACCAAAGCTGAAATTATTACCCCGCCAGAAGAATTACTCAAAATCCAGACCACTGGTCGTGGTAGTTACCGTATGCGAGCGGTATATACCATTGAGAAAAATGAAATCGTAATTACTGAGCTGCCATATCAAGTCTCTGGTTCTAAGGTAATTACTCAAATTGCTGACCAGATGCAGGCTAAAAAGCTGCCATTAGTCGTTGATGTGCGTGATGAATCGGATCATGAAAACCCGACACGACTCGTGATTGTACTGCGCTCTAACCGTATTGATGCGGAAGCAGTAATGAGTCACTTATTTGCGACCACCGATTTAGAATCAAGCTATCGTGTCAATTTAAACATGATTGGCGAAGATGGCCGTCCTCAGGTGAAATCAATTCGTCGTATTTTGCTTGAATGGATCGAGATCCGTAAAAAAACGGTAACTCGTCGTTTGCAGTACCATTTAAACCGTATTGAAAAGCGCCTGCATATTTTGGCAGGTCTTTTAATTGCTTATCTCGATATTGATACAGTCATTCGTATTATTCGTGAAGAAGACCAGCCTAAGCCAGTCTTGATGGAACACTTTAATATTGATGAGATACAGGCCGAGGCGATTTTAGAGCTTAAATTACGTCATTTGGCAAAGCTTGAAGAGATGGAAATTCGTCATGAACAAGATGAGCTTTCCGCGAAAGCTGCCATTATTCGTGAACAACTCGAAAATCCTGAATCTTTAAAAAATTTGATTATTGGCGAATTAAAAGAAGATGCGAAAAAGTTCGGTGATGAGCGCCGTTCTCCAATTGTTGCACGTGCTGAAGCGGTTCAAATTAAAGAACAGGATTTAATGCCAGCTGAAACGGTAACAGTCGTGTTGTCTGAAGCAGGCTGGGTTCGTGCGGCAAAAGGTGCGGATGTGGATGCTGAAAATCTGAACTACCGTGCTGGGGACCAATATTTAAGTCATGCTGTCGGGAAAACCAATCAGCGAGTTTACTTCCTTGATGAAACAGGGCGCAGCTATGCCTTGCCAATTAGTAACTTACCTTCAGCGAGAGGCTTGGGGGATCCATTAAGTTCTAAATTATCACCAGCAAGTGGCGTATCGTTTATTCAGGTTTATTTAGATGATGATGAGTCTGAGTTGATTGCTGCAAGTTCGGCAGGTTATGGTTTTAAAACGCAAACCAAGCAATTAGATACCAATGCGAAAGCCGGTAAGACATTCTTAACGGTTCCGGATAAGGCAAAGGCTTTACCACTTATTTCTGCCCAAAACATGACGCATTTGGCTGTACTGAGCTCAGCAGGGCGTTTGTTAATTTTAGATTTGGCAGAACTACCAAATTTAAATAAAGGTAAAGGTAATAAGTTGATACAACTTGAAGGCAAAGAGCAAATTTTATCCATGACAACCCTGAACTTAGATGAAATAATTCAGGTGGTTGCAGGTCAACAACATCTCAAATTAAAAGGTGATGATCTACAAAAATACATGGGTAAACGTGCTTCGAAAGGTCAGCTCTTACCACGTGGATATCAAAAAGCAAATAAACTGTTGATTCAGAGATAA
Fluoroquinolones
Fluoroquinolone-resistant DNA topoisomerases
Drugs
1
MEG_8148|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation
ATGGATCAATTCGCCAAAGAGACCCTGCCCACCTCCCTCGAGGAGGAAATGCGCCGTTCGTATCTCGATTACGCGATGAGCGTGATCGTCGGACGTGCCCTTCCGGATGTCCGCGATGGCCTGAAGCCCGTGCACCGGCGCGTACTGTTCGCGATGCACGAACTGAACAACGACTGGAACCGCGCGTACAAGAAATCGGCGCGTATCGTCGGCGACGTGATCGGTAAGTACCACCCGCACGGCGACACGGCGGTCTACGACACGATCGTGCGGATGGCGCAGGACTTCTCGCTGCGCTACATGCTGATCGACGGGCAGGGCAACTTCGGCTCGATCGACGGCGACAATGCGGCGGCGATGCGGTACACCGAAATTCGCATGGCGAAGATCGGGCACGAGCTGCTCGCCGACATCGACAAGGAAACGGTCGATTTCGAGCCGAACTACGACGGCAACGAAACGCAGCCGTCGGTCCTGCCGTCGCGGATCCCGAACCTGCTGATCAACGGCTCGTCGGGCATCGCCGTCGGCATGGCGACCAACATTCCGCCGCACAACCTGAACGAAGTCGTCGACGCGTGCCAGCACCTGCTGAGCAACCCCGACGCGACGGTCGACGAACTGATCGAGATCATCCCGGCGCCGGATTTCCCGACGGCCGGCATCATCTACGGCGTCGCCGGCGTGCGCGACGGCTACCGCACCGGCCGCGGCCGCGTCGTGATGCGCGCGGCCACGCACTTCGAGGAGATCGACCGCGGCCAGCGGATGGCGATCATCGTCGACGAGCTGCCGTACCAGGTCAACAAGCGCTCGCTGCTCGAGCGGATCGCCGAGCTCGTCAACGAGAAGAAGCTCGAAGGCATTTCCGATATCCGCGACGAATCCGACAAGAGCGGCATGCGGGTCGTGATCGAGCTCAAGCGCGGCGAAGTGCCGGAAGTGGTGCTGAACAACCTGTACAAGGCGACGCAGCTGCAGGACACGTTCGGCATGAACATGGTCGCGCTCGTCGACGGCCAGCCGAAGCTGCTGAACCTGAAGGAAATCCTGCAGTGCTTCCTGTCGCACCGGCGCGAAGTGCTGACGCGCCGCACGATCTACGAACTGCGCAAGGCGCGCGAGCGCGGCCACGTGCTCGAAGGTCTCGCGGTCGCGCTCGCGAACATCGACGAGTTCATCGCGATCATCAAGGCCGCGCCGACGCCGCCGATCGCGAAGCAGGAGCTGATGACGAAGTCGTGGGATTCGTCGCTCGTACGCGAGATGCTGACGCGCGCCGAATCCGAGAACGCGGCGGCGGGCGGCCGTGCCGCGTACCGTCCGGAAGGGCTGAATCCGGCGTACGGGATGCAGGCCGACGGGCTGTACAGGTTGTCCGACACGCAGGCGCAGGAAATCCTGCAGATGCGTCTGCAGCGCCTGACCGGCCTCGAGCAGGACAAGATCATCGGCGAGTATCGCGAAGTGATGGCGCAGATCGCCGATCTGCTCGACATCCTCGCGCGCCCGGAGCGCATCACGACGATGATCGGCGACGAGCTGACGACGGTGAAGGCCGAATTCGGCGATGCGCGCCGCTCGCGGATCGAGCTGAACGCGACCGAACTGAATACCGAAGACCTGATCACGCCGCAGGACATGGTCGTCACGATGTCGCATGCCGGCTACGTGAAGTCGCAGCCGCTGTCGGAGTACCGCGCGCAGAAGCGCGGCGGCCGCGGCAAGCAGGCGACGCAGATGAAGGAAGACGACTGGATCGAGACGCTCTTCATCGCGAATACGCACGACTACATGCTGTGCTTCTCGAACCGCGGTCGCGTGTACTGGATCAAGGTCTACGAGGTGCCGCAAGGTTCGCGCAACTCGCGCGGCCGTCCGATCGTCAACATGTTCCCGCTGCAGGAAGGCGAGAAGATCAACGTCGTGCTGCCGGTGAAGGAATTCTCGGCCGACAAGTTCGTGTTCATGGCGACGTCGCTCGGCACGGTCAAGAAGACGCCGCTCGAAGCGTTCAGCCGTCCGATGAAGAAGGGCATCATCGCGGTCGGCCTCGACGAGGGCGACTATCTGATCGGCGCGTCGATCACCGACGGCGCGCACGACGTGATGCTGTTCTCCGATTCGGGCAAGGCCGTGCGCTTCGACGAGAACGACGTGCGTCCGATGGGCCGCGAAGCGCGCGGCGTGCGCGGCATGCAGCTCGAGGACGGGCAGCAGGTCATCGCGCTGCTGGTCGCGGGCAGCGAGGAGCAGTCCGTGCTCACCGCAACCGAGAACGGCTTCGGCAAGCGTACGCCGATCACCGAGTACACGCGTCACGGCCGCGGCACGAAGGGTATGATCGCGATCCAGACCTCCGAGCGTAACGGCAAGGTCGTCGCTGCGACGCTCGTCGATCCGGAAGATCAGATCATGCTGATCACGACGGCCGGCGTGTTGATTCGCACGCGCGTTTCCGAGATCCGCGAGATGGGACGGGCGACGCAAGGTGTTACACTCATCAGTCTCGATGAGGGTACGAAGCTTTCGGGTCTGCAGCAGATTGCCGAGGCCGAAGAGGGCGATGGCGAAGCCGACGAGGCGTCGGACGGCGAAGCCTGA
Fluoroquinolones
Fluoroquinolone-resistant DNA topoisomerases
Drugs
1
MEG_8455|Drugs|betalactams|Penicillin_binding_protein|PBP1|RequiresSNPConfirmation
ATGATTAAAAAGATTTTAACGACTTGTTTTGGTTTGGTTTTTGGGTTTTGTGTATTTGGAGTGGGTTTGGTTGCCATTGCTATTTTGGTAACGTATCCGAAACTGCCGTCTTTGGATTCTTTGCAGCATTACCAGCCTAAAATGCCGTTGACTATTTATTCGGCGGATGGGGAAGTCATCGGTATGTATGGGGAGCAGCGGCGCGAATTTACAAAAATCGGCGATTTCCCAGAGGTGTTGCGGAATGCGGTTATCGCCGCCGAGGATAAACGCTTTTACCGGCATTGGGGGGTGGATGTTTGGGGTGTTGCCCGCGCTGCCGTCGGCAATGTCGTGTCCGGCAGCGTGCAGTCGGGTGCGAGTACGATTACGCAGCAGGTGGCGAAAAATTTTTATTTGAGCAGTGAAAAAACGTTCACACGCAAATTCAATGAGGTGTTGCTTGCCTATAAAATCGAGCAGTCTTTAAGCAAAGACAAAATCCTCGAGTTGTATTTCAATCAGATTTACCTCGGTCAGCGCGCCTATGGTTTTGCATCTGCCGCGCAAATCTATTTCAATAAGAATGTCCGAGATTTGACTTTGGCGGAAGCCGCCATGCTTGCGGGACTGCCCAAGGCTCCGTCTGCCTATAATCCGATTGTTAATCCAGAACGTGCCAAGTTGCGCCAGAAGTATATTTTGAACAATATGCTCGAGGAGAAGATGATTACCGTGCAACAGCGCGATCAGGCGTTGAATGAGGAACTGCATTACGAGCGGTTTGTTCGGAAAATCGATCAGAGTGCTTTATATGTGGCGGAAATGGTGCGTCAGGAACTGTATGAGAAATACGGTGAAGATGCCTATACGCAGGGTTTTAAGGTTTATACCACGGTCCGCGCCGATCATCAGAAGGTGGCAACCGAGGCATTGCGCAAGGCTCTACGGAATTTCGATCGCGGCAGCAGCTACCGCGGTGCGGAAAACTATATCGATTTGAGTAAGAGTGAAGATGTCGAGGAGACTGTCAGCCAGTATCTGTCGGGACTCTATACCGTCGATAAAATGGTTCCCGCCGTTGTGTTGGATGTGACTAAAAAGAAAAATGTCGTCATACAGCTGCCCGGCGGCAGGCGGGTTACGCTTGACAGGCGCGCCTTGGGTTTTGCGGCCCGCGCGGTCAATAATGAAAAAATGGGGGAGGACCGTATCCGCAGGGGCGCGGTCATCCGTGTCAAAAACAACGGCGGGCGTTGGGCGGTGGTTCAAGAGCCGTTGCTGCAGGGGGCTTTGGTTTCGCTGGATGCAAAAACCGGAGCTGTGCGCGCGCTGGTCGGCGGTTATGATTTTCACAGCAAAACATTCAATCGTGCCGTTCAGGCAATGCGGCAGCCGGGTTCGACCTTTAAGCCGTTTGTCTATTCGGCGGCATTATCTAAGGGGATGACCGCGTCCACAGTGGTTAACGATGCGCCGATTTCCCTGCCGGGGAAAGGGCCGAACGGTTCGGTTTGGACACCTAAAAATTCAGACGGCAGATATTCCGGCTACATTACTTTGAGACAGGCTCTGACGGCTTCCAAGAATATGGTTTCCATCCGTATTTTGATGTCTATCGGTGTCGGTTACGCGCAACAGTATATCCGGCGTTTCGGCTTCAGGTCGTCCGAGCTGCCGGCAAGCCTGTCTATGGCTTTAGGTACGGGCGAGACAACGCCGTTGAAAGTGGCGGAGGCATATAGCGTATTTGCGAACGGCGGATATAGGGTTTCTTCGCACGTAATCGATAAGATTTATGACAGAGACGGCAGGTTGCGCGCCCAAATGCAACCTTTGGTGGCCGGGCAAAATGCGCCTCAGGCAATCGATCCGCGCAATGCCTATATTATGTATAAGATTATGCAGGATGTGGTCCGTGTTGGTACGGCAAGGGGGGCAGCTGCGTTGGGAAGAACGGATATTGCCGGTAAAACGGGTACGACCAATGACAATAAGGATGCGTGGTTTGTCGGTTTTAACCCTGATGTGGTTACTGCCGTATATATCGGCTTCGACAAACCTAAGAGTATGGGGCGTGTCGGCTACGGCGGTACGATTGCGGTGCCGGTTTGGGTGGACTATATGCGTTTTGCGTTGAAAGGAAAGCAGGGCAAGGGGATGAAAATGCCTGAAGGTGTGGTCAGCAGCAATGGCGAATACTATATGAAGGAACGTATGGTAACCGATCCGGGCTTGACGCTGGACAACAGCGGTATTGCGCCGCAACCTTCCCGACGGGCAAAAGAAGATGACGGGGGCGCGGCAGAAGGCGGACGGCAGGCGGCGGATGACGAAGTCCGCCAAGATATGCAGGAAACGCCGGTGCTTCCGAGTAATACTGGTTCCAAACAGCAGCAGTTGGATTCCCTGTTTTAA
betalactams
Penicillin binding protein
Drugs
1
MEG_8633|Drugs|betalactams|Penicillin_binding_protein|PILQ|RequiresSNPConfirmation
ATGAATACCAAACTGACAAAAATCATTTCCGGTCTCTTTGTCGCAACCGCCGCCTTTCAGACGGCATCGGCAGGAAACATTACAGACATCAAAGTTTCCTCCCTGCCCAACAAACAGAAAATCGTCAAAGTCAGCTTTGACAAAGAGATTGTCAACCCGACCGGCTTCGTAACCTCCTCACCGGCCCGCATCGCCTTGGACTTTGAACAAACCGGCATTTCCATGGATCAACAGGTACTCGAATATGCCGATCCTCTGTTGAGCAAAATCAGTGCCGCACAAAACAGCAGCCGTGCGCGTCTGGTTCTGAATTTGAACAAACCGGGCCAATACAATACCGAAGTACGCGGGAACAAAGTTTGGATATTCATTAACGAATCGGACGATACCGTGTCCGCCCCCGCCCGCCCAGCCGTAAAAGCCGCGCCTGCCGCACCGGCAAAACAACAGGCTGCCGCACCGTTTACCGAGTCCGTAGTATCCGTATCCGCACCGTTCAGCCCGGCAAAACAACAGGCAGCGGCATCGGCAAAACAACAGGCGGCGACACCGGCAAAACAAACCAATATCGATTTCCGCAAAGACGGCAAAAATGCCGGCATTATCGAATTGGCGGCATTGGGCTTTGCCGGGCAGCCCGACATCAGCCAACAGCACGACCACATCATCGTTACGCTGAAAAACCATACCCTGCCGACCGCGCTCCAACGCAGTTTGGATGTGGCAGACTTCAAAACACCGGTTCAAAAGGTTACGCTGAAACGCCTCAATAACGACACCCAGCTGATTATCACAACAACCGGCAACTGGGAACTCGTCAACAAATCCGCCGCGCCCGGATACTTTACCTTCCAAGTCCTGCCGAAAAAACAAAACCTCGAGTCAGGCGGCGTGAACAATGCGCCCAAAACCTTCACAGGCCGGAAAATCTCCCTTGACTTCCAAGATGTCGAAATCCGCACCATCCTGCAGATTTTGGCAAAAGAATCCGGGATGAACATTGTTGCCAGCGACTCCGTCAACGGCAAAATGACCCTCTCCCTCAAAGATGTGCCTTGGGATCAGGCTTTGGATTTGGTTATGCAGGCGCGCAACCTCGATATGCGCCAGCAAGGGAACATCGTCAACATCGCGCCCCGCGACGAGCTGCTTGCCAAAGACAAAGCCTTCTTACAGGCGGAAAAAGACATTGCCGATCTGGGCGCGCTGTATTCCCAAAACTTCCAATTGAAATACAAAAATGTGGAAGAATTCCGCAGCATCCTGCGTTTGGACAATGCCGACACGACCGGAAACCGCAACACGCTTGTCAGCGGCAGGGGCAGCGTGCTGATCGATCCCGCCACCAACACCCTGATTGTTACCGATACCCGCAGCGTCATCGAAAAATTCCGCAAACTGATTGACGAATTGGACGTACCCGCGCAACAAGTGATGATTGAGGCGCGTATCGTCGAAGCGGCAGACGGCTTCTCGCGCGATTTGGGCGTTAAGTTCGGCGCGACAGGCAGGAAAAAACTGAAAAATGAGACGAGCGCATTCGGCTGGGGCGTGAACTCCGGCTTCGGGGGCGGCGATAAATGGGAGGCCCAAACCAAAATCAACCTGCCGGTTGCCGCTGCCGCAAACAGCATTTCGCTGGTGCGCGCGATTTCCTCCGGCGCGTTGAATTTGGAATTGTCCGCATCCGAGTCGCTTTCAAAAACCAAAACGCTTGCCAATCCGCGCGTGCTGACCCAAAACCGCAAAGAGGCCAAAATCGAATCCGGTTACGAAATTCCTTTTACCGTAACTACAGCCTCGGGCGGCGGCAACTCTACCAACACGGAACTCAAAAAAGCCGTCTTGGGGCTGACCGTTACGCCGAACATCACGCCCGACGGACAAATCATCATGACCGTCAAAATCAACAAAGACTCGCCTGCACAATGTGCTTCAGGCAACAACACAATCCTATGTATTTCGACCAAAAGCCTGAATACGCAGGCTATGGTTGAAAACGGCGGCACTTTGATTGTCGGCGGTATTTATGAAGAAAACAACGGCAATACGCTGACCAAAGTCCCCCTGTTGGGCGACATCCCCGTTATCGGCAACCTCTTTAAAACACGCGGGAAAAAAACCGACCGCCGCGAACTGCTGATTTTCATTACCCCGAGGATTATAGATACGGCCGGCAACAGCCTGCGCTATTGA
betalactams
Penicillin binding protein
Drugs
1
MEG_8149|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation
ATGCAAGATAATTCAGTCAATGAAACAAAAAATATTGTAGAAGTGGGGATTGATTCTTCTATTGAAGAGAGCTATTTAGCTTATTCCATGAGCGTGATCATAGGGCGCGCTTTACCGGACGCTAGAGATGGCTTAAAGCCCGTGCATAGGCGTATTTTGTATGCGATGCATGAATTAGGCCTTACTTCAAAAGTCGCTTACAAAAAAAGCGCTAGGATCGTGGGTGATGTGATTGGTAAATACCACCCCCATGGCGATAATGCGGTTTATGATGCGCTAGTGAGAATGGCGCAAGATTTTTCCATGCGTTTGGAATTAGTGGATGGGCAGGGCAACTTTGGCTCTATTGATGGCGATAACGCCGCAGCGATGCGTTACACTGAAGCCAGAATGACTAAGGCGAGTGAAGAAATTTTAAGGGATATTGATAAAGACACCATTGATTTTGTGCCTAATTATGACGATACCTTAAAAGAGCCAGATATTTTACCAAGCCGTCTGCCTAACCTTTTAGTCAATGGGGCTAATGGGATCGCTGTGGGGATGGCGACTTCTATCCCCCCTCACAGGATGGATGAAATCATAGACGCTTTAGTGCATGTCTTAGAAAACCCTAACGCTGGATTAGATGAAATCTTAGAATTTGTCAAAGGGCCTGATTTTCCCACTGGTGGGATCATTTATGGCAAGGCGGGTATTATTGAAGCCTATAAAACGGGGCGAGGACGCGTGAAAGTGCGGGCCAAAGTGCATGTGGAAAAAACAAAAAATAAAGAAATCATCGTTTTAGATGAAATGCCTTTTCAAACCAATAAAGCCAAATTAGTGGAACAAATCAGCGATTTAGCGCGAGAAAAGCAAATTGAAGGCATTAGTGAAGTGCGCGATGAGAGCGATAGAGAGGGCATTAGAGTGGTGATTGAATTAAAAAGAGACGCGATGAGTGAAATTGTCTTAAACCACCTCTACAAACTCACCACTATGGAAACCACTTTTAGCATCATTTTACTCGCTATTTACAATAAAGAGCCTAAGATTTTCACGCTTTTAGAGTTGTTGCACCTTTTCTTAAACCACAGAAAAACCATTATTATAAGACGCACGATTTTTGAATTAGAAAAGGCTAAGGCCAGAGCGCATATTTTAGAGGGCTATTTGATCGCACTAGACAATATTGATGAAATCGTGCGACTCATTAAAACAAGCCAAAGCCCAGAAGCGGCTAAAAACGCCTTAATGGAGCGTTTCACTTTGAGCGAGATTCAAAGCAAGGCCATTTTAGAAATGCGTTTGCAACGCTTAACAGGCCTTGAAAGGGATAAGATCAAAGAAGAATACCAAAACTTGTTGGAGCTTATTGATGATCTCAATGGCATTTTAAAGAGCGAAGATCGCTTGAATGGAGTCGTCAAAACAGAGCTTTTAGAAGTCAAAGAGCAATTTTCTTCTCCAAGGCGCACTGAAATTCAAGAATCTTATGAAAATATTGACATAGAAGATTTGATCGCTAATGAGCCTATGGTAGTGAGCATGAGTTATAAAGGCTATGTGAAAAGAGTGGATTTAAAAGCTTATGAAAAGCAAAATCGTGGTGGTAAAGGCAAGCTTTCAGGCAGCACTTATGAAGACGATTTCATTGAAAACTTTTTTGTGGCTAACACGCATGATATTTTGCTCTTTATCACCAATAAGGGGCAATTGTATCATTTGAAAGTCTATAAAATCCCAGAAGCGAGCCGGATCGCTATGGGTAAAGCCATTGTAAATTTAATCTCGCTCGCTCCGGATGAAAAGATCATGGCGACTCTAAGCACCAAAGACTTTAGCGATGAACGCTCTTTGGCCTTCTTCACGAAAAATGGCGTGGTGAAGCGCACCAATTTGAGCGAATTTGAAAGCAACAGGAGTTGTGGTATCAGAGCGATTGTTTTAGATGAAGGCGATGAATTAGTGAGCGCAAAAGTTGTGGATAAAAACGCTAAGCATTTGCTCATCGCATCGCATTTGGGCATTTTCATTAAATTCCCTTTAGAAGAGGTGCGCGAGATCGGAAGAACTACTCGTGGGGTTATAGGCATCAAGCTGAATGAAAACGATTTTGTTGTCGGTGCGGTCGTTATTAGCGATGATGGCAACAAGCTTTTGAGCGTGAGTGAAAACGGGCTTGGCAAGCAAACTTTAGCCGAAGCGTATAGAGGGCAATCTCGTGGAGGTAAGGGGGTCATTGGCATGAAGCTCACTCAAAAAACCGGCAATCTAGTGGGCGTTATCAGCGTGGATGATGAAAATTTGGATTTGATGATCCTTACTGCAAGCGCAAAAATGATCAGAGTTTCTATTAAAGATATTAGAGAAACCGGAAGAAACGCTAGTGGGGTAAAGCTCATAAACACCGCCGATAAAGTCATGTATGTCAATTCTTGCCCTAAAGAAGAAGAGCCAGAAAATTTAGAAACCTCTTCGGCACAAAATTTGTTTGAGTGA
Fluoroquinolones
Fluoroquinolone-resistant DNA topoisomerases
Drugs
1
MEG_8152|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation
ATGCAAAATTACCAGAGCCATAGTATTAAGGTTTTAAAAGGCTTAGAGGGGGTTAGGAAACGCCCTGGAATGTATATTGGTGATACCAATGTGGGTGGGTTGCACCACATGGTGTATGAAGTCGTGGATAACGCTGTAGATGAGAGCATGGCGGGTTTTTGCGATACGATTAATATCACTTTGACCGATGAGGGTTCATGCATCGTAGAAGATAACGGGCGAGGCATTCCTGTAGATATTCACCCCACGGAAAAAATCCCCGCTTGCACCGTGGTTTTAACGATTTTGCATGCGGGGGGCAAGTTTGATAACGATACTTATAAAGTTTCAGGCGGTTTGCATGGCGTGGGCGTTTCGGTTGTGAACGCTTTGAGCAAACGCTTGATTATGACCATTAAAAAAGAGGGTCAAATTTATCGCCAAGAGTTTGAAAAGGGTATTCCTACTAGCGAGCTTGAAATCATTGGCAAAACCAAAAGCGCTAAAGAAAGCGGCACGACTATTGAATTTTTCCCTGATGAAAGCGTGATGGAAGTCGTTGAATTTCAAGCGGGTATTTTACAAAAACGCTTTAAAGAAATGGCGTATCTTAACGATGGCTTAAAAATTTCTTTCAAAGAAGAAAAAACCCAACTGCAAGAGACTTATTTCTATGAAGACGGCTTGAAACAATTCGTTAAAGACAGCGCTAAAAAAGAATTGCTCACCCCCATTATTTCGTTTAAAAGCATGGATGAAGAAACGCGCACTTCTATAGAAGTCGCTCTAGCGTATGCTGATGATTATAATGAAAACACTTTAAGCTTTGTGAATAACATTAAAACTTCTGAAGGTGGCACGCATGAGGCGGGCTTTAAAATGGGCTTGTCTAAAGCAATTTTGCAATATATTGGCAATAATATTAAAACCAAAGAGTCACGCCCCATCTCTGAAGATATTAAAGAGGGGTTGATCGCTGTTGTGAGCTTGAAAATGAGCGAGCCTTTGTTTGAAGGGCAGACTAAATCCAAACTCGGCAGTTCGTATGCGCGCGCGTTGGTTTCAAAATTAGTCTATGATAAAATCCATCAATTTTTAGAAGAAAACCCTAACGAAGCCAAAATCATTGCCAATAAAGCCCTACTAGCTGCAAAAGCCAGAGAAGCCAGTAAGAAAGCCAGAGAGCTTACAAGGAAAAAAGATAATTTGAGTGTCGGCACTTTGCCTGGAAAATTAGCCGATTGCCAGAGTAAAGACCCCTTAGAGAGTGAAATCTTTTTAGTGGAGGGCGATAGTGCGGGCGGGAGCGCTAAACAAGGGCGCGATAGGGTTTTCCAAGCGATCTTGCCCCTAAAAGGTAAGATTTTAAATGTGGAAAAAAGCCATTTATCAAAAATCCTAAAATCAGAAGAAATTAAAAACATGATCACGGCTTTTGGGTGCGGCATTCAAGAGAGTTTTGATATAGAAAGATTGCGCTATCATAAAATCATTATCATGACCGATGCTGATGTGGATGGGAGCCATATCCAAACCTTGCTGATGACTTTTTTCTATCGTTATTTGCGCCCGCTGATTGAACAAGGGCATGTTTATATCGCTCAAGCCCCTCTTTACAAATACAAGAAGGGCAAGACAGAAATTTATCTTAAAGACAGCGTCGCTTTGGATCATTTTTTAATTGAGCATGGCATCAATTCGGTGGATATTGAAGGGATTGGCAAGAACGATTTGATGAACTTGTTAAAAGTGGCACGCCATTACCGCTATGCGCTTTTGGAATTAGAAAAACGCTACAATTTGCTAGAAATTTTACGCTTTCTCATTGAAACTAAGGACGCCTTAAGCCTTGATATGAAAGTTTTAGAAAAAAGCATTTTAGAAAAATTAGAGGGCTTGAATTATCAGATCTTACGCTCTTTTGCCACTGAAGAAAGCTTACATTTGCACACGCAAACCCCTAAAGGCTTGGTGGAATTTAACCTAGATGACAATCTCTTTAAAGAAGTGTTGTTTGAAGAAGCGAATTACACTTACCAAAAGCTTATGGAGTATAATTTAGACTTCTTAGAAAATAAGGATATTTTGGCGTTTTTAGAAGAAGTGGAAAATCACGCTAAAAAGGGAGCGAATATCCAGCGCTATAAGGGGCTAGGCGAGATGAACCCTAATGATTTGTGGGAAACGACCATGCATAAAGAAAACCGCAGCTTGATCAAACTCAAAATTGAAGATTTAGAAAAAACCGATGCAGTCTTTTCGCTTTGCATGGGCGATGAAGTAGAGCCTAGAAGAGCCTTTATCCAAGCGCATGCTAAAGATGTGAAACAACTAGATGTGTAA
Fluoroquinolones
Fluoroquinolone-resistant DNA topoisomerases
Drugs
1
MEG_8458|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation
ATGGATAATAAAAACATTGATCCCAACTTCAACCCAGAACGATTTTTAGAAACCCAAAAATACAAGGGCTCTATTACGGCTTTAATCTTTTTATTGCTTTTTTTTATTTTTTTAATGGTGGCTTTTAAAAAAGCTTTTTTTGCCCAAGCCAACATGCCTAATCTAGTGATGAGCAAACAAGACACTGCGGCTAGGGGGACTATCTATAGTCAAGACAACTACAGCCTAGCCGCTTCGCAAACCCTTTTCAAACTGGGCTTTGATACAAGGTTTTTAAACCCGGATAAAGAAGATTTTTTCATTGATTTCCTTTCTATTTATAGCAATATCCCTAAAAAGTCCTTAAAAGACGCCATCAATACGAAAGGCTATATTATTCTAGCCTATGATCTCACGCCCAATATGGCCGCTAACATTAGAGACTTGAATAAGAAATTTTTAGCCTTTGGGGTTTTTCAAAATTTCAAAGACGCGCACGATAAGGTGTGGCAAAAGCAAGGGCTAAACATTGAAGTGAGCGGCGTTTCCAGGCATTACCCTTATCAAAATAGCCTAGAGCCAATCATTGGCTATGTGCAAAAACAAGAAGAAGACAAGCTCACTTTAACTACCGGTAAAAAAGGCGTTGAAAAATCTCAAGATCACTTGCTTAAAGCCCAACAAAATGGCATAAGAACAGGCAAAAGAGATGTGAGTTTTAATTTTATTCAAAACCACTCTTACACAGAGGTTGAGCGCCTTGATGGCTATGAGGTGTATTTGAGCATTCCTTTAAAACTCCAAAGAGAAATTGAAACCCTATTGGATAAAACCAAAGACAAACTCAAGGCTAAAGAAATCCTAGTGGGTATCATTAACCCTAAAAGCGGGGAAATCTTATCGCTAGCTTCAAGCAAGCGCTTCAATCCTAACGCCATTAAAACCAGCGATTATGAAAGCTTGAATTTGAGCGTTGCCGAAAAGGTTTTTGAGCCAGGCAGCACGATCAAACCCATTGTTTATTCCTTGCTGTTAGACAAGAATTTGATCAACCCTAAAGAACGCATTGATTTAAACCATGGCTATTACCAATTAGGAAAATACACCATTAAAGACGACTTTATCCCTAGTAAAAAAGCCGTTGTGGAAGATATTTTGATCCAATCTAGCAATGTGGGCATGATAAAAATCAGCAAAAATCTCAACCCGGAGGATTTCTATAATGGGCTTTTAGGCTATGGATTTTCTCAAAAAACCGGCATTGATTTATCCTTAGAAGCCACAGGAAAGATCCCTCCTTTGTCCGCTTTCAAGCGTGAAGTGTTAAAGGGGAGCGTCTCTTATGGCTATGGGCTGAACGCGACTTTTTTGCAGCTTTTAAGGGCTTATGCGGTGTTTTCTAATGAAGGCAAATTGACTACCCCCTATTTAGTGCAACGAGAGACCGCCCCTAATGGCGATATTTACATCCCTAGCCCCAAACCCACTTTTCAAGTCATTAGCCCCAAAAGCGCCAGGAAAATGAAAGAAACCTTAATCAAAGTGGTGCGTTATGGCACAGGCAAAAACGCTCAATTTGAAGGGTTATACATAGGGGGCAAAACAGGCACGGCTAGGGTTGCTAAAAACGGGAGTTACAGCGCGGAATCCTACAACAGCTCTTTTTTTGGGTTCGCTGAAGATGAAAGGCAGGTTTTTACTATCGGCGTGGTTATCTTAGGCTCGCACGGCAAGGAAGAATATTATGCTAGCAAGATTGCAGCCCCTATTTTTAAAGAAATCACCGAAATTTTAGTGCGTTACAATTACCTATCGCCCTCTATTGCGATTCAAAACGTGCTCGAGAAAAACCGCTTTAAGATAAAATAA
betalactams
Penicillin binding protein
Drugs
1
MEG_8457|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation
ATGAAAAATCTTCGCTATAAGCTTTTGCTCTTTGTTTTTATAGGGTTTTGGGGGTTATTGGTTTTAAATTTATTTATTTTAAGCGTTAAAAATCAAGAATACTATGAAAAATTGGCCGAACGCAACATGACCAAAAAGGAATTTCTAGTCCCTACAAGGGGCGATATTACAGACAGAAATGATGAGTTTTTAGCCACTAACGAATTGGTGTTTGGCGTGTTTTTGCCTAGTAGACTGAAACAAAAAGAACTTTTGGAAAAAATTGAAATCATCCAAAAGTTTTTCCCTAACTTTTCCAAAGAAACGCTTTTAAACAATTACCAAAAAGAAAATTCGCTTTATAACCACAACCTCATTAAAGTGGTGGGATTCATTCCTTATATCGCCATGCAACCTCTTTATGCCAAACTCATCCAAACTCAAGGCATTTTTGCTCTTCCCTTAGACAAGCGCTACTACCCTAATAACGCTTTAGCTTCACATGTTTTAGGCTATGTGGGGGTGGCAAGCTTGCAAGATCTAAAAGACGATGAAGAAAATCAATACAGCCAGATTGTAGGCAAAACCGGCATTGAAAAAGAATATAACAAGCTTTTACAAGGCAAGGTGGGCTATAAAATCATGCGTGTCAATGCACTCAATCAAGAATTAGCCACTTTAGAAGTAGTGCCGCCAAGCACCAACAACCACTTGCAATTGAGTTTAGACAAACGCTTGCAAAAAGAAGCGGACAAGCTCTTTGAAAATAAGAGAGGGGCTATTTTAGTGATGAACGCAGAAAATGGGGAATTGCTCGTTGCAGGAAGTTACCCTGAATACAATTTGAACGATTTTGTAGGCGGGATCAGTCAAGACAAATGGCAAAAACTTCAAGATGATATTTATAACCCCTTATTAAACCGCTTCGCTAACGCTTTGTATCCGCCGGGATCTGTGGTTAAAATGGGCGTGGGCTTGAGCTTTTTAGAAAACCTTCATATCACAGAAAACACCACCATACCCACCCCGCCTTTTATTGAAGTGGGCAAGCGCAAATTCAGGGACTGGAAAAAAACAGGGCATGGCAATTCTAATTTGTATAAAGCGATTAGGGAGTCCGTGGATGTGTATTTTTATAAGTTTGGGCTTGAAATCTCTATAGAAAAACTCTCTAAAACCTTAAGAGAAGTGGGCTTTGGGGAAAAAACAGGCGTTGATTTGCCGAATGAATTTGTGGGGATTGTGCCGGATAATTTGTGGAAACTCAAACGATTCAATCAAGATTGGCGCGTTGGGGACACGCTCATTACTGCTATTGGGCAAGGCTCTTTTTTAGCCACGCCCTTACAAGTGCTAGCCTATACGGGACTCATTGCGACAGGCAAACTGGCAACGCCTCATTTTGCTATCAATAATAAACAGCCGCTCAAAGACCCCCTGAATAGTTTTCAAAAAAAGAAGCTCCAAGCCTTGCGCGTGGGCATGTATGAAGTGTGTAACCATAAAGACGGCACCGCTTATCATTCCACAAGGGGTTCTAAGGTTACTTTAGCGTGTAAAACCGGCACCGCGCAAGTCGTGGAAATCGCTCAAAACATCGTCAATCGCATGAAAGAAAAGGATATGGAGTATTTCCATCGATCCCATGCGTGGATTACCGCATTTTTGCCTTATGAAAAACCCAAATACGCTATCACTATTTTAGTAGAACATGGGGAAGGGGGGTCAAAACTAGGGGGCTTGTTAGTGAAAATGAGCAATAAACTCTATGAGCTTGGCTATCTTTAA
betalactams
Penicillin binding protein
Drugs
1
MEG_8454|Drugs|betalactams|Penicillin_binding_protein|PBP1|RequiresSNPConfirmation
ATGCTAAAAAAGATTTTTTATGGTTTTATCGTTTTATTTTTGATTATCGTAGGGTTGTTAGCCATTCTTATCGCTCAAGTTTGGGTAACTACGGATAAGGATATTGCTAAAATTAAAGATTATCGCCCGGGCGTCGCTTCACAGATTTTAGACCGAAAAGGGCGTTTGATCGCTAATATCTATGATAAGGAATTTCGTTTTTATGCGCGTTTTGAAGAAATCCCCCCACGATTTATTGAAAGCCTTTTAGCGGTAGAAGACACCCTCTTTTTTGAACATGGGGGGATCAATTTAGACGCTATCATGCGCGCTATGATTAAAAACGCTAAAAGCGGTCGTTACACCGAGGGGGGTAGCACCCTAACCCAACAACTCGTTAAAAACATGGTGCTCACACGAGAAAAAACCCTAACCAGAAAACTCAAAGAAGCTATCATTTCCATACGCATTGAAAAAGTCTTAAGCAAAGAAGAAATTTTAGAGCGCTATTTGAACCAAACTTTTTTTGGGCATGGGTATTATGGCGTGAAAACCGCAAGTTTAGGGTATTTTAAAAAACCCCTTGACAAACTCACGCTTAAAGAAATCGCCATGTTAGTCGCCTTGCCTAGGGCTCCGAGTTTTTATGATCCTACCAAAAATTTAGAATTTTCACTTTCTAGGGCTAATGATATTTTAAGGCGGTTGTATTCTTTAGGCTGGATTTCTTCTAACGAGCTCAAATCCGCTCTCAATGAAGTGCCAATCGTCTATAACCAAACTTCCACGCAAAATATCGCTCCCTATGTCGTGGATGAAGTATTGAAGCAATTGGATCAATTAGACGGGTTAAAAACTCAAGGCTATATTATAAAGCTCACGATAGATTTGGATTACCAACGCTTAGCGTTAGAGTCCTTGCGTTTTGGGCATCAAAAAATCTTAGAAAAAATCGCTAAAGAAAAGCCAAAAACTAACGCGTCTAATGAAGATGAAGACAACTTGAACGCTAGCATGATAGTTACAGACACGAGCACCGGTAAGATTTTAGCTTTAGTGGGAGGGATTGATTATAAAAAAAGCGCTTTCAATCGCGCCACGCAAGCCAAACGGCAATTTGGGAGCGCGATCAAGCCTTTTGTGTATCAAATCGCTTTTGATAATGGCTATTCCACGACTTCTAAAATCCCTGATACCGCGCGAAACTTTGAAAATGGCAATTATAGTAAAAACAGCAAACAAAACCATGCATGGCACCCCAGCAATTATTCTCGCAAGTTTTTAGGGCTTGTAACCTTGCAAGAAGCTTTGAGCCATTCATTAAATCTAGCCACGATCAATTTAAGCGATCAGCTTGGCTTTGAAAAAATTTATCAATCTTTAAGCGATATGGGGTTTAAAAACCTCCCTAAAGACTTGTCTATTGTGTTAGGGAGCTTTGCTATCTCACCCATTGAAGCGGCTGAAAAGTATTCTTTATTTTCTAATTACGGCACTATGCTCAAACCCATGCTCATTGAAAGCATCACTAACCAACAAAACGATGTCAAAACTTTCACGCCTATGGAAACCAAAAAGATCACCTCCAAAGAACAGGCTTTTTTAACCATTTCAGTGCTGATGAATGCGGTAGAAAACGGCACAGGGAGTTTGGCTCACATTAAAGGTTTAGAAGTCGCCGGTAAAACCGGAACTTCTAACAACAATATTGACGCTTGGTTCATTGGCTTTACCCCCACCTTGCAAAGCGTGATCTGGTTTGGGAGGGACGATAACACGCCTATTAGCAAAGGAGCGACAGGAGGCGTTGTGAGCGCGCCTGTGTATTCGTATTTCATGCGTAATATTCTAAGCATTGAACCTTCTTTAAAAAGAAAGTTTGATGTCCCCAAAGGCTTGCGTAAAGAAATTGTGGATAAAATCCCCTACTATTCAACCCCCAATTCCATCACCCCCACCCCCAAAAGAACAGACGATAGCGAAGAACGCTTGTTGTTCTAA
betalactams
Penicillin binding protein
Drugs
1
MEG_8671|Drugs|MLS|Macrolide-resistant_50S_rRNA_mutation|RPLD|RequiresSNPConfirmation
ATGGAATTGAAAGTAATTGACGCTAAAGGACAAGTTTCAGGCAGCCTGTCTGTTTCTGATGCTTTGTTCGCCCGCGAATACAATGAAGCGTTGGTTCACCAGCTGGTAAATGCCTACTTGGCAAACGCCCGCTCTGGTAACCGTGCTCAAAAAACCCGTGCCGAAGTAAAACACTCAACCAAAAAACCATGGCGTCAAAAAGGTACCGGCCGCGCCCGTTCCGGTATGACTTCTTCTCCGCTGTGGCGTAAAGGCGGTCGCGCGTTCCCGAACAAACCCGACGAAAACTTCACTCAAAAAGTAAACCGTAAAATGTACCGTGCCGGTATGGCGACTATCCTGTCCCAATTGGCGCGTGACGAGCGTTTGTTTGTGATTGAGGCGTTGACTGCCGAAACTCCCAAAACCAAAGTTTTTGCCGAACAAGTAAAAAATTTGGCTCTGGAGCAAGTGCTGTTTGTAACCAAACGGCTCGACGAGAATGTTTACTTGGCTTCACGCAACTTGCCAAACGTATTGGTTTTGGAAGCTCAACAAGTTGATCCTTACAGCTTGCTGCGTTATAAAAAAGTAATCATCACTAAAGATGCGGTTGCACAATTAGAGGAGCAATGGGTATGA
MLS
Macrolide-resistant 50S rRNA mutation
Drugs
1
MEG_8254|Drugs|MLS|Macrolide-resistant_23S_rRNA_mutation|MLS23S|RequiresSNPConfirmation
TGAAATGATAGAGTCAAGTGAATAAGTGCATCAGGCGGATGCCTTGGCGATGATAGGCGACGAAGGACGTGTAAGCCTGCGAAAAGCGCGGGGGAGCTGGCAATAAAGCAATGATCCCGCGGTGTCCGAATGGGGAAACCCACTGCATTCTGTGCAGTATCCTAAGTTGAATACATAGGCTTAGAGAAGCGAACCCGGAGAACTGAACCATCTAAGTACCCGGAGGAAAAGAAATCAACCGAGATTCCGCAAGTAGTGGCGAGCGAACGCGGAGGAGCCTGTACGTAATAACTGTCGAGGTAGAAGAACAAGCTGGGAAGCTTGACCATAGCGGGTGACAGTCCCGTATTCGAAATCTCAACAGCGGTACTAAGCGTACGAAAAGTAGGGCGGGACACGTGAAATCCTGTCTGAATATGGGGGGACCATCCTCCAAGGCTAAATACTCATCATCGACCGATAGTGAACCAGTACCGTGAGGGAAAGGCGAAAAGAACCCCGGGAGGGGAGTGAAACAGAACCTGAAACCTGATGCATACAAACAGTGGGAGCGCCCTAGTGGTGTGACTGCGTACCTTTTGTATAATGGGTCAACGACTTACATTCAGTAGCGAGCTTAACCGGATAGGGGAGGCGTAGGGAAACCGAGTCTTAATAGGGCGATGAGTTGCTGGGTGTAGACCCGAAACCGAGTGATCTATCCATGGCCAGGTTGAAGGTGCCGTAACAGGTACTGGAGGACCGAACCCACGCATGTTGCAAAATGCGGGGATGAGCTGTGGGTAGGGGTGAAAGGCTAAACAAACTCGGAGATAGCTGGTTCTCCCCGAAAACTATTTAGGTAGTGCCTCGAGCAAGACACTGATGGGGGTAAAGCACTGTTATGGCTAGGGGGTTATTGCAACTTACCAACCCATGGCAAACTCAGAATACCATCAAGTGGTTCCTCGGGAGACAGACAGCGGGTGCTAACGTCCGTTGTCAAGAGGGAAACAACCCAGACCGCCGGCTAAGGTCCCAAATGATAGATTAAGTGGTAAACGAAGTGGGAAGGCACAGACAGCCAGGATGTTGGCTTAGAAGCAGCCATCATTTAAAGAAAGCGTAATAGCTCACTGGTCGAGTCGTCCTGCGCGGAAGATGTAACGGGGCTCAAATCTATAACCGAAGCTGCGGATGCCGGTTTACCGGCATGGTAGGGGAGCGTTCTGTAGGCTGATGAAGGTGCATTGTAAAGTGTGCTGGAGGTATCAGAAGTGCGAATGTTGACATGAGTAGCGATAAAGCGGGTGAAAAGCCCGCTCGCCGAAAGCCCAAGGTTTCCTACGCAACGTTCATCGGCGTAGGGTGAGTCGGCCCCTAAGGCGAGGCAGAAATGCGTAGTCGATGGGAAACAGGTTAATATTCCTGTACTTGATTCAAATGCGATGTGGGGACGGAGAAGGTTAGGTTGGCAAGCTGTTGGAATAGCTTGTTTAAGCCGGTAGGTGGAAGACTTAGGCAAATCCGGGTTTTCTTAACACCGAAGAAGTGATGACGAGTGTTTACGGACACGAAGCAACCGATACCACGCTTCCAGGAAAAGCCACTAAGCTTCAGTTTGAATCGAACCGTACCGCAAACCGACACAGGTGGGCAGGATGAGAATTCTAAGGCGCTTGAGAGAACTCGGGAGAAGGAACTCGGCAAATTGATACCGTAACTTCGGGAGAAGGTATGCCCTCTAAGGTTAAGGACTTGCTCCGTAAGCCCCGGAGGGTCGCAGAGAATAGGTGGCTGCGACTTGTTTATTAAAAACACGAGCACTCTTGCCAACACGAAAGTGGACGTATAGGGTGTAACGCCTGCCCGGTGCCGGAAGGTTAATTGAAGATGTGCAAGCATCGGATCGAAGCCCCGGTAAACGGCGGCCGTAACTATAACGGTCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCCGCACGAATGGCGTAACGATGGCCACACTGTCTCCTCCCGAGACTCAGCGAAGTTGAAGTGGTTGTGAAGATGCAATCTACCCGCTGCTAGACGGAAAGACCCCGTGAACCTTTACTGTAGCTTTGCATTGGACTTTGAAGTCACTTGTGTAGGATAGGTGGAAGGCTTGGAAGCAAAGACGCCAGTCTCTGTGGAGTCGTCCTTGAAAATACCACCCTGGTGTCTTTGAGGTTCTAACCCAGACCCGTCATCCGGGTCGGGGACCGTGCATGGTAGGCAGTTTGACTGGGGCGGTCTCCTCCCAAAGCGTAACGGAGGAGTTCGAAGGTTACCTAGGTCCGGTCGGAAATCGGACTGATAGTGCAATGGCAAAAGGTAGCTTAACTGCGAGACCGACAAGTCGGGCAGGTGCGAAAGCAGGACATAGTGATCCGGTGGTTCTGTATGGAAGGGCCATCGCTCAACGGATAAAAGGTACTCCGGGGATAACAGGCTTGATTCCGCCCAAGAGTTCATATCGACGGCGGAGTTTGGCACCTCGATGTCGGCTCATCACATCCTGGGGCTGTAGTCGGTCCCAAGGGTATGGCTGTTCGCCATTTTAAAGTGGTACGTGAGTTGGGTTTAAAACGTCGTGAGACAGTTTGGTCCCTATCTGCAGTGGGCGTTGGAAGTTTGACGGGGGCTGCTCCTAGTACGAGAGGACCGGAGTGGACGAACCTCTGGTGTACCGGTTGTAACGCCAGTTGCATAGCCGGGTAGCTAAGTTCGGAAGAGATAAGCGCTGAAAGCATCTAAGCGCGAAACTCGCCTGAAGATGAGACTTCCCTTGCGGTTTAACCGCACTAAAGGGTCGTTCGAGACCAGGACGTTGATAGGTGGGGTGTGGAAGCGCGGTAACGCGTGAAGCTAACCCATACTAATTGCCCGTGAGGCTTGACTCT
MLS
Macrolide-resistant 23S rRNA mutation
Drugs
1
MEG_8020|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML
ATGCCTTTTGATAACAAACAAACTCCACGCTGGAGTTATTCCCTGCCATTTGCGCTCGCGTTGATGGCTCCCTTCGACATTCTCGCCTCGCTGGCCATGGACATCTACTTGCCGGTCGTACCGTCCATGCCTGCGATCCTGCAAACGACACCCGCCATGGTGCAGCTGACGCTCAGCCTCTACATGGTGATGCTGGGTGTCGGGCAGCTTCTTTTCGGCCCGTTGTCCGACCGTTTCGGACGCAGGCCCATCCTGCTTGGCGGTGGACTGGTGTTCGCCCTTTCGTCCTTCGCTCTGGCGATTACCGACAATGCCACCGTTTTCGTATTGCTTCGTTTCGTACAGGCAACAGGTGCCTCGGCAGCACTTGTCGCCACTTTCGCAACGGTCCGCGACGTCTATGCGACGCGCCCCGAAGGCGCGACGATCTACGGCCTTTTCAGCGCCATGGTTTCCTTCGTCCCTGCGCTTGGGCCGATTGCAGGCGCCCTGATTGCAAAAGGGTTCGGATGGCGGACAATCTTCGCATTGCTGGGCGTTTTCAGTCTCGTCGCAACATGGCGCGCCTTGCGCCACTGGCACGAGACACGACCGACCAGCAGCGCGCCGGGCACAGGCGGTCTGGGGCGGATCATGAAGGATTTTCCCTTCTGGACCTATACGCTCGGTTTTGCGACGGCGATGGGCACGTTCTTCGTGTTCTTTTCCACCGCACCGCGCATTCTGATCGAACGCGGCGGTTTCCCGGAAACCGGCTTCAGTCTTGCCTTCGCAAGCGTTGCCATCGTCATGATCGCCGCCACGTGCATCCTGCCTCGCCATACGCAGAAATGGGGTGCCCGTAAAAGCGTGGCCCTTGGCATGACCGTGCTCCTTGCCAGCGCGCTCCTGCTTCTGGCGGGTGAGAAACTACTACAACCATCGTTCACAAGCCTCATCGTCCCGATGTGGCTTGCTGCTGTCGGGATTGTTTTCACTGCATCGATGACGGCAAATGGAGCGCTTGCAGCCTTTGATGACAATGCAGGCATGGCGGTCGCAGTCTATTTCTGCATTCAAAGCCTGATCGTCAGTCTCGCAGGAACCGCACTGGTCATTTTCCTGCCGGGCGATACTGCCTGGCCATTGATCGTTTTCTGCACAATCATGCCATTGCTGGTTCTGGCCATGCTCGTGAGGCTACGAAAGAACTGA
Phenicol
Phenicol resistance MFS efflux pumps
Drugs
1
MEG_8013|Drugs|Phenicol|Chloramphenicol_acetyltransferases|CATA
ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTCTGTGATGGCTTCCATGTCGGCAGAATACTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA
Phenicol
Chloramphenicol acetyltransferases
Drugs
1
MEG_8436|Drugs|betalactams|Class_D_betalactamases|OXA
ATGCGTAGAACCCGGGTCCTCGTGTTGAGTTTTACACTCCTCCTGGCTTTACTGGCAGCTTGCAACCCACTCCAGACCGCCACGTCCCAACCCTTGCCGAACACAACCGTTCAGACGGAAACCGACCTTCCGGTTTCCGAAGAAAAACCGGAACTGGAAAATTTCTTCGAGGGAATGAAGGGCGCCTTTGTGTTGTACGACTTGAATGGTCAGAAAACGATCCGTTTCAATACACAGCGCTGCGCCGAACCCTTCCTGCCGGCGTCCACCTTCAAAATTCTAAACGCCCTAATTGGTTTGGAGACCGGCGTTATCTCGGACGAAAATTACAAGATTGCGTGGGACGGCACGAACTACGAGATCGCCTCCTGGAATCAGGATCAGACCCTCGCGACGGCGTTCCAAAATTCGGTCGTCTGGTATTACCAGGAACTCGCCCGGCGCGTCGGGGAAGAGAGAATGCGGCATTATGTGGAATTGGCCGATTATGGCAACCGGGACATCTCTGGCAAGATCGATACATTCTGGCTGGAAGGCGGCCTTCGAATATCAGCCGACCAACAGGTGGATTTTCTGAAGCGGTTCTATCAAAATGATCTGCCGTTTTCCACCTCATCGATCGACATCGTGAAGAAGATCATGATTTTGGAGTCGACCGATTCCTATACCTTTCGCGGAAAAACCGGATCGGTTCAACGTGTTCCCATCCACACCGGCTGGTTCGTGGGTTACCTGGAACGGGATGGGAATGTGTATTTCTTCGCGACCAACATTGAAAGCACCGATCCGGATGGATTTGCAAGCGGTGCGGCCGCGAGGGAAATTACAGAGAATATCCTGGTCGAGGAGGGTCTGCTGCCGCCCCGCTGA
betalactams
Class D betalactamases
Drugs
1
MEG_8415|Drugs|betalactams|Class_D_betalactamases|OXA
ATGTCCCGCCTGCTTCTCTCCAGCCTGCTGGCTGCCGGTCTGCTCGCCGCTCTGCCTGCCTCCGCCGCCAGCGGCTGTTTTCTCTATGCTGACGGCAACGGCCAGACCCTCTCCAGCGAAGGGGACTGCTCCAGCCAGCTGCCGCCCGCATCCACCTTCAAGATCCCGCTGGCACTGATGGGCTATGACAGCGGCTTTCTGGTGGATGAAGAGCATCCAGCACTGCCCTTCAAACCGGGTTACGACGACTGGCTGCCCGCCTGGCGCGAAACCACTACCCCGCGCCGCTGGGAAACCTACTCGGTGGTCTGGTTCTCCCAGCAGATCACCGAATGGCTGGGGATGGAGCGCTTCCAGCAATACGTCGACCGCTTCGACTACGGCAACCGGGATCTCTCCGGCAATCCGGGCAAGCATGACGGCCTGACCCAGGCCTGGCTAAGCTCCAGCCTCGCCATAAGCCCGGAGGAGCAGGCCCGCTTCCTCGGCAAGATGGTGAGCGGCAAGCTGCCGGTCTCGGCGCAGACCCTGCAGTACACCGCCAATATCCTCAAGGTGAGCGAGATCGATGGCTGGCAAATCCACGGCAAGACCGGCATGGGCTACCCGAAGAAGCTGGATGGCAGCCTCAACCGCGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAACCGGGCAAGCAGCTGATCTTCGTCCATACCGTGGTGCAAAAGCCCGGCAAGCAGTTCGCCTCCCTCAAGGCGAAAGAAGAGGTGCTGGCCGCCCTGCCCGGGAAGCTGAAGACCCTGTAA
betalactams
Class D betalactamases
Drugs
1
MEG_8005|Drugs|betalactams|Class_B_betalactamases|BLAB
ATTATGAAGAATATAATGCGGGCACTGATCCTTGTTTTTGGTTTTATGAGTTTTTTTATGTTTGGACAGGAGAATCCTGACGTCAAAATTGAAAAGCTAAGAGATAATCTGTATGTATACACAACCTACAATACATTTAACGGGACTAAATATGCCGCTAATGCAGTATATCTGGTAACTGATAAGGGTGTTGTGGTTATAGACTGTCCGTGGGGAGAAGACAAATTTAAAAGCTTTACGGACGAGATTTATAAAAAACACGGAAAGAAAGTTATTATGAATATTGCAACACATTCTCATGATGATCGTGCCGGAGGTCTTGAATATTTTGGTAAAATAGGTGCAAAAACTTATTCTACTAAAATGACAGATTCTATTTTAGCAAAAGAGAATAAGCCAAGAGCACAATATACTTTTGACAATAATAAATCTTTCAAAGTAGGAAAATCCGAGTTTCAGGTTTACTATCCCGGAAAAGGACATACAGCAGATAATGTGGTGGTATGGTTTCCAAAAGAAAAAGTATTGGTTGGAGGTTGTATTATAAAAAGCGCTGATTCAAAAGACCTGGGGTATATTGGAGAAGCATATGTAAATGACTGGACGCAGTCTGTACACAATATTCAACAGAAGTTTTCCGGTGCTCAGTACGTTGTTGCGGGGCATGATGATTGGAAAGATCAAAGATCAATACAACGTACACTAGACTTAATCAATGAATATCAACAAAAACAAAAGGCTTCAAATTAA
betalactams
Class B betalactamases
Drugs
1
MEG_7870|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC3-PRIME
ATGAGCATCATTGCAACCGTCAAGATCGGCCCTGACGAAATTTCAGCCATGAGGGCTGTGCTCGATCTCTTCGGCAAAGAGTTTGAGGACATTCCAACCTACTCTGATCGCCAGCCGACCAATGAGTATCTTGCCAATCTTCTGCACAGCGAGACGTTCATCGCGCTCGCTGCTTTTGACCGCGGAACAGCAATAGGTGGGCTCGCCGCCTACGTTCTACCCAAGTTCGAGCAAGCGCGAAGCGAGATCTACATTTATGACTTGGCAGTCGCTTCCAGCCATCGAAGGCTAGGAGTCGCAACTGCCCTGATTAGCCACCTGAAGCGTGTGGCGGTTGAACTTGGCGCGTATGTAATCTATGTGCAAGCAGACTACGGTGACGATCCGGCAGTCGCTCTCTACACAAAGCTTGGAGTTCGGGAAGACGTCATGCACTTCGACATTGATCCAGGAACCGCCACCTAA
Aminoglycosides
Aminoglycoside N-acetyltransferases
Drugs
1
MEG_8006|Drugs|betalactams|Class_B_betalactamases|BLAB
ATAATGAAAGGATTAAAAGGGCTATTGGTTCTGGCTTTAGGCTTTACAGGACTACAGGTTTTTGGGCAACAGAACCCTGATATTAAAATTGAAAAATTAAAAGATAATTTATACGTCTATACAACCTATAATACCTTCAAAGGAACTAAATATGCGGCTAATGCGGTATATATGGTAACCGATAAAGGAGTAGTGGTGATAGACTCTCCATGGGGAGAAGATAAATTTAAAAGTTTTACAGACGAGATTTATAAAAAGCACGGAAAGAAAGTCATCATGAACATTGCTACACATTCTCATGACGATAGAGCCGGAGGTCTTGAATATTTTGGTAAACTAGGTGCAAAAACTTATTCTACTAAAATGACAGATTCTATTTTAGCAAAAGAGAATAAGCCAAGAGCAAAGTACACTTTTGATAATAATAAATCTTTTAAAGTAGGAAACACTGAGTTCCAGGTCTATTATCCGGGAAAAGGTCATACAGCAGATAATGTGGTGGTATGGTTCCCTAAAGACAAAGTATTAGTAGGAGGCTGCATTGTAAAAAGCGGTGATTCGAAAGACCTTGGGTTTATTGGGGAAGCTTATGTAAACGACTGGACACAGTCCATACACAACATTCAGCAGAAATTTCCCGATGTTCAGTATGTCGTTGCAGGTCATGACGACTGGAAAGATCAAACATCAATACAACATACACTGGATTTAATCAGTGAATATCAACAAAAACAAAAGGCTTCAAATTAA
betalactams
Class B betalactamases
Drugs
1
MEG_8441|Drugs|betalactams|Class_D_betalactamases|OXA
ATGCCAAAAATACTAAAACATCTTAGCCTTTGCGCATCTGTAATGATTGGACTGACGTTGCTAGGTTGCCAAAATTTGCACGCCCCAACTCAAAGCGCCGTGTCAAAAAAACACGATCAAACCGAGATCGCTTCTTTATTCCAACATACTCAAACTGTTGGCGTATTTGTTACATATGATGGGCAAACATTTCAAGAATATGGCAATGCGTTGAGTCGATCGAATACGGCTTATATTCCAGCCTCAACCTTCAAGATGTTAAATGCTCTGATTGGGATACAGCATCACAAAAGTTCGCCCAACGAAGTGTTTAAATGGGATGGCAAAAAGCGTGCTTTTGCGAGCTGGGAAAAAGATTTAACTTTAGCCGAGGCGATGCAGGCATCAGCAGTGCCTGTTTATCAGGAATTGGCTCGGCGTATCGGGTTAGAGTTGATGGCGAACGAAGTAAAACGCGTTGGCTTTGGCAATACTGAGATCGGAACGCAAGTCGATGATTTTTGGTTGGTTGGCCCGCTTAAGATTACCCCCGTTGACGAAGTGAAATTTGCTTATGCTCTGGCAAATAAGCAGCTTGCATTTGACCAATCTGTGCAAGAACAAGTGAAACAGATGGTCTTCGTTGATGAAGTTCATGGAACTAAGATTTATGCCAAAAGTGGTTGGGGTATGGATGTAACACCGCAAGTGGGTTGGTGGACGGGCTGGATTGAACAACCGAATGGACAGGTGATTGCATTTGCTTTAAATCTGGAAATAAATAAGCCTGAGCACGGTGATGCGCGTAAAGCGATTGTTTATCAAGCATTACAACAATTGAAATTGTTACAGAAGCAATAA
betalactams
Class D betalactamases
Drugs
1
MEG_8721|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_pumps|TOPR
ATGACCTCTCACTTCATGCTCCGTCGCGCTCTGCTGCCCCTGGCCATCGCCGCCCTGGCGGGTTGTTCGCTGGCCCCGACCTACGAGCGCCCGCAGGCACCGGTCGCGTCGCACTGGCAAGCCGCCGACGCGGAGGGCACCCGTGCCCAGGCGCTGGACTGGCAGACCTTCATCGTCGATGCCGACTTGCGCCGCGCGGTGGATACGGCGCTGAGCAACAACCGCAGCCTGCGCCAGGCGCTGCTGGATATCGAAGCTGCGCGTGCCCAGTACCGCATCCAGCGTGCTGATCGCCTGCCTTCGATCAACGCCAATGCCAGCGGCAACCGCCAGCGCCTGCCTGCCGATCTGTCGCAGACCGGGCGCTCGGAAGTGACCAGCAACTATCAGGTCGGCCTCGGCCTCGCGGAGTACGAAGTCGACCTGTTCGGCCGCGTGCGCAACCTCTCCGAGGCCGCGCTGGAGACCTACCTGGCGACCGAGGAGGCGACCCGTGCCACGCAGATCAGCCTGGTTGCCGAGGTCATCCAGGCCTACCTGACCCGCGATGGTGCGCTACGCCGCATGGCCCTGGTCGAACAAACCCTGGACAGCCGCATGGCCTCGCTGGAGCTGGTCAGCCAGCGCCGTGCAGCGGGGGCCGCCACCGCCCTGGATTACCAGGAAGCGGTCGGCCTTGCCGAACAGGCTAGGGCCGAGCGCGAGAGCACCGAACGCCAGTTACGCCAGGCGGACAACGCCCTGGTCCTGTTGCTCGGCACGCCAGATGCCGCTCGCCTGCTGCCCGCGACGCCCCGCGACGACCTGATGGTGCTGCAGGACATCGCCCCCGGCACCAGCTCGGAACTGATCGAACGGCGCCCGGACATTCTCGCCAGCGAGCACCGCCTCAAGGCGCGCAATGCCGATATCGGTGCAGCTCGCGCCGCGTTCTTTCCCCGGATCAGCCTGACCGGTTCGGTGGGCAGCTCCAGTGCCGAGTTGTCCGGATTGTTCGATGGCGGCTCGCGGGCCTGGAGCTTTGCCCCGACGCTGTCGCTGCCGATCTTCGCCGGTGGCCGCAACCGCGCCAACCTGGACCTCGCCGAAGTGCGCCAGGACGCGGCGGTGGCCGACTACGAAGGCACCATCCAGACCGCCTTCCGCGAAGTGGCCGATGCCCTGGCCGCCACCGACACCCTGCGCCGCGAGGAGGCTGCCCGCCAGGCTCTGGCCGGTTCCAGCGAGGCTGCGATGGCCCTGGCTAAGGCGCGTTACGAGGGCGGCGTGGACGACTACCTGCGTTATCTTGACGCCCAGCGCAGCACCTTTAGCAACCAGACCACACTAATTCAAATCAGCACGGAACGGCAGATTGCGCTGGTTGACCTGTTCAGGTCTCTGGGCGGTGGCTGGGGCCAAACTGAACCGATGGCCGGGATCGGCGCTGAGTGA
Multi-drug resistance
Multi-drug RND efflux pumps
Drugs
1
MEG_8260|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRG
ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTACGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGCTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCCGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGGTTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA
MLS
MLS resistance ABC efflux pumps
Drugs
1
MEG_8245|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFF
ATGGATAATATGAATTGGAAACGGAAATTTATTGCGATTTTTACAGGGCAGTTCTTTTCACTATTAAGCAGTGCTGCTGTTCAATTTAGTATCATTTGGTGGTTAACAGATACATCAGGAGGTTCTCCACTGATTTTAACATTAGCAGGACTGGCTGGTTTTATGCCACAAGCATTGTTAGGTCCTTTTGCAGGAACTATTACTGATCGTTATTCACGAAAAGTGATTATGATAATTGCAGATATGACGGTTGCACTTGGAAGTTTAGCTTTATTTGTATCAATGTATTTTTATGATCCGAGTATTATATTGGTGATAATTGTATTGATCGTTCGTTCATTAGCAACTGCATTCCATATGCCGGCTATGCAAGCGTCTATTCCACTAATAGCCCCAAAAGAGCATTTGACAAAAGTTTCTGGATGGGGACAGACAGTGGCTTCTATATCAAATATTGTTGGTCCAGCAGCGGGGATGTCATTACTAGCGATAAGCTCCGTTGAGTGGGTTCTATTACTAGATGTCTTTGGGGCAGTAATTGCTAGTAGTATTTTGCTATTTATTCACATTCCAAATGTACAGAGTTCAGAAACTGTTGATTCTTCTAGTTTTATCAGCGATATGAAAGAAGGATATCATGCACTTGTAAAACATCCTGTTTTATTAAGGTTAACAGTCACGATTACGATTGTTTCGGTGCTGTATATTCCGCTAGGCACTTACTTTCCGCTTATGACACGAAATCATTTCGAGAAGGGCGTAGTTGAAGCTGGAATAATCGAAATTGTTTTTGCTGTTGGCCTCATCTTTGGTGGTATATTAATGGGGATTTTCGGAGATCGATTTGAAAAATTGAAACTCATTGTTAGCGGAATGATACTGATGGGGATTGCCTTATTCATTTCTGGCACACTTCCATCAACTTTATTCTATGGATTTATCGTAATGGCTGGTCTAGTGGGATTGTCTGGTCCATTATTTTCAGCTCCGTTTTATGCTCTTATCCAAACCGAAATTGAACCTCATTTACTTGGGAGAGTGTTTAGTTTTGTTGGAAGTTTGGCATTACTTGCAACACCGTTGGGTTACGCATTTGCTGGGGTTCTGATCCACTTAACAAATGTGGCCGTATTATTTTTGATTACAGGTATATTAATTGTATTAAATGCTGTTATCGTAAGGAAAGCAAAATAG
MLS
MLS resistance MFS efflux pumps
Drugs
1
MEG_8418|Drugs|betalactams|Class_D_betalactamases|OXA
ATGTGGATGCTAAAAGCGATATCTTGTTCAGTTTTAAGCTGGATGCTGTTAAGTGCATGCAGTCAGCAACCTCTTAAGGACCAAATGCAGCAGCCATTGATGATGCAACAACCACGGTTAGCTGAGTTGAATCATATGTTTCAAGCAGTGGGCAGTGCGGTAGTTTTTGTTACTTATGATGGGGAAAAATTGCAGCGTTTTGGCAATGATTTGCAAAGAGCTGAAACTGCCTATATACCTGCTTCAACTTTTAAAATGTTAAATGCTTTAATTGGTTTACAGCAGCGTAAAACCACGACCACTGAAGTATTTTTATGGGATGGAAAAGCACGCGCAATGAAAAGTTGGGAACGGGATATGACTTTGGCTGAGGCGATGCAAGTCTCAGCAGTTCCCATCTATCAAACCTTGGCTCGACGCATTGGTCTGCCGTTGATGCAAAAAGAGCTTCATCGAGTTGGTTATGGAAATGCTCAGATTGGTACACAGGTTGATCGCTTTTGGTTAGATGGACCCTTAAAAATTACACCGCAACAAGAAGCTGAATTTGCTTACAGACTTGCGACCCAGACCTTACCTTTTGATGCACATGTGCAACAAGAGGTGAAACAAATGCTTTATGTGGAGCGTCGTGGTGTTGCTAAGTTGTATGCTAAGTCAGGATGGGGAGCCGATGTAAAACCTCAGGTGGGTTGGTATGTGGGATGGGTGGAACAGCCCAATGGCAAAATTTTGGCCTTTGCTTTAAATATGCAGATACAGAATGAGCAGCAATTGGCAATGCGTAAACAGCTCACCCTAGATGCTTTAGATAAACTTAGTATCTTTCCTTATTTATAA
betalactams
Class D betalactamases
Drugs
1
MEG_7878|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC6-PRIME
ATGAGTACCAACCATGGCTCAGTCACACTGCGCCTCATGACCGAGCAGGACCTTCCCATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAGGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTCACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA
Aminoglycosides
Aminoglycoside N-acetyltransferases
Drugs
1
MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML
GTGCCCAATCGTAAATCACCAACCTGGACCTATTCGGTGCCGGCAGCGTTGCTGCTGATGGCACCCTTCGACATCCTCGCCTCGCTGGCGATGGATATCTACCTTCCGGTCGTGCCGGCCATGCCCGGTATTCTCGGCACCACCCCGGCAATCATCCAGCTGAGCCTGAGCCTCTATATGATCGTTCTCGGCGTCGGGCAGATCGTCTTCGGACCCATTTCCGATCGCATCGGTCGGCGTCCCGTCCTCATCGGCGGGGCGCTCGCCTTTGCGGCCGCGTCATTGCTGATCGCCGCGACATCGTCGGCCCCGACCTTCCTTGCCCTGCGCCTCCTTCAGGCGATCGGCGCATCGGCAGCGCTTGTCGCCACCTTTGCGACGGTCCGCGACGTCTATGCGGAGCGGCCGGAGGGCGTGACCATCTACGGGCTCTTCAGCGCGATGCTCGCCTTCGTCCCGGCCCTCGGGCCGATCGCCGGCGCGCTTCTGGCCGATTACTTCGGCTGGCAGGCGATCTTCCTGACACTCGGTGTGCTGGCAATCGCCGCCACGGCAAACGCCCTGCCGCGATGGCGGGAAACGCGACCCGTCGGCGCCGAGGAGCAAAGGCGGGCTTTCGCCCCGATCCTTAAGGATGGAGCGTTCTGGACCTACACTCTCGGCTTCAGCGCCGCGATGGGCTCGTTCTTCGTGTTCTTCTCGACCGCACCACGCGTGCTGATCGACCGGGCGGGTTACTCCGAGCTCGGCTTCAGCCTGGTCTTTGCAACGGCAGCGGTGGTGATGATCGTCACCACCCGTTTCGCCAAACGCTTCGTCGCGCTTTGGGGCATCGCCGGCAGTTTTGCCCGCGGGATGGGGCTACTTCTCCTCGGCGCGATGCTGCTTGTCGTCGGGGAAAGCGTGTCCCCACCATCGTTCTGGACCTTCATTCTGCCGATGTGGGTCATTGCCGTCGGCATCGTCTTTACCGGCTCGGTCACCGCCAATGGAGCGCTGCAAGCCTTCGGCCACGTGGCGGGTACCGCAGTCGCGCTCTACTTCTGCATCCAAAGCCTGATCGTCGGGGTGCTCGGCACTGTGGCCGTGGTGCTGCTCGGCGGCGATACCGCCTTTCCATTAGCCGGCTATTCGTCGATCATGGCGATCGGCACGCTGATCGCTCTCGGTCGTTTGACACGGCAACGAGCGGCGGACGCCTGA
Phenicol
Phenicol resistance MFS efflux pumps
Drugs
1
MEG_8247|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_pumps|MEXC1
ATGAACAAATTCCGCGAATGGATCACTTTTTCCGTGATCTCCTGTTTGGTCGCCGTGACCCTGGTTGGCTGCGACAAGCCCGAAGAGCAACGGGAAGAGGCGCCAGCGCGTGAAGTCGATGTGCTCAGCGTGAAGACCGAGCCCTTCACAGTGTTCGCCGAGCTACCAGGGCGCATCGAGCCGGTGCGTGTCGCCGAGGTGCGCGCGCGGGTGGCGGGGATCGTGCTCAAGCGCACCTTCGAGGAAGGGGCCGACGTGAAGGCCGGTGACGTGCTGTTCCAGATCGACCCTGCGCCGTTCAAGGCGGCCCTGTCGCGGGCGCAAGGTGAACTGGCTCGCGCCGAGGCGCAGCTGTTCCAGGCTCAGGCGATGGTTCGCCGTTACGAACCACTGGTGAAGATCGACGCCGTCAGCCAGCAGGATTTCGACAACGCCATGGCCGCTCTGCAGAGCGCCCAGGCCGACAAGCGCTCGGCCCAGGCCAATGTCGAAACTGCCCGCCTGGACCTGGGTTATGCCGAGGTTCGCGCCCCCATCGCCGGGCGTATCGGTCGCGCCCAGGTCACCGAAGGGGCTCTGGTAGGCCAGGGCGAAGCCACGCTGCTGGCACGTATCCAGCAACTCGATCCGGTGTACGCCGACTTCACCCAGCCTGCTGCCGATGCCCTGCGCCTGCGCGCGGCAATCGCCGAGGGCAAGGTTGCCGGTGCGAGCGACCAGCCGCTGTCGCTGCGTGTCGACGGTACCGATATCGAGCGCAAGGGCACGCTGCTGTTCACCGATATCTCGGTGGATCGCAGCACCGGGCAGATCGCCCTGCGAGGCCAGTTCGACAACCCCGAGGGCGTGCTGCTGCCGGGTATGTACGTGCGTGTGCGCACGCCGCAGGGGCTCAACCAGAACGCCATCCTGGTGCCGCAACGTGCCGTGCAGCGTTCGGCTGACGGCCAGGCCAGCGTGATGCTGCTGGGCGAGGGCGATACCGTCGAGGTGCGCCAGGTCACTACTGGCGCCATGCAAGGCTCGCGCTGGCAGATCAGCGAGGGCCTGCAGGCCGGCGACAAGGTGATCACCAGCTCGCTGGCGGCTATCCGTCCGGGCGCCAAGGTCATCCCACGCGAGCAAGGCGCCGCCGAAAAAGCTCCACAGTCCCAAGCCCAGTAA
Multi-drug resistance
Multi-drug RND efflux pumps
Drugs
1
MEG_8248|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_pumps|MEXD1
ATGCCCCTGTTTTTCATCCGACGCCCCAATTTTGCCTGGGTAGTCGCCCTGTTCATCTCGCTAGGTGGCCTGCTGGTCATTCCGTTCCTGCCGGTGGCACAGTACCCCAACGTGGCGCCGCCGCAGATTACCGTGACCGCCACCTATCCCGGCGCCTCGGCGCAGGTGCTGACCGACTCGGTGACCAGCGTCATCGAGGAAGAACTCAACGGCGCCAAGAACCTGCTGTACTTCGAGTCCACCAGCAACGCCAACGGCATAGCCGAGATCACCGTCACCTTCCAGCCGGGGACCGACCCCGAACTGGCCCAGGTCGACGTGCAGAACCGTCTGAAGAAGGCCGAGGCGCGCATGCCGCAGGCCGTGCTGACCCTCGGCATCCAGACCGAGCAGGCCACCGCCGGCTTTCTGCTGATCTATTCGCTGCGCTACAAGGATGGCGACAAGAACGCCAACACCACGGCACTGGCGGACTACGCGGTACGTAACGTCAACAACGAGATTCGCCGTCTGCCCGGTGTCGGCAAGCTGCAGTTCTTCGACTCCGAAGCCGCCATGCGCGTGTGGATCGACCCGCAGAAACTGGTCGGTTACGGCCTGTCCATCGACGACGTCAACAACGCCATCCGCACCCAGAACGTGCAGGTGCCGGCCGGCGCCTTCGGCAGCACGCCGGGCTCCAGCGAGCAGGAGCTGACCGCGACGCTGACCGTCAAGGGCACCCTGGACAACCCCGAGGAATTCGCCGCCATCGTGCTGCGTGCCAACCAGGACGGCTCGCGCCTGACCCTGGGCGACGTGGCACGCATCGAGGTCGGCAGCCAGGACTACAACTTCGGCTCGCGCCAGGACGGCAAGCCCGCCGTTGCCGCCGCCGTGCAGCTGTCGCCCGGTGCCAACGCGATCCAGACCGCCGAGGCGGTCAAGCAGCGTCTGACCGAGCTGTCGGCCAACTTCCCGGACAACGTCGAGTTCTCCGTGCCGTACGACACCTCGCGCTTCGTCGACGTGGCCATCGACAAGGTCATCATGACCCTCATCGAGGCCATGGTGCTGGTGTTCCTGGTGATGTTCCTGTTCCTGCAGAACGTGCGCTACACCCTGATCCCGTCCATCGTCGTGCCGGTGTGTCTGCTTGGTACCCTGACCTTCATGTACCTGCTTGGCTTCTCGGTGAACATGATGACCATGTTCGGCATGGTGCTGGCCATCGGCATCTTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGGATCATGGCCGAGGAAGGCCTGGCGCCGGTGCCGGCGACCATCAAGGCGATGGGGCAGGTGTCCGGGGCGATCATCGGTATCACCCTGGTTCTGTCGGCGGTGTTCCTGCCGCTGGCCTTCATGGCGGGTTCGGTGGGGGTGATCTACCAGCAGTTCTCGCTGTCGCTGGCGGTGTCGATTCTGTTCTCGGGCTTTCTCGCGCTGACCTTCACCCCGGCGCTGTGCGCCACGCTGCTCAAGCCGATTCCTGTAGGCCATCACGAGAAGACTGGCTTCTTCGGCTGGTTCAACCGCAAGTTCACCAGCCTGACCAGCCGCTACACGAAGCTCAACGACAAGCTGGTGCCGCGAGCCGGGAGGGTGATGTTCATCTACCTGGGCGTGGTGGTGCTGATGGGCTTTCTCTACATGCGCCTGCCGGAATCCTTCGTGCCGGTGGAAGACCAGGGTTACATGATCGTCGACATCCAGCTGCCGCCCGGCGCCACCCGTGAGCGTACCTCGGCCGCTGGTGGAGAGCTGGAGTCATTTCTGATGGCCCGCGAGGCCGTGCAGACGACCTTCCTGGTGCTTGGCTTCAGCTTCTCCGGCATGGGCGAGAACGCGGCCATTGCCTTCCCGCTGCTCAAGGACTGGTCCGAGCGAGATTCTTCGCAGTCGCCGGAAGCCGAGTCGGCTGCGGTCAACCAGCACTTCGCCAACCTCGATGACGGCGCGATCATGGCGGTGCCGCCACCGCCGGTCGAAGGCCTGGGCAACTCGGGTGGTTTCGCCCTGCGCCTGCAGGACCGCGCCGGCCTTGGCCGCGATGCCCTGTTGGCAGCGCGCGATGAAGTGCTGGGCAAGGTCAACGGCAATCCGAAGTTCCTCTACGCCATGATGGAAGGTCTGGCCGAGGCGCCGCAGCTGCGCCTGGTGATCGACCGTGAGCAGGCGCGCACGCTGGGAGTCAGCTTCGAAGCGATCAGCAGCGCGCTGTCCACTGCGTTCGGCTCGTCGGTGATCAACGACTTCGCCAACGCCGGCCGCCAGCAGCGCGTGGTGGTACAGGCCGAACAGGCCGAGCGCATGACACCGGAAAGCGTCCTGCGCCTGCATGTGCCCAACGACAGCGGCAGCCTGGTACCGCTGAGTGCTTTCGTCACCACGAGCTGGGAAGAAGGCCCGGTGCAGGTCGCGCGTTACAACGGTTACCCGTCGATCCGCATTGCCGGTGACGCCGCGCCCGGCGTGAGCACTGGCGAGGCGATGCTCGAACTGGAGCGCATCGCTGCCGAGCTGCCCGAAGGTATCGGTTACGAGTGGACCGGGCTGTCGTATCAGGAGCGGGTCGCCAGCGGGCAGGCGACGATGCTGTTCGCCCTGGCCATCACCGTGGTGTTCCTGCTGCTGGTGGCGCTCTACGAGAGCTGGGCGATCCCGCTGACGGTGATGCTGATCGTGCCGGTCGGCGCACTCGGCGCGGTACTGGCGGTGACTGCTATCGGCCTGCCCAACGACGTGTACTTCAAGGTCGGCCTGATCACCGTGATCGGCCTGGCGGCGAAGAACGCCATTCTCATCGTCGAGTTCGCCAAGGACCTGTGGGAAGACGGCTACTCGCTGCGCGATGCTGCTGTCGAAGCCGCGCGCCTGCGTTTCCGCCCGATCATCATGACCTCCATGGCGTTCATGCTCGGCGTGGTGCCGCTGGCCATCGCCACTGGCGCCGGCGCTGCGAGCCAGCGCGCACTGGGCACCGGGGTGCTGGGCGGGATGCTCAGCGCGACCATGCTCGGGGTGATCTTCGTGCCGATCTTCTTCGTCTGGGTGCTGTCGCTGCTGCGCACCAAACCTCAGCAAACCGACAACCATCCCCTGCATAAAGCGGAGTAA
Drug and biocide resistance
Drug and biocide RND efflux pumps
Multi-compound
1
MEG_8420|Drugs|betalactams|Class_D_betalactamases|OXA
ATGCGCCCTCTCTTCTTCAGCGCCCTTCTCCTACTCTTCTCCGGGCATGCCCAGGCCAGCGAATGGAACGACAGCCAGGCTGTGGACAAGCTCTTCGGCGCGGCCGGGGTGAAAGGCACCTTCGTCCTCTACGATGTGCAGCGGCAGCGCTATGTCGGCCATGACCGGGGACGCGCGGAAACCCGCTTCGTTCCCGCTTCCACCTACAAGGTGGCGAACAGCCTGATCGGCTTATCCACAGGGGCGGTTAAATCCGCCGACGAGGTTCTTCCCTATGGCGGCAAGCCCCAGCGGTTCAAGGCCTGGGAACACGACATGAGCCTGCGCGACGCGATCAAGGCATCGAACGTACCGGTCTACCAGGAGCTGGCGCGACGCATCGGCCTGGAACGGATGCGCGCCAATGTTTCCCGCCTGGGTTACGGCAATGCGGAAATCGGCCAGGTTGTGGATAACTTCTGGCTGGTGGGACCGCTGAAGATCAGCGCGATGGAGCAGACCCGCTTTCTGCTCCGACTGGCACAGGGAGAATTGCCATTCCCCGCCCCGGTGCAGTCCACCGTGCGCGCCATGACCCTGCTGGAAAGCGGCCCGGGCTGGGAGCTGCACGGCAAGACCGGCTGGTGCTTCGACTGCACGCCGGAACTCGGCTGGTGGGTAGGCTGGGTGAAGCGCAACGAGCGGCTCTATGGCTTCGCCTTGAACATCGACATGCCCGGCGGCGAGGCCGACATCGGCAAGCGCGTCGAACTGGGCAAGGCCAGTCTCACGGCCCTCGGGATACTGCCCTGA
betalactams
Class D betalactamases
Drugs
1
MEG_8715|Drugs|Tetracyclines|Tetracycline_resistance_MFS_efflux_pumps|TET64
TTGAATCCTTCCATGATTGCCATCCTGACGACCGTCGTGCTTGACGCGATCGGCGTCGGGCTCGTGATGCCGATCCTGCCCGGGCTGCTGCGCACCCTCGCCGGCGCGGGCGGCGCCGACACGCACTACGGCATGCTGCTCGCGCTGTACGCGCTGGCGCAGTTCCTGTGCGCCCCCGTCCTTGGCGCGCTGAGCGACCGCTTCGGCCGCCGGCCCGTGCTGCTCGCGTCGCTCGCGGGCGCCGCGCTCGACTACCTGCTGATGGCGTATGCGCCGACGCTCGCGTGGCTCTATGCCGGGCGGCTGATCGCGGGCATCACGGGCGCGAACGTCGCGGTCGCGACCGCGTACGTCACCGACGTGACCGCGGAACCCGATCGCGCGCGCCGTTTCGGTCAATTGGGCGCCGCGATGGGGATCGGCTTCATCGCCGGCCCGGTGCTCGGCGGCCTGCTCGGCGCGTGGCATCTGCGCGCGCCGTTCGCCGCCGCGGCGCTGCTCAATGCGCTCAATCTCGCACTCGTCTGGCGGAGCCTGCCGGAATCGCGGCCGCCGGCCGCGCGCGCCGGCCGCGCCACGGTGAGCCTCAACGCGTTCGCGAGCCTGCGGCGGCTGCGCGGCGGCCCGGCGCTCGTCCCGCTGATCGGCGTCTACGTGATCGTGGCGCTGGTGTCGCAGGCGCCCGCGACGCTGTGGATCCTGTACGGACAGGCGCATTTCGGCTGGTCGACGCCGGTCGCGGGCCTGTCGCTCGCCGGCTACGGCGCGTGCCACGCGCTCGCGCAGGCGTTCGCGATCGGGCCGCTGATCGCGCGGCTCGGTGAGCGTCGCGCGCTCGCGCTGGGCCTCGCCGGCGACGCGCTCGGCCTCGTGGTCATCGCGTTCGCCAACGCGGCCTGGGTGCCGTTCGCGCTATTGCCGCTGTTCGCGGCGGGCGGCATGACGCTGCCGGCGCTGCAGGCGATGCTCGCGCGCCAGGTCGACGATGCCCGGCAGGGCGAGCTGCAGGGCACGCTCGCGAGCGTCGCGAGCCTGATCGGCGTCGCCGGGCCGCTCGTCGTCACCGCGGCCTATGCGGCAACCCGCGACGCGTGGCCCGGGCTCGTCTGGGCCGCGGCCGCGTTGCTCTACCTGCTGGTGCCGCCGCTGCTGGCCCACGCGCGGCCGGCGCGAGAAAGTCCGGCCGCGTAA
Tetracyclines
Tetracycline resistance MFS efflux pumps
Drugs
1
MEG_8653|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRB
ATGACGCTCGCGCTGACCGCCGAAAAAATCGAAAGAAACCGCTTCACTGGGCTGAAAGTTGAAAACAGCACATTTCATCACTGTGATTTCTCCGGGGCTGACCTGACCGGCACGGAGTTTATCGGCTGCCAGTTTTATGACCGCGAAAATCAAAAGGGCTGTAATTTCAGCCGCGCCATTTTGAAAGATGCGATTTTCAAAAACTGTGATTTATCGATGGCGGATTTCAGGAACGCCAGCGCGCTGGGCATCGAAATTCGTGGCTGTCGCGCGCAAGGTGCAGATTTTCGCGGCACCAGTTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCCTACATCACTAACACCAATCTTAGCTACGCCAATTTTTCGAAAGCGGTGCTGGAGAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGCACTCAGGTTCTTGGCGCGACGTTCAGTGGGTCAGATCTCTCCGGCGGGGAGTTTTCCTCATTCGACTGGCGCGCAGCCAACGTGACGCATTGCGATCTGACCAACTCAGAATTGGGTGATTTAGACGTGCGGGGCGTTGATTTACAGGGCGTCAAACTGGATAGCTATCAGGTGTCATTGATAATGGAGCGACTTGGTGTCGCGATTATCGGCTAG
Fluoroquinolones
Quinolone resistance protein Qnr
Drugs
1
MEG_8682|Drugs|betalactams|Class_C_betalactamases|RSC
ATGTACGGAAAAACCATAACCAGAGTGGGGGGCGTTGCCATTACCGCGCTGTTCCTCGGTGCCGGCAGCTGCGTCGCCGGGGATGATGTAGAAAAAAGGGTCAGGGCTGTCGTGGACGCAGCCATTCGGCCGGCTATGCAGGCGCATGCCATCCCTGGCATCGCGGTGGCGGTATCACTCAATGGGGAGCAGTATTACTTTAACTACGGCGTCGCCTCCAAAGAGAGTGGGCAGATGGTCACCGAGGATACGATTTTCGAGATCGGCTCGGTCAGTAAAACCTTCACGACGACCCTCGCATCCTACGCGCAGGAAAGTGGAGCGCTCTCCCTATCCGACCACGCAAGCCAATACCTGCCTTCGCTACGTGGCAGCAGTTTCGACAGCATCAGCCTGCTCGATCTTGCGACCTACACGCCCGGCGGTCTGCCGCTGCAGTTTCCGGACGCTGTGGACAGTCACGAAAAGATGATCGGTTATTACTACAACTGGAAACCGACCTATGCCGCCGGAACACACAGGCTCTACTCGAACCCGAGCATCGGCCTGCTCGGCTTTCTAACCGCTGAAAGCATGGGTGAGCCTTTCGAAGATCTACTGGAAAAGAAGCTGTTCCCGAAGCTCGGCCTAAGGCAGAGCTACATCAGGGTTCCACAAGAGCAGATGAGCCACTACGCGTACGGTTATAGCCGAGAGGACAAACCGATCAGGGTGGGCCCAGGCGTTCTGGATGCCGAGGCTTATGGCGTGAAATCCAGCTCGGCCGACATGATTCATTTCGTCGAGGCAAACATGCAGGCGGCTGATCTGGATGAGCCGCTGCAACATGCGATTGCCGCAACGCATAGGGGCTACTACAAGGTCGGCGACATGACTCAGGGGCTGGGATGGGAGTTTTACCCCTACCCGATAGAACTCGACCGTTTGCTTGCGGGCAACTCGGCCAAAATGATCCTTGAAGCGAATGAAATTACTCGACTCAACCCTCCGCTGATTCCGAAGGGCGACGTGCTCATTAACAAGACAGGCTCGACGAGCGGTTTTGGTGCATACGTGGCCTTTGTTCCAACCAAGGGTATCGGCATCGTGATGCTGGCGAACAAGAACTACCCCATCCCTGCAAGGGTGAAAGCCGCCCACCAAGTATTGACGGCCCTGGATGCTCGGACTGGATCTAATGCACACCATTGA
betalactams
Class C betalactamases
Drugs
1
MEG_8683|Drugs|betalactams|Class_D_betalactamases|RSD1
ATGAAAAGTTACGTAGACAAGAAATGGATGATAATCTTTCTTATAGTGTGTGTATCCTGTACTTCAAAGGCGATAAAAAAAGAAGCATTTCCTGGTTTTAAACCTTTCTTTGATGAATACGGCGTGCAGGGTTGTTTTATTCTCTACGACCTGAAGAATGATAATTACGAGATATATAACTCTCAACGATGTGAGCAGGGCTTTCTGCCCGCTTCTTCGTTTAAGATCCTTAACGCCATGATTGGACTGGAAACCGGTGTTGTGACCAGTAAAGACATGGTTATCCCCTGGGATGGGGTTACAAGGGAGGTGGAAAGCTGGAACAGGGACCATACACTGGCCTCAGCCATCCAGAATTCGGTGGTTCCTTATTTCCAGGAAATGGCCCGCCGCATAGGTCCTGAAAGGATGAAAAAGTATGTCAATGAAGCCGATTACGGGCAAATGGATGTAACGGCCCAGACTATTGATCATTTCTGGCTAAGGGGGAATTCCCGCATCACTCCCTGGGAACAGATGAACTTTCTGCTGAACTTCTACCAGAATAAGCTGCCCATTTCTGAAACCAACATTGATATTGTCAAGCAACTGATCATCCTTGAAGAAAATGAACGTTGGATCTTTAGGGGCAAGACAGGCTGGGCCAAACAGGATGGTCAGAACATTGGCTGGCTGATCGGTTATTATGAAAATGATAAAAATACCTGGCTTTATGTCTGCAACGTTGAGGCTTCAGATAACAATATCGAGAACTTCAAAGCCAGCAGACGCGGCATTACTGAAAAAGTGTTTAAATCAATGGGTTTGATGGAGTAG
betalactams
Class D betalactamases
Drugs
1
MEG_8102|Drugs|Aminoglycosides|Gentamicin-resistant_ATP-binding_protein|GAR
ATGATTATTCTGCTTAATGGACCGCTCGGAATCGGTAAATCCACGCTATCTGAGGCATTGACGGAACGGGTTGATTGGTGCGCCATGCTTGACGGCGACCACCTCATCGAACTCAATCCACCTCCTGCCAATGAGCAGGAAACGCTTCTTTCTGTGAGCACACTGCTCATTGCTCACTATCAGAGCGTCGGCTACCGCAACTTCGTTCTCAATCACCTGTGGACCGTTCCCGCCGACCTCAGTCAGTTTCGCGCCAAGCTTTCGGAGCTTGACTCAGACGTTCATTGCTTCCGTTTGACATTGCCGGTTGAGGAGAACCTCCGACGTATTGAGCGTAGAGCAAGTGCAACCGGACTTGACCGATCGTACGAGTTGGAGGTGTTTGCCGAGGAGCACACAGTTTTCTCTGGATGTTACGGACACGAACTTGGCGTTCCACTAGATGCATCGAGTTCGCCAGGCGAGCTTGCGAGCCAAGTTCTGGCGTTGCTTGGACTTCATTAG
Aminoglycosides
Gentamicin-resistant ATP-binding protein
Drugs
1
MEG_8431|Drugs|betalactams|Class_D_betalactamases|OXA
ATGAAAATTCTGATTTTACTGCTTTTAGTTAGTTGCTTGGGCCTGACGGCGTGTAGCCTGCCCGTTTCATCTTCCCCATCTCAAAGCACTTCAACTCAATCTACCCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCGCAGGTGTTTTAGTGATTCAGCGTGATCAACAGATACAGGTCTATGGCAATGATTTAAGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTTCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGCCTTGAATTGATGGAACAGGAAGTGAGACGTATTCAATTCGGCAATCAACATATTGGGCAGCAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAAGTCGAATTTGTCTCTGCGCTTGCTCAAGAGCAGCTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTTTTACAGGAACAGCAAGCTTATCGCCTATATGCCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCGCTGAATATGCAGATGCAAAATGGTATGGATCCGGCGATCCGCCTTGAGATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA
betalactams
Class D betalactamases
Drugs
1
MEG_8007|Drugs|betalactams|Class_A_betalactamases|BLAPAM
ATGCGTTTGCTCGCCAGCCTCGCGCTGCCCCTGTTCGCCGCCAACCTGGCGGTCGCCGCCCCCGCCCAGCTGCCCCAGCTGGAGGCCTACAAGGGCCTCGACGCCTGGCTGGTGCCGGTGGAGCCCCTGCGCATCAGCGACCACGTGTGGCAGATCGGCACCGCCAGCATCAGCGCCCTGCTGGTGAAGACCGACGCCGGCGCGGTGCTCATTGACGGCGGCATGCCCCAGGTGGCCGACCACCTGCTGGCCAACATGAAGAAGCTCGGCGTGGCCCCGCAGGATGTGCGCCTGATCCTCCACAGCCACGCCCACATCGACCACGTCGGCCCGCTGGCGGCAATCAAGCGCGCCACCGGCGCCATGCTGGTGAGCAACGCCGAATCCGCCGTGCTGCTGCAGCGCGGCGGCGCCAACGACATCCACTTCGGCAGCGGCATGCTCTTCGAACCGATCCAGACCGACCGCCTGGTGCAGGACGGCGAGGCCGTGACCCTGGGCGACACCACCTTCACCGTGCACTTCACCCCGGGGCACACGCCCGGCAGCATGAGCTGGACCTGGGCCGACACCCGGGACGGCAAGCCCCTGCGCATCGCCTACAGCGACAGCCTCAGCGCGCCGGGCTACCAGCTGCGCCACAACGCCCGCTACCCGCACCTCGTGGAAGCCTTCCGCGCAAGCTTCGCCGCCGTCCGCGCCCTGCCCTGCGACCTGCTGCTCACGCCCCACGCCGAAGGCAGCGGCTGGGACTACGCCAACGCCGCCAGGCCGCACCCGCAGCCGGTCAGCTGCAAGGCCTACGCGGACAAGGCCGAGGCGAATCTCGACAAGATGCTCGCCGAGCAGGCGAACAAGCGCTGA
betalactams
Class A betalactamases
Drugs
1
MEG_8069|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA
TTGAAAATTTCATTAATCGCAGCGCAGTCAGAAAATGGCGTTATTGGTAATGGTCCAGAAATTCCATGGTCGGCGAAAGGTGAGCAGTTACTATTTAAAGCGCTAACATATAATCAGTGGCTTCTTGTTGGAAGAAAAACGTTTGAGTCTATGGGTATTCTTCCAAATAGAAAGTATGCTGTTATTTCAAAAAATGGAATTTCACCTCATCCTGAAAATGTACTAGTATTTTCGTCCATTGAAAATGCATTAAATGAATTGCCCAATATAACAGAGCATTTATATATTTCTGGCGGTGGTCAAATATATAATAGCCTTATTGAAAAGGCAGATACTATCCACTTATCTATTGTTCACACGGTGGTAGAAGGCAATGTAATATTTCCAAAAATACCTTCTAATTTCAATTTGGTATTTGAGCAATTCTATTCGTCAAATATTAATTATACTTATCAAATTTGGCAAAAAGGTTAA
Trimethoprim
Dihydrofolate reductase
Drugs
1
MEG_8034|Drugs|betalactams|Class_C_betalactamases|CMY
ATGATGAAAAAATCAATATGCTGCGCGTTGCTGCTGACAGCCTCTTTCTCAACGTTTGCCGCGTCAAAAACAGAACAACACATTGCCGATATCGTCAATCGCACCATCACACCGCTGATGCAAGAACAGGCTATTCCGGGTATGGCCGTGGCGATTATCTACCAGGGGAAACCGTATTACTTTACCTGGGGTAAAGCCGATATCGCCAATAACCGTCCCGTTACTCAGCAAACACTGTTTGAACTTGGCTCGGTCAGTAAGACGTTCAACGGCGTGTTGGGTGGCGATGCTATCGCCCGCGGCGAAATCAAGCTCAGCGATCCGGTCACGCAATACTGGCCAGAATTGACGGGCAAACAATGGCGGGGTATCAGCATGCTGCACTTAGCCACCTATACGGCGGGTGGTCTGCCGCTTCAGATCCCCGACGACGTTACGGATAAAGCCGCATTACTGCGCTTTTATCAAAACTGGCAGCCGCAATGGGCTCCAGGTGCTAAACGTCTCTATGCTAACTCCAGTATTGGCCTGTTTGGCGCACTAGCGGTGAAACCTTCAGGGATGAGCTATGAAGAGGCGCTAACCAGACGCGTCCTGCAGCCTTTAAAACTGGCGCATACCTGGATTACGGTTCCACAGAGCGAACAAAAAGATTATGCCTGGGGCTATCGCGAAGGAAAGCCAGTGCATGTTTCCCCCGGACAACTTGATGCCGAAGCCTATGGCGTGAAATCCAGCGTCGTCGATATGACTCGTTGGGTTCAGGCCAACATGGACGCCAGCCAGGTTAAGGAGAAAACGCTCCAGCAGGGCATTGAGCTTGCGCAATCACGTTACTGGCGTATTGGCGATATGTATCAGGGACTGGGCTGGGAGATGCTTAACTGGCCGGTGAAAGCCGACTCGATAATCAGCGGTAGCGACAGCAAAGTAGCGCTGGCAGCACTTCCCGCCGTTGAGGTAAATCCGCCAGCCCCGGCCGTGAAAGCCTCATGGGTGCATAAAACAGGGTCTACTGGCGGATTTGGCAGCTACGTTGCCTTCGTGCCAGAAAAAAAACTTGGCATCGTGATGCTGGCAAACAAAAGCTACCCTAACCCGGCTCGCGTAGAGGCCGCCTGGCGCATCCTGGAAAAGTTGCAATAA
betalactams
Class C betalactamases
Drugs
1
MEG_8655|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRB
ATGACGTTGTCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTAAACTGTGATTTTTCGGGCGTCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAACCAGAAAGGGTGCAATTTCAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCAATGGCGGATTTTCGCAACGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAGGGTGCAGATTTTCGCAGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAACCGATGGATGGGAACTCAGGTGCTGGGTGCGACCTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGACTGCAAATTTTACGCATTGTGATTTGACCAATTCCGAACTGGGTAATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTACCAGGCCGCGTTGCTGATGGAGCGGCTTGGTATCGCTGTGATTGGTTAA
Fluoroquinolones
Quinolone resistance protein Qnr
Drugs
1
MEG_8239|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR
ATGCCTTCCCTTATAAAAATAAAAATTGTTCCGCTTATGTTTTTTTTGGCACTGTATTTTGCATTTATGCTGAACTGGCGTGGAGTTCTCCATTTTTACGAAATCCTTTACAAATTAGAAGATTTTAAGTTTGGTTTCGCCATTTCATTACCAATATTGCTTGTTGCAGCGCTTAACTTTGTATTTGTTCCATTTTCGATACGGTATTTAATAAAGCCTTTTTTTGCACTTCTTATCGCACTTAGTGCAATCGTTAGTTACACAATGATGAAGTATAGAGTCTTGTTTGATCAAAACATGATTCAGAATATTTTTGAAACCAATCAAAATGAGGCGTTAGCATATTTAAGCTTACCAATTATAGGATGGGTTACTATTGCTGGCTTTATCCCTGCCATTTTACTTTTCTTTGTTGAAATTGAATATGAGGAAAAATGGTTCAAAGGGATTCTAACTCGTGCCCTATCGATGTTTGCATCACTTATAGTGATTGCGGTTATTGCAGCACTATACTATCAAGATTATGTGTCAGTGGGGCGCAACAATTCAAACCTCCAGCGTGAAATTGTTCCAGCCAATTTCGTTAATAGTACCGTTAAATACGTTTACAATCGTTATCTTGCTGAACCAATCCCATTTACAACTTTAGGTGATGATGCAAAACGGGATACTAATCAAAGTAAGCCCACGTTGATGTTTCTGGTCGTTGGTGAAACCGCTCGCGGTAAAAATTTCTCGATGAATGGCTATGAGAAAGACACCAATCCATTTACCAGTAAATCTGGTGGCGTGATCTCCTTTAATGATGTTCGTTCGTGTGGGACTGCAACCGCTGTATCTGTCCCCTGCATGTTCTCCAATATGGGGAGAAAGGAGTTTGATGATAATCTCGCTCGTAATAGCGAGGGTTTGTTAGATGTGTTGCAGAAAACGGGGGTCTCCATTTTTTGGAAGGAGAACGATGGCGGCTGCAAAGGCGTCTGCGACCGAGTTCCTAACATCGAGATCAAACCGAAGGATTACCCAAAGTTCTGCGATAAAAACACATGCTATGACGAGGTTGTCCTTCAAGACCTCGATAGTGAAATTGCTCAAATGAAAGGGGATAAGCTGGTTGGCTTCCACCTGATAGGTAGCCATGGCCCAACCTACTACAAACGCTACCCTGATGCTCATCGTCAGTTCACCCCTGATTGTCCACGCAGTGATATCGAAAACTGCACGGATGAAGAGCTCACCAACACCTATGACAACACCATCCGCTACACCGATTTCGTGATTGCAGAGATGATTGCCAAGTTGAAAACCTACGAAGATAAGTACAACACCGCATTGCTCTACGTCTCCGATCACGGTGAATCACTGGGAGCTATGGGGCTTTACCTGCACGGTACACCGTACAAGTTTGCACCGGATGATCAGACCCGCGTACCTATGCAGGTGTGGATGTCACCTGGTTTCATCAAAGAAAAAGGCATGAATATGGAATGTTTGCAGAAAAATGCCGCAGCCAATCGCTATTCTCATGACAACATATTTTCTTCTGTCCTGGGAATATGGGATGTGAAGACAGCTATCTACGAACAAGAATTAGATATCTTTAAGCAATGTCGGAATAATTGA
Lipopeptides
Colistin phosphoethanolamine transferase
Drugs
1
MEG_7904|Drugs|betalactams|Class_C_betalactamases|ACT
ATGAAGACAAAATCCCTTTGCAGTGCCCTGCTGCTCAGCACCTCCTGCTCTGTTCTCGCCGCGCCGATGTCAGAGAAACAGCTGTCTGACGTGGTGGAACGTACCGTTACCCCCCTGATGAAAGCGCAAGCCATTCCGGGCATGGCGGTAGCGGTGATTTATCAGGGTCAGCCGCACTACTTTACCTTCGGAAAGGCCGATGTTGCGGCGAACAAACCTGTCACCCCGCAAACCCTGTTTGAGCTGGGCTCTATAAGTAAAACCTTCACTGGCGTATTAGGTGGCGATGCGATTGCGCGCGGAGAAATATCGCTGGGCGACCCCGTGGCAAAGTACTGGCCCGAGCTAACAGGCAAGCAGTGGCAGGGTATTCGCATGTTGGATCTGGCGACCTACACCGCGGGTGGCCTGCCGCTACAGGTGCCGGATGAGGTCACGGATAACGCCTCCCTGCTGCGCTTCTATCAACACTGGCAACCGCAGTGGAAACCAGGCACAACGCGTCTTTATGCGAACGCCAGCATCGGGCTTTTTGGCGCCCTCGCGGTTAAACCCTCCGGTATGAGCTTTGAACAGGCCATGACGAAGCGGGTCTTCAAGCCACTCAAACTGGACCATACATGGATTAACGTTCCGAAAGAAGAAGAGGCGTATTACGCCTGGGGATACCGTGATGGTAAAGCGGTCCACGTTTCACCGGGAATGTTGGATGCCGAAGCGTATGGTGTCAAAACCAACGTCCAGGATATGGCGAGCTGGGTGAAGGCCAACATGAACCCTGCCGCTCTTCCGGATTCAACGCTGAAACAGGGTATTGCCCTGGCACAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAGGGTCTGGGCTGGGAGATGCTCAACTGGCCGGTAGAATCCAAAACCGTCGTGGAGGGCAGCGATAACAAGGTGGCTCTTGCACCGTTACCGGTGGCAGAAGTGAACCCTCCAGCTCCGCCAGTAAAAGCATCATGGGTACATAAAACAGGCTCGACGGGTGGATTCGGCAGCTATGTCGCATTTATTCCTGAGAAGGAACTCGGCATTGTTATGCTGGCGAACAAGAGCTACCCGAACCCGGCGCGCGTGGAAGCGGCATACCGTATTCTGAGCGCTCTGCAGTAA
betalactams
Class C betalactamases
Drugs
1
MEG_8713|Drugs|Tetracyclines|Tetracycline_resistance_MFS_efflux_pumps|TET62
ATGCAGACGGAAGCACGGATCAATAAATCTCTGGCCATTGTGCTCAGTGTCATTGTGCTGGATGCAATGGGGCTCGGGCTTGTGATGCCGGTTCTGCCGGAGTTGTTGCGCGGACTGGTGCCAGGCGGACAGGTAACAGGGCATTATGGTATGTTGCTGGCTGTCTATGCGCTGATGCAGGTGTTCTTTGCGCCGCTGCTAGGGCGATTGTCAGATCGCTATGGCCGCCGTCCGGTGCTGATTATGTCGCTTGCCGGTGCAGCAATTGACTATGCCGTCATGGCAGCAGCACCGGTGCTCTGGGTGATTTATATCGGCCGCATGATTGCCGGTATTACCGGAGCGACAGGTGCGGTTGCGGCATCGGCGATTGCCGATACGATGCCGTCAAACCAGCGGGCGCGCTGGTTCGGTTATATGGGCGCCTGTTACGGTGCCGGAATGATTGCGGGGCCTGCGATCGGCGGGCTGGCAGGCAGCCTGTCTGTGCACGCCCCCTTTATCGCGGCTGCTGTACTGAACGGAACCGGTTTTCTGCTGGCTTATCTTTTTCTCAAAGAGACACGTCCGGCAGGTTCGCAGCCGGCAGTTTCAGAAACATTCAGTTTGCGTGAGTTTCTGTTGCCGGTCAGCTTTCTCAAAGGGATGACCGCACTTGCGCTGGTGTTTTTCATTATCCAGCTGGTGGGGCAGCTTCCTGCAACATTGTGGGTGATCTATACGGAAGATCGTTTCGCGTGGGACACAACCATGGTCGGCTTTTCACTGGCGGCTTTCGGTGCCGTGCATACCGTGTTTCAGGCTTTTGTGACCGGCCCGCTCTCAGCCCGTTTTGGTGAGCGCCGCACATTGATCATCGGCATGGCTGCCGATGCCTGCGGTTTTCTGGCGCTGGCCATGATCACGCAAAGCTGGATGATACTGCCGGTACTATTGCTGCTGGCAACCGGCGGTGTCGGCATGCCCGCATTGCAGGCAATGTTGTCTGGGGCTGCCGGAGAGGATGAGCAGGGGAGTTTGCAGGGCACACTGACCAGCCTGACGAACCTGAGTTCGATTATCGGGCCCCTTGGTTTCTCGGCTTTCTACGCAATAACCGCAGTTGCATGGAATGGCTGGGTGTGGATTGGCGGTGCTGCGCTTTATTGCATCAGCTTCGCGATCCTGCGCCGGTCTTCATAA
Tetracyclines
Tetracycline resistance MFS efflux pumps
Drugs
1
MEG_8066|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA
TTGAAAGTATCATTGATGGCTGCAAGAGCGAAAAATGGCGTAATCGGTTGCGGTCCTAACATTCCTTGGTCTGCCAAAGGGGAACAGCTTCTTTTCAAAGCACTGACCTATAACCAATGGCTTTTGGTAGGGCGCAAAACATTTGAGTCTATGGGGCCGCTGCCCAATAGGAAATACGCGGTTGTTACCCGCTCAAACTGGACAGCGGCTAATGAAAACGTAGTGGTTTTCCCGTCGATTGACGAAGCGATGGGTAGATTAGGCGAGATCACTGACCATGTCATCGTCGCCGGTGGTGGAGAAATCTACCATGAAACGATACCCATGGCCTCTACTCTGCATGTGTCGACAATCGACGTTGAGCCAGAGGGAGACGTTTTCTTTCCGAACATTCCTGGGAAGTTTGATGTCGTTTTTGAGCAACAATTTACATCAAACATTAACTATTGCTATCAAATCTGGCAAAAGGGTTAA
Trimethoprim
Dihydrofolate reductase
Drugs
1
MEG_8068|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA
TTGTTTTTGAGTGTGGGTATGGCATTTCAGGATTTAGAAGTCGTTCATGTCGTTGCAATGGATCAGCAGCGCTGTATTGGTAAGGACAATGACCTGCCTTGGCATATCTCAGCAGATCTAAAACATTTTAAGGAAATCACCCAGGGCGGTGTAATTGTAATGGGACGTAAGACCCTTGAATCCATGGGACGTGCCTTGCCTAAACGTGTCAACTGGGTCATTACCCGTGATACAGACTGGTCTTTTGAAGGTACTAAAGTCGCACACACGATTGAAGATGCCTTGAACCAAGCTGTTGCAGATGTAAAAGCGTCAGAAAAACCGGAGTCTATTTATATTATTGGGGGTGGTGAAATCTTCAAACAGACAATGAGTATTGCTGACCGTCTGGAACTGACCCATGTCGAACTGGATGTACAAGGTCATGCCTTCTACCCGGAAATTCCTGCTGAATTCAAAAAAGTTTTTTCCGAACAACATATCGACGACAAAACTGGGATTGCTTTTGAGTTTGCAACTTATAGAAAATGA
Trimethoprim
Dihydrofolate reductase
Drugs
1
MEG_8719|Drugs|Tetracyclines|Tetracycline_inactivation_enzymes|TETX
ATGAGTTTATTAAACAATAAAAAAGTTGCAATTATCGGTGGCGGACCAGTTGGACTAACAATGGCAAACTTGTTACAACAAAACGGTATTGACATTACCGTTTACGAAAGAGATGAAAACCCAAAAGCACGAGTTTGGGGCGGAACGCTTGACCTTCACAAAAATTCAGGACAAGAAGCAATGAAAAAAGTAGGATTGTTGCAAACCTACTATGATTTGGCGCTACCTATGGGCGTAAACTTTGCTGATGAGAAGGGTAACATTATAGCAACAAGAAACCCGACACTCGAAAATAAGTTTGACAACCCCGAAATAAATAGAAACGCGTTGCGAAAAATGTTGCTTGGCAGCTTGAAAAATGACACAGTTGTTTGGGATAGAAAATCTATTGGGCTTGAACAAGAAAACGGAAAATGGCTGCTACATTTTGAAAATAAGCCAACTGCATTGGCCGACTTTATTATTGTTTCCAATGGTGGAATGTCTAAAATAAGAAATTTTGTTTCAGATAATGAAGTCGAAGAAACAGGTACTTTTATTATTCAGGGCGACATTCCTGAACCAGAAACGAACTGCCCTGAATTTTATAAGTTGTGCAACAACAATAGACTAATGACCGCACATCAAGGGAATTTATTAGTTGCGAATCCATTTAACAACGGAATGTTAACTTACGGTGTCATTTTCAAAAAGCCTGAAGAATGGAATAATGGAAAAGGATTAGATTTTAAGCCCACAAAAAGCGTTTCCGAGTTCTTGACAAACAGGTTTTCAAATTGGAGCAATGAATACAAGGAGTTAATTCGTTCAACAACTTTTTTCGTTGGTTTAACAATAAAAATATTTCCGCTAGACAAAAAGCCTTGGAAGAGTAATCGTCCGTTACCCATAACTTTAATTGGCGACACAGCTCACCTAATGCCACCTTTTGCAGGGCAGGGCGTAAACATTGGACTAATGGACGCTTTGATTTTGTCAGAAAATCTTACAAACGGGAAATTTGGAACGATACAAAGTGCTATTGATGACTATGAACAACGAATGTTTGTTTACGCAACAGAAGCACAAGCGGACTCGACAAAGAATGAAATAGAAATGCGAAATCCGAGCTTTACTTTTCAACAGCTAATGAATGTATAA
Tetracyclines
Tetracycline inactivation enzymes
Drugs
1
MEG_8658|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRVC
ATGGAAAAATCAAAGCAATTATATAATCAAGTAAACTTCTCACATCAGAATTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGGTCAAACCTTCGAGATTCACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTCCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAACTTATTGAAAAGTGTGATCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCGGCAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAACTTAATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATAATTGTTCCTGACTAA
Fluoroquinolones
Quinolone resistance protein Qnr
Drugs
1
MEG_8240|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR
ATGCCCGTACTTTTCAGGATGAGGGTAATCCCCCTGGTTTTACTTCTGGCACTCGTTTTTGCATTCTTACTTAACTGGCCGGTGTTGCTGCATTTCTACGATATCCTGAGCCGTCTTGAACATGTGAGGGCGGGGTTCGTCATCTCCATTCCGTTTGTGCTGGTTGCAGCGCTTAACTTTGTGTTTATGCCCTTCTCGGTTCGCTACCTGCTTAAACCCTTCTTTGCCCTGTTGCTGGTCACCGGTTCGGTGGTGAGTTACGCCACACTGAAATATAAAGTGATGTTTGATCAGTCCATGATCGAAAATATACTGGAAACAAACCCACAGGAAGCGCATTCCTACCTGAATGGCTCACTGGTGCTGTGGCTGGTCTTTATGGGCATTCTTCCGGCTATCCTGTTGTTTTTGATTAAAATTGAATATACAGACAAATGGTACAAAGGGGTTGCCCACCGGCTGCTTTCCATGCTCGCTTCGCTGATCCTGATTGCAGGTGTTGCCGCTCTGTATTACCAGGATTATGCTTCTGTCGGGCGCAATAACCCGACGCTGAACAAAGAAATTATCCCGGCAAACTATGCGTACAGCACTTTCCATTACGTGAAGGATACCTATTTTACGACGAAAATGCCTTTCCGGACGCTGGGGGATGATGCAAGGCGCGTTACCCGGAATGGTAAACCCACGCTGATGTTCCTGGTAATTGGCGAAACGGCACGGAGCCAGAATTTCTCCATGAACGGCTACCCGCGTGACACAAATGCCTTTACCAGCAAAATCGATGGCGTTATTTCGTTCAGGAATATGCGTTCCTGCGGCACGGCGACCGCAGTCTCGGTGCCCTGTATGTTCTCGGATATGAACCGGACGGATTACGATGGTAAAAAGGCTGCCGGCAGTGAAAATGTCCTCGACATTGTGCAGAAAACGGGGGTTTCGCTGTTGTGGAAAGAAAACGATGGCGGGTGTAAAGGCGTATGCAGCCGTATCCCGACTGTCGAAATTAATCCCGGTATCAGTAAAAAACTGTGTGACGGTAAAACCTGCTATGACGATGTTATGCTGGAAAACCTGGATACCGAAATCGGCAAAATGGCCGGAGACAAGCTGATCGCCTTCCATATGATTGGCAGCCATGGACCGACCTATTACCAGCGTTATCCGGCAGAGCATCGTCACTTCATGCCGGAATGTGCGCGCAGCGATATCGAAAACTGCACGCAGGAACAGCTGGTTAATACCTACGACAATACCATTCGCCACACCGACTATGTGTTAGCGCAGATGATTGAAAAGCTTAAGCAATACAGCGAACAGTACAACACCGTACTGCTGTATGTGTCCGATCACGGCGAATCTCTGGGAGAGAGCGGACTGTATCTGCACGGTACCCCCTACAAACTGGCACCGGATCAGCAGACGCACATCCCGATGCAGCTCTGGATGTCGCCAGACTTCATTGCTGCTAAAAATATTAACGCCGCGTGTCTGCAGCATAATGCCGTTAACAGGACATATTCCCACGATAACCTTTTCGCGTCCGTACTGGGGCTCTGGGACATCACCACCGGGGCCTATCTTCCGGAAAGCGACCTGTTCCGCGAATGTCGTGGATAG
Lipopeptides
Colistin phosphoethanolamine transferase
Drugs
1
MEG_8638|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT
ATGAAAGGTAAAAATATGAATTTAGCCTTTGGGTTGGAAGAAATTTATGAGGATGCTGAGTTTCAAATCGGAGATTTGGATAAGGTCGGTATTGTCGGCGTGAACGGAGCCGGAAAGACCACCTTGTTCCGCCTGCTGTTGGGAGAACTTGAACTTGATAATGGTTCACTGACCAGTGGAAATGCCCGTATTGGTTATCTCCCACAGGAAATTGTCTTGGAAGATGAGGATATTACCGTTTGGGATTTCCTTTTTGAGGGACGTCCGATTAAAAAGTATGAGCAGGAATTGGAAGAAATCTATAAAAAGCTTGAAACCGCAGTCAATGCAGAGCAGGAAGCACTGCTTGCCCGAATGGGAACATTGCAAGAACGCTTGGAGTATTTCGACTTCTATGAGGCAGAAACAATTCTGTTGGAGTTTGCAGATAAAATGAGCATTGATGCAGAATTATATCATCGTCCGATGAGAGAGCTTTCAGGCGGACAAAAATCCAAAATGGCATTTGCCAGACTACTATATTCAAAACCGGAAATTCTATTGTTGGATGAGCCTACCAACCATTTAGATGTCAGCACAAAGGATTTTGTTATAAAATACTTAAAGAATTATAGGGGTTCGGTACTGATTATCAGCCATGATATTGATTTTCTAAATCGGATTATCAACAAAATTATGTACATCAACAAAGCTACCCATAAAATATCTGTTTATGATGGAGACTACTACATCTACAAGAAAAAGTATGCAGAGGAACAGCGGATTCGTGAAATGGCGATTGTACAGCAGGAAAAAGAAATAAAGGAGCTTTCCGATTTTGTACAAAAAGCAAAACAAGCCAGTCAGACCAATCATCACCTCAAACGAATGGGTCAAGAGCGAGCCTTGCGGCTTGATAAAAAGCGTGGAGAGCTGCAAAAGAGAAATCGACTGTACAAGCGTGTGAAGATGGATATTCGCCCCAAGCGTGAAGGGGCACAAGTTCCCTTAGAGGTGGAAAATATCACCTTCCACTATTCGGGGTATCCCACCCTTTATCAGAACCTTTCCTTTCAGATTAACGGAAGAGAACGATTTCTTGTGGTGGGTGAAAACGGTGTCGGTAAATCCACCTTATTGAAATTGATGATGGGTATTCTCAGTCCAGATGAAGGATGCATTCGCTTTAACCAGAAAACTGATATTGCATATTATGCACAGGAACTCGAACAGCTTGATGAAAACAAAACGGTCATTGACAATGTGGAGTCTGAAGGATATACACCGTGGCAAATCAGAGCCGTACTGAGCAACTTCCTGTTTTATGATGACGATGTAAACAAGAAAGTATCTGTGCTGTCCCCTGGAGAAAAAGCAAGGGTTGCCCTTTGCAAAATCCTATTACAGAAAGCCAATCTTTTGATACTGGACGAGCCGACCAACCACCTTGACCCAGAAACGCAGAAAATCATTGGCGGCAACTTCAATTTGTTTGAGGGAACCATTATTGCCGTTAGCCATAACCCATCCTTTGTGGAACAAATCGGAATTAGCCGTATGCTTATTTTGCCCAGCGGTCGAATTGAACCCTATTCCCGTGAGCTGCTTGAGTATTATTATGAAATCAACACTCCCGAAGAAGAACAGAAATACTAA
Multi-drug resistance
Multi-drug ABC efflux pumps
Drugs
1
MEG_8207|Drugs|betalactams|Class_A_betalactamases|KPC
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGGATGACAAGGATGACAAGTACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8421|Drugs|betalactams|Class_D_betalactamases|OXA
ATGACAATCCGAATCTTTGCAATATTTTTCTCCACTCTTATTTTTGCCACTTTCGCGCATGCACAAGAAGGCACGCTAGAACGTTCTGACTGGAAGAAGTTCTTCGACGATTACCAAGCCAAAGGCACGATAGTTGTGGCAGACGAACGTCAAGCAGATCGCATCCTATCGGTTTTTGATCAAGCACGGGCGACAAAACGTTACTCGCCTGCATCAACATTCAAGATTCCACACACACTTTTTGCACTTGATGTAGGTGCTGTTCGTGATGAGTTCCAGGTTTTCCGATGGGACGGTATTAAACGAAGCTTTGCAGGACACAATCAAGACCAAAACTTGCGATCAGCTATGCGAAACTCTACGCTCTGGGTTTATGAGCTATTTGCAAGAGAGATCGGTGAGGAAAAAGCCAAACGCTATTTAAAGCAAATAGGTTATGGCAACGCCGACCCTTCGACAAGCAAAGGCGATTATTGGATAGATGGCACTCTAGAAATTTCTGCGTACGAACAGATTTCGTTTCTCAGAAAACTCTATCGAAATGAATTGCCATTTCGGGTAGAGCATCAGCGCTTGGTCAAAGATCTCATGATTACGGAAGCCGGGCGCAACTGGATTCTGCGCGCAAAGACTGGCTGGGAAGGTAGGTTTGGCTGGTGGGTGGGATGGGTTGAGTGGCCTACCGGCGCCGTATTCTTCGCATTGAATATCGATACGCCAAACAGAATGGATGATCTTTTCAAAAGAGAGGCAATCGTGCGGGCAATCCTCCACTCTATCGACGCGTTGCCGCCCAACTAGT
betalactams
Class D betalactamases
Drugs
1
MEG_7972|Drugs|betalactams|Class_B_betalactamases|AIM
ATGACGCTCCGCTCCACCCTGCTTTCCGCTCTGGTCGCGCTCGCGCTTCCCTCCGCCGCGCTCGCTTCCGACGCGACCACGGCCAAAGCCTGCGCCGACGATGCCGGCTGGAACGATCCCGCCACGCCGCTGAAGGTCTACGGCAACACCTGGTACGTCGGCACGTGCGGCATCAGCGCCTTGCTGGTGACCTCCGATGAAGGCCACATCCTGGTCGACGCCGCCACGCCGCAGGCCGGCCCGCAGATCCTCGCCAATATCCGCGCCCTCGGCTTCAAGCCGGAGGATGTGCGTGCCATCGTGTTCTCGCACGAGCACTTCGACCATGCCGGCAGCCTGGCCGAGTTGCAGCAGGCCACGGGCGCGCCTGTGTATGCGCGTGCGCCTGCCGTTGCCACGCTCAAGCGCGGCGCCAGCGATCGCAGCGATCCGCAGCATGAGGTACTCGATCCGTTCGCGCCGGTCCAGCAGGTGGTCGTACTCGACGACGACGGCGTGGTGCGTGTCGGTCCGCTCGCCCTGCAGGTCGTTTCCACGCCGGGACACACGCCCGGCGGCACCAGCTGGACCTGGCGCTCGTGCGAGGGCGACGACTGCCGGCAGATGGTCTACGCCGACAGCCTGACCGCGATCTCCGACGACGTGTACCGCTACAGCGACGATGCGGCGCACCCTGGTTACGTGGCGGCATTCCGCGAGACGCTGGCGCGGGTCGCGGCACTCGAGTGCGACATCCTGGTGACGCCACATCCGTCGGCCAGCCAACTCTGGTCCCGCATCGGTCCTCGCGCCGACCGCCCGCTGGTCGACACCAGCGCCTGCCGCACCTATGCACAGACCGCGACGCAGCGGCTGGACAAGCGGCTCGCGGACGAAGCGTCGAAGCCCCCCGTGCCTGCGCCTTGA
betalactams
Class B betalactamases
Drugs
1
MEG_8416|Drugs|betalactams|Class_D_betalactamases|OXA
ATGAATAAAGGTTTGCACAGAAAGCGCCTGAGTAAGCGTTTGCTGCTGCCCATGTTGTTGTGTTTATTGGCTCAGCAAACGCAGGCAGTGGCAGCGGCGCAGACCAAGGTCAGTGAAGTCGGCTCTGAGGTCACGGTCGAGGGTTGGCAAGAGGTACGCCGCTGGGACAAGTTGTTTGAATCTGCAGGTGTTAAAGGCTGTTTGCTGCTTTTGGATCAAAAGCGTTCTTTGGGGCTATCTAACAATCTAAGTCGCGCCGCCGAAGGCTTTATTCCTGCTTCTACCTTCAAGATCCCCTCTAGCCTGATTGCGTTGCAAACCGGGGCGGTGCGCGATGAAACCAGTCGTTTTAGCTGGGACGGAAAAGTTCGGGAAATTGCTGCCTGGAACCGGGATCAGAGTTTTCGCACCGCAATGAAGTACTCCGTGGTGCCTGTGTATCAGCAGCTGGCCAGGGAGATAGGCCCCAAAGTGATGGCAGCTATGGTGCGGCAACTGGAATATGGTAATCAGAATATCGGTGGCCAAGCGGACAGCTTCTGGCTCGACGGTCAACTTAGGATAACGGCGTTCCAACAAGTGGATTTTCTGCAGCAACTGCATGACAACAAGTTGCCTGTGTCTGAGCGCAGCCAGCGAATTGTCAAACAGATGATGCTGACCGAAGCGAGTACTGACTATATCATTCGCGCCAAGACAGGCTATGGTGTACAGCAAACGCCGGCCATAGGTTGGTGGGTCGGTTGGTTGGAGTTGGACGACAATACTGTCTATTTCGCCATTAATCTGGAGCTGACCTCCGCAAGCCAGTTACCGTTGCGCCAACAACTGGTGAAACAGGTGCTCAAGCAGGAACTGCTACTGCCTTGA
betalactams
Class D betalactamases
Drugs
1
MEG_8681|Drugs|betalactams|Class_A_betalactamases|RSA
ATGCAACTAGCTAGGTCGACGATCCTCACTGTTTTGCTCTGTCTGCCGATTGCTGTAACGGCTACGACTAAGGAGGAGATCCAAAAGATTGAGCGTCAGCGCAACCTCACGGTTGGCATCGCTCTTGTAGACGACGGGGGAACACTCCTGTTCGGTCATCGCGAAACGCAGCGCTTCGCCATGTGCTCGACATTTAAGTTGCCGCTGGCGGCTGCAACGCTTAAGCAAATCGAGAGCGGAAAGTGGTCTGCCGCCGAGCGGCTGAGCTATAGCGCTGGCCAATTAGATGCCTACGCGCCAGCTGCCAAGAGATATCTACCTACAGGCTACATCACGGTAGCTGAGGCTAACCAAGCCTCGGTCCAGCTCAGCGATAATACTGCTGCCAACTTGCTGCTTGACAAACTCGGAGGGCCATCGCAGCTCACATCCATGTTTCGCTCCCTCGGCGATTCCGTGAGTCGCCTGGATAGAAGAGAACCCGATTTGAACACCAACGTTTCGGGTGACCCGCGCGACACGACTACGCCGGGCGCGATGGCACGCATTGTCGCAAAGCTGGTATATGGAAACTATCTAAGTACAGCAGGCCGAGAGCAATTGCAGCGGCTTCTCATTGGCAATAACACAGGCGACTCGAGGATTCGCGCTGGAATCGCATCTGGCTGGACGACTGGCGACAAAACGGGTTCCTGCGACAATGGCGGACGAAATGACGCTGCGTTCCTGGTAAGCCCTGATGGCCGCAGATTTGCGCTGACAGTGTACCTGAACGCCCCATCGCTTGACGACAAGGCACGGAACGAGGTGGTCGCTACGGTAGCTCGCTTGGCGGTTGAGAGTATCCGCTAG
betalactams
Class A betalactamases
Drugs
1
MEG_8695|Drugs|betalactams|Class_C_betalactamases|SFDC
ATGCTGAAGAAATCCCTATCCTGTGTGCTGTTGCTCGCCACCTCAAGTTCAGTGTTTGCCGCACCGCAAACGGAAAAACAGATAGCCGACATTGTTAATCGCACCGTTGCGCCATTGATGCAAGAGCAGGGCATTCCCGGCATGGCCGTGGCGGTGATTTATCAGGGGCAGCCTTACTACTTCACCTGGGGATTGGCAGACGTTGCCGGCAAGCAACCCGTCACGCAGCAGACCTTATTCGAGCTGGGTTCGGTCAGTAAAACGTTCACAGGAGTGCTGGGCGGTGATGCCATTGCTCGCGGTGAAATCAACCTAAGCGATCCGGCGAGCAAGTACTGGCCAGCACTGTCTGGCAAGCAATGGCAGGGGATCACCTTGCTGCACCTGGCAACCTATACCGCCGGTGGCTTACCGCTGCAGATACCGGAAAATGTTACCGATGAAGCATCGCTGCAGAATTATTATCAAACCTGGCAACCGCAGTGGGCTCCGGGCACCAAGCGCCTATACTCGAACGCCAGTATTGGCCTGTTTGGCGCACTGATGGTCAAACCGTCAGGCATGAGTTTTGAACAGGCGATGACCCAACGCGTGTTCCAACCGTTGAAGCTATCGCAAACCTGGATAAACGTGCCGCAGCAGGAAGATAAGCACTACGCCTGGGGCTATCGCGATGGGAAAGCGGTTCGCGTTTCTCCGGGCATGTTTGATGCCGAAGCCTACGGCGTTAAGTCGTCGATAGAGGATATGGCAAGCTGGGTTCAGGCTAACATGGCGCCTGCTAAAGTGAAGGATGCCTCGCTGCAGAAGGGGATTACGCTTGCCCAGTCGCGCTACTGGCATGCCGGTGATATGTATCAAGGTCTGGGTTGGGAAATGCTGAACTGGCCGGTTAAAGAGAAAACTGTGGTCGAGGGTAGCGATAATAAAAACGCACTGGCAGCGCTGAGCGTCACAAAAATCACTCCGCCAGCGCCACTATCAAGCGCCTCTTGGGTACATAAAACTGGCTCAACCGGTGGATTTGGCAGCTATGTAGCCTTCATTCCTCAACAGGATCTCGGCATCGTGATGCTGGCTAACAAAAATTATCCTAATCCTGTGCGGGTTGAGGCGGCTTATCGCATTCTTGAAGCGTTACAGAAGTAA
betalactams
Class C betalactamases
Drugs
1
MEG_8417|Drugs|betalactams|Class_D_betalactamases|OXA
ATGAAACTTTTTTTTTGTTTCGCGCTTTTGATTTTAATCTCCGTAAAGGCTTTTGGACAGATCGATCTCCAGAGGCCTTTTCAAGATTGCGCGTTAGAGGGAAGCATCACCGTCTTTGATTACAAAAACAAAAAATGGACGTTCAGCGACCGGAGCGACGCGCGGCGCGAGACGCTGCCGGCTTCGACCTTTAAGGTCATCAATTCGCTGATCGCGCTCGAAACAGGCGCGGTCGAAGACGAAAAAGAGGTTTTCAAATGGGACGGCCGGCGGCGCGAGGTCGATGCGTGGAACGCCGACACCGATATGGAAAACGCTTTTCGAAATTCGACCGTCTGGTTTTATGAAGAATTGGCGAAACGCGCCGGCAAGGAAAAATACCGCGAGATTCTCAAAAAAAGCCGTTACGGAAACGGGAAAATCGACGGCGGCGAGGGCGTTAATTTCTGGGTTACCGGAGAGTTCGGCGTCACGCCGGAAAATCAGATAAAATTTTTGAAGGCGTTCTACGAAGAACGGCTTCCCTTTTCGCGCCGGAGTTTCGAGATCGTCAAACGCATCATGCTCGAAGAAAAAGCGGATAAATACACATTGCGCGCGAAAACCGGCTGGACGCGTTTCGGCGGAAAGGATACGGGCTGGTGGATCGGCTACGTCGAACGCAGCGACAATACATACTTTTTCGCCACGCGCGTAACGAAACCGCGCGAGACGCAAAACCCGCGCTTCGGCGAATGCCGCAAACTGATTACGCGCGACGTTTTGCGGCAAATGAAAATCATCGAATAG
betalactams
Class D betalactamases
Drugs
1
MEG_8212|Drugs|betalactams|Class_C_betalactamases|LAQ
ATGAAAAAATCCCTTTGCGCCGTGCTGCTGCTCACCGCTTCATGCTCTGCGCTTGCCGCGCCTCAAACTGAAAAACAGATCGCTGATACCGTCAATCGCATCATGACCCCGCTCATGAAAGAACAGGCGATTCCGGGCATGGCCGTCGCCGTGATTTATCAAGGAAAGACGCACTATTTTGTCTACGGCAAAGCAGATATCGCCGCGAATCAGCCCGTCACTCAGCACACCTTGTTTGAGCTGGGCTCCGTGAGCAAAACCTTTACCGGCGTTCTGGGCGGCGAAGCCATCGCACGCGGTGAAATCAGGCTTGACGATCCCGCCAGCAAATACTGGCCTGCGCTGACGGGTAAACAATGGAAAGGCATTACTCTGCTGCATCTGGCTACTTACACCGCAGGCGGTTTGCCGCTGCAAGTGCCGGATGAGGTAACCGATCAGGCGGCGCTTCTGCATTTCTACCAAAACTGGCAACCGCAGTGGACGCCGGGCGCAAAACGCCTGTACGCCAACGCCAGTATCGGTTTATTCGGCATGCTGGCGGTCAAGCCATCAGGGATGGATTTTGAACAGGCAATGACCTCACGCGTGTTCCAGCCGCTGGAACTCAATCACACCTGGATTAACGTCCCGGCAGCAGAGGAGAAGCATTACGCCTGGGGCTATCGTGACGGTAAACCGGTGCACGTTTCGCCCGGCATGCTTGATGCGGAATCTTACGGCGTCAAAACGACCATTGAAGATATGGCGAGCTGGGTTCGGGCCAATATGAATCCTGCGGGCGTTAAAGATGAAATGCTTAAGCAAGGAATCGAACTGGCACAGTCACGTTACTGGCGTATCGGGGAGATGTATCAGGGCTTAGGCTGGGAAATGCTGAACTGGCCGGTGAAAGCAAAAACCGTCGTCGACGGCAGCGATAACAAAATCGCACTGGCATCGCTGACGGCCGTCGAAGTGAATCCTCCCGCGCCCGCAGTTAAAGCCTCGTGGGTGCACAAGACGGGTTCAACCGGCGGATTTGGGAGCTACGTCGCCTTTATTCCTGAAAAGAACATCGGCATCGTGATGCTGGCGAATAAAAGCTATCCTAACCCTGCGCGTGTCGATGCGGCGTATCGTATCCTGGACACGTTGAAATAA
betalactams
Class C betalactamases
Drugs
1
MEG_8160|Drugs|betalactams|Class_A_betalactamases|IMI
ATGTTATTTAATTCGAAGCCAAGTAGAATATCCATCCTGTTAAGCTCTTTTTTGATTTCAATATCATTTTCCTCACAGGTCAATGCAAGTGGCATTGATGAGATTAAGAAACTTGAAACAGATTTCAATGGGAGGATTGGTGTGTATGCCTTAGATACCGGCTCTGGTAAATCATTTTCATACAAAGCGAATGAACGATTTCCTCTGTGTAGTTCTTTCAAAGGTTTTTTGGCTGCTGCTGTATTAAAGGGCTCTCAAGATAACCAACTTAATATTAATCAGGTTGTAAATTACAATACAAGAAGTTTAGAATTCCATTCCCCCATTACAACTAAATATAAAGAAAATGGAATGTCTTTAGGTGATATGGCTGCTGCTGCATTACAATATAGCGACAACGCTGCTACTAATATTATCCTTGAACGTTATATTGGTGGCCCTGAGGGCATGACTAAATTCATGCGGTCGATTGGAGATAAAGATTTTAGACTTGATCGTTGGGAGTTAGATCTTAACACAGCTATTCCTGGCGATGAACGTGACACATCCACACCCGCAGCAGTTGCTAAAAGTTTAAAAAACCTTGCTCTAGGTAATATACTTAACGACCATGAAAAGGAAATCTATCAGACATGGTTAAAGGGTAACACAACTGGCGCAGCGCGTATTCGTGCTAGCGTGCCAAACGATTGGGTAGTTGGCGATAAAACCGGTAGTTGCGGAGCATACGGTACGGCAAATGATTATGCTGTAGTCTGGCCAAAGAACAGGGCTCCTCTTATCATTTCTGTGTACACTACAAAAAATGAAAAAGAAGCCAAGCATAACGATAAGTTAATTGCAGAAACTTCAAGAATTGCAATTAAAAACCTTAAGTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8274|Drugs|Aminoglycosides|16S_rRNA_methyltransferases|NPMB
ATGGTAAAGCAGATCCGCGGCAGCACCATCTGGCAACTAACGCGTGAAGAATTAGAGGAATGTATCAGCACGTATCGAGAGGTCGCTATCGACCTAGGTACGGGCGATGGGCGTTTTGTTTTGGACCTGGCCAAACTGGAAGCGGATACGTTCGTCATCGGAATAGATGCGAACGCGAAGCCGCTCGAAAAGCCCTCGGTCAAGATCACGCGAAAACCTGCCAAAGGCGGACTTCCGAACGCTCTCTTTGTTCAGGCCGCCGCTGAGGATCTTCCGAGTGAACTCGCCTCGGTTGCTGATAGTGTTACGGTCAATCTACCTTGGGGCAGCTTGCTCCGGGCGGTTCTTCTGCCCGATTCGGAAGTTCTTCGTGGTATTCGCCGGCTGGTAAAGCCCGGCGGCGAACTTGAGGTCGTGACCGCGATCGATCCGGTTCGCGATCTTCAGGAACTTGCCCGGCTCGGACTTTCACAGTTGACCGAGCAGCACTTCGAGACGGATCTCGTTCAGGCTTATCGAAACGCCGGATTAGAGAGGGGTAAAAACACTGGTTTCGCAAAGGCTGGTGCGCTTCCTATAGAGACGACCTGGGGCAAGCGTCTTTCCCGATCATCGGAGCGTTCGGTTCGCCGGCTAAGGTTCACCGCGGTATGA
Aminoglycosides
16S rRNA methyltransferases
Drugs
1
MEG_8424|Drugs|betalactams|Class_D_betalactamases|OXA
ATGCCGAAAAAATTAAAATTACTCGTTCTATCTGTAGTTGTGATGCCCTCAATAATATTATTGGGCTGCCAAAATATTCAGCCACACGTTCAAGCTTTAGTCACACAGAAACAGACTGAAGATCAGATCGCAACTGCATTTGAAAATATCCAGACCTCCGGTGTACTGGTCACTTATGATGGCAAAACTATTCAAACATATGGCAATGCGCTTAACCGGGCCGATCAGCGCTATATTCCGGCTTCTACTTTTAAAATGCTGAATGCTTTGATTGGTATCCAGCATCATAAGACTTCACCGAATGAAGTATTTAAATGGGATGGACAGAAGCGGGCTTTTACCAGCTGGGAAAAAGACTTAACCCTGGCAGAAGCCATGCAGGCTTCGGCTGTACCTGTGTATCAGGAACTGGCGCGCCGTATCGGTCTGGAATTAATGGCCAGTGAAGTAAAACGGGTCGGGTATGGCAATCAGTCGATTGGAACGCAAGTGGATAATTTCTGGTTAGTGGGACCTTTAGAAATTACCCCTGTTGAGGAAGTAAAATTTGCCTATGCCTTGGCGAAAAAACAACTTGCATTTGACTCATCAACCCAGCAACAAGTTAAAGATATGTTGCTGATTGAAGATATTCAGGGCACCAAAATCTATGCCAAAAGCGGATGGGGCATGGATGTAAATCCTCAGGTGGGATGGTGGACAGGTTGGGTAGAACAACCCAATGGACAGGTCACTGCATTTTCACTGAATATGGAAATGAAAAAGGCAGCACATGCAGAAGCACGTAAAGCCATTGTTTATCAGGCCCTGCAACAGCTCGGTTTAATTGGGCAATAA
betalactams
Class D betalactamases
Drugs
1
MEG_8425|Drugs|betalactams|Class_D_betalactamases|OXA
ATGTATAAAAAAGTCCTTGTCGTTGCGACAGCTACTCTATTTTTATCTGCCTGCTCCTCTAACACGGTAAAACAACATCAAATACATTCTATTTCCGCCAATAAAAATTCAGAAGAAATTAAATATCTGTTTGATCAGGCACAGACCACAGGAGTTTTAGTGATTAAGCGTGGGCAAACCGAAGAAATTTATGGCAATGATCTTAAAAGAGCATCAACCGCTTATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTAATTGGACTTGAACATCATAAGGCAACTACAACTGAAGTATTTAAATGGGATGGGCAAAAACGTTTATTTCCTGATTGGGAAAAGGACATGACACTGGGCGATGCCATGAAAGCTTCTGCGATTCCAGTTTACCAAGAATTAGCCCGACGAATTGGTCTAGATCTTATGTCTAAAGAGGTGAAACGAATTGGTTTTGGTAATGCTAACATTGGTTCAAAAGTAGATAATTTTTGGCTCGTTGGCCCTCTAAAAATTACACCTCAACAAGAAACCCAATTTGCTTATCAATTAGCCCTTAAAACGCTTCCATTTAGCCAAGATGTACAAGAACAAGTTCAATCAATGGTGTTCATAGAGGAAAAAAATGGAAGTAAAATTTATGCCAAAAGTGGTTGGGGGTGGGATGTTGAACCACAAGTTGGCTGGTTAACCGGTTGGGTCATTCAACCACAAGGAGAAATTGTGGCATTCTCGCTCAATTTAGAAATGAAAAAAGGAATTCCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAACAACTCGGTGTTTTATAA
betalactams
Class D betalactamases
Drugs
1
MEG_8426|Drugs|betalactams|Class_D_betalactamases|OXA
ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGAACAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATAGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGTATGGGCAAAAGCGTTTATTTCCCGATTGGGAAAAAGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGTACGGTTTGCTTATAAATTAGCCAACAAAACTCTTCCCTTTAGCAAAAATGTACAAGAACAAGTTCAATCTATGCTGTTCATTGAAGAAAAAAATGGACGAAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGATCCTCAAGTGGGTTGGTTTACAGGCTGGATCGTTCAACCTCAGGGAGAAATTATAGCTTTCTCACTTAATTTAGAAATGAAGAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAGCAGCTAGGTATTTTATAG
betalactams
Class D betalactamases
Drugs
1
MEG_8427|Drugs|betalactams|Class_D_betalactamases|OXA
ATGAAAACTCTTATTTTGTTGCCTTTACTTAGTTGCTTGAGCCTGACAGCCTGTAGCTTGCCTGTTTCAAATTCGTCCTCTCAAATCACTTCAACTCAATCTATTCAAACCATTGCCAAATTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGCCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATATTCCTGCTTCAACCTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGCATTCGATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTAGTCGGACCTTTGAAAGTTACTCCAAAACAGGAAGTCAAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTGTTACAGGAGCGACAAGCTTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGGGCTTTATCCGAAAGCTGAAGGGTAA
betalactams
Class D betalactamases
Drugs
1
MEG_8428|Drugs|betalactams|Class_D_betalactamases|OXA
ATGTCTAAAAAATTAAAATTACTCGCGCTATGTGCAACTGTAATCTCAGCTGCAACACTGGTCGGTTGTCAAAATATTCAGTCCCAAGCTCAACCTCTAGTCTTAAAGAAACAGACGCAGGATCAGATCGCAACTGCATTCGAAAATATCCAGACAACTGGTGTATTGGTCACCTATGATGGCAAAAAATTTCAAAAATATGGCAATGATCTCAGCCGTGCAGATCAGCGTTACATTCCTGCCTCAACTTTTAAAATGCTCAATGCCTTGATTGGTATACAGCACCATAAAACCTCACCTAATGAAGTGTTTAAATGGGATGGACAGAAGCGGGCTTTTCGTAGCTGGGAGAAGGACTTAACGCTTGCTGAGGCAATGCAGGCTTCGGCTGTACCTGTCTATCAGGAGTTGGCGCGCCGTATCGGTCTAGAATTAATGGCAAGTGAAGTAAAGCGGGTTGGCTACGGTAATCAAAATATAGGGACGCAAGTTGATAATTTTTGGTTGGTGGGGCCTTTGGAGATTACGCCAGTTGAGGAAGTGAAATTTGCTTATGCCTTAGCCAAACAGCAACTTCCATTTGATCCCTCAACACAGCAGCAAGTCAGAGATATGTTGTTGATCGAAAATGTTCAGGGAACCAGAATCTATGCCAAAAGCGGTTGGGGAATGGATGTAAATCCTCAAGTCGGACGGTGGACAGGTTGGGTCGAACAACCAAATGGTCAAGTCACTGCATTTTCGCTGAATATGGAAATGAAAAAAGCAGAACATGCGGATGCGCGTAAAGCGATTGTTTATCAAGCTTTACAACAGTTAGGTTTATTACCTCAATAA
betalactams
Class D betalactamases
Drugs
1
MEG_8429|Drugs|betalactams|Class_D_betalactamases|OXA
ATGCCGAAAAAATTAAAATTACTCGCTCTATCTGTAGTTGTGATGCCCTCAATAATATTATTGGGCTGCCAAAATATTCAGCCACACGTTCAAACTTTAGTCGCGCAGAAACAGACTGAAGATCAGATCGCAACTGCATTTGAAAATATCCAGACCTCCGGTGTACTGGTTACCTATGATGGCAAAGCTATTCAAAAATATGGCAATGCGCTTAATCGGGCCGATCAGCGCTATATTCCTGCTTCCACCTTTAAAATGTTGAATGCCTTGATTGGTATCCAGCATCATAAGACTTCACCGAATGAAGTATTTAAATGGGATGGACAGAAGCGGGCATTTACCAGCTGGGAAAAAGACTTAACCCTGGCAGAAGCCATGCAGGCTTCGGCTGTACCTGTGTATCAGGAACTGGCGCGCCGTATCGGTCTGGAATTAATGGCCAGTGAAGTAAAACGGGTCGGGTATGGCAATCAGTCGATTGGAACGCAAGTGGATAATTTCTGGTTAGTGGGACCTTTAGAAATTACCCCTGTGGAGGAAGTAAAATTTGCCTATGCCTTGGCGAAAAAACAACTTGCATTTGACTCATCAACCCAGCAACAAGTTAAAGATATGTTGCTGATTGAAGATATTCAGGGCACCAAAATCTATGCCAAAAGTGGATGGGGCATGGATGTAAATCCTCAGGTGGGATGGTGGACAGGTTGGGTAGAACAACCCAATGGTCAGGTCACTGCATTTTCACTGAATATGGAAATGAAAAAGGCAGCACATGCAGAAGCACGTAAAGCTATTGTGTATCAGGCTTTACAACAACTGGGTCTATTGCCCCAATAA
betalactams
Class D betalactamases
Drugs
1
MEG_8432|Drugs|betalactams|Class_D_betalactamases|OXA
ATGAAAAAATTTGTACTCCCTTTACTTAGTATTTCAATTTTATTGTCTTTGACTGCATGCTCATCAGTTCAAACTACATTTCAAAATGTTTCATTGGTTTCAAATGAAAAAAATAAAGAGGCTATCAAAGGTTACTTTGATGAGGCCCAAACTCAAGGTGTAATTGTTATTAAGGATAATGAACACGTTGCTATGTATGGAAATAGTTTAACACGAGCACATACACAATATGTTCCAGCATCAACATTTAAAATTTTGAATGCTTTAATTGGATTAGAGAATAATAAAGTAACCACAGATGAGATGTTTAAGTGGGATGGTAACAAAAAAGCTTTCTCAATTTGGGAAAAAGATATGAACCTAGGGGAGGCAATGAAATTATCTGCAGTTCCTGTATATCAAGAGCTTGCAAGTCGTATTGGTTTAGATTTAATGCAGAAAGAAGTAAAACGGGTTAATTTTGGTAATGCTAATATTGGAACTCAAGTCGATAATTTTTGGTTAGTTGGTCCTTTGAAGATTTCACCTATACAAGAGGTTAAATTTGCTGATGATCTTGCACATAACAAATTACCATTCAAAATAGAGACACAAGAAACAGTTAAAAATATGCTTCTAATTAAAGAAATTAATGGAAGTAAAATTTATGCCAAAAGTGGTTGGGGGATGGACGTTAAACCTCAAGTAGGTTGGTTAACTGGTTGGGTGGAACAGCCTACAGGGAAGATAATTTCATTTTCATTAAATTTAGAAATGAAAAAAAATATGGCAGGTTCTATCCGTAATGAAATTACTTATAAAACATTAGCGAATCTTGGGATCATTTAA
betalactams
Class D betalactamases
Drugs
1
MEG_8433|Drugs|betalactams|Class_D_betalactamases|OXA
ATGTATAAAAAAGTCCTTGTCGTTGCAACAGCTACTCTATTTTTATCTGCCTGCTCTTCTAATACGGTAAAACAACACCAAATACACTCTATTTCCGCCAATAAAAATTCACAAGAAATTAAATCTCTGTTTGATCAGGCACACACCACGGGAGTTTTAGTGATTAAGCGTGGGCAGACCGAAGAAATTTTTGGCAATGATCTTAAAAGAGCATCAACAGAATATGTTCCCGCCTCTACATTTAAAATGCTAAATGCTTTAATTGGACTTGAACATCATAAAGCAACGACAGCTGAAGTATTTAAATGGGACCGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTTTAGGCGATGCAATGAAAGCTTCTGCTATTCCAGTTTATCAAGAACTAGCCCGAAGAATTGGACTTGATCTTATGGCTAAAGAGGTAAAACGTATTGGTTTCGGTAATGCGGACATTGGTTCAAAAGTAGATAATTTTTGGCTTGTCGGCCCACTTAAAATTACACCTGAACAAGAAACCCAATTTGCTTATGAATTAGCTAATAAAACTCTTCCATTTAGTAAAAATGTACAAGAACAAGTCCAATCAATGGTGTTCATAGAAGAAAAAAATGGACGTAAAATTTATGCTAAAAGTGGTTGGGGATGGGATGTTGAACCACAAGTTGGCTGGTTAACAGGCTGGGTCGTTCAACCGCAAGGAGAAATTGTGGCATTCTCGCTCAATTTAGAAATGAAAAAAGGAATTCCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAACAACTCGGTGTTTTATAA
betalactams
Class D betalactamases
Drugs
1
MEG_8434|Drugs|betalactams|Class_D_betalactamases|OXA
ATGTCCCGCATTCTGTTGTCCGGCCTGCTTGCCGCCGGCCTCTTCTGTGCCTTGCCCGCCAGCGCCACCACGGGTTGCCTGCTGTTTGCCGATGGCAGCGGCAAACCCCTCAGCGCCCAGGGTGACTGCGCCAGCCAGCTGACGCCTGCCTCCACCTTCAAGATCCCACTCGCGCTGATGGGCTATGAGAGCGGCTTCCTGGTGGATGAACAGTTGCCCGCCCTGCCATTCAAAGCCGGTGACCCTGACTTCCTGCCGGAGTGGAAGCAGACCACCACCCCGAGCAACTGGATGAAATTCTCGGTGATCTGGTATTCCCAACGCCTCACCGAATGGCTGGGAGAGGCGCGCTTCCAGCAGTACGTCGACCGCTTCGACTACGGCAACCGGGAGCTCTCGGGCAACCCGGGCAAGCACGACGGTCTGACCCAGGCCTGGCTCAGCTCCAGCCTCGCCATCAGCCCCCAGGAACAGGCCCGCTTCCTCGGCAAGCTGGTGAGCGGCAAGCTGCCGGTCTCCGCCGAGGCGGTGCGCCGCACCAGCACGCTGCTGCGTCAGCCCGACATCGATGGCTGGCAGATCCACGGCAAGACCGGCATGGGCTACCCCAAGCTGCTGGATGGCAGCCTCAACCGGGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAGCAGGACAAGAAGCTCATCTTCGTGCACACAGTGGTGCAAAAACCCGGCAAGCAGTTCGCGTCCCTCAGGGCAAAGGAAGAGGTGTTTGCCGCCTTGCCAACAGAGCTGAAGAAACTCTGA
betalactams
Class D betalactamases
Drugs
1
MEG_8208|Drugs|betalactams|Class_A_betalactamases|KPC
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8209|Drugs|betalactams|Class_A_betalactamases|KPC
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
betalactams
Class A betalactamases
Drugs
1
MEG_8210|Drugs|betalactams|Class_A_betalactamases|KPC
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
betalactams
Class A betalactamases
Drugs
1